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Muscle mitochondrial function and N+/K+ -ATPase activity are
unaffected by sepsis in pigs
M Von Seth, L Hillered, A Otterbeck, K Hanslin, A Larsson, J Sjölin,
M Lipcsey
Uppsala University, Uppsala, Sweden
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Introduction
Imbalance in cellular energetics has been suggested to be an import-
ant mechanism for organ failure in sepsis and septic shock. We
hypothesized that such energy imbalance would either be caused by
metabolic changes leading to decreased energy production or by
increased energy consumption. Thus, we set out to investigate if
mitochondrial dysfunction or decreased energy consumption alters
cellular metabolism in muscle tissue in experimental sepsis.
Methods
We submitted anesthetized piglets to sepsis (n = 12) or placebo (n =
4) and monitored them for 3 hours. Plasma lactate and markers of
organ failure were measured hourly, as was muscle metabolism by
microdialysis. Energy consumption was intervened locally by infusing
ouabain through one microdialysis catheter to block major energy
expenditure of the cells, by inhibiting the major energy consuming
enzyme, N+/K + -ATPase. Similarly, energy production was blocked
infusing sodium cyanide (NaCN), in a different region, to block the
cytochrome oxidase in muscle tissue mitochondria.
Results
All animals submitted to sepsis fulfilled sepsis criteria as defined in
Sepsis-3, whereas no animals in the placebo group did. Muscle glucose
decreased during sepsis independently of N+/K + -ATPase or cyto-
chrome oxidase blockade. Muscle lactate did not increase during sepsis
in naïve metabolism. However, during cytochrome oxidase blockade,
there was an increase in muscle lactate that was further accentuated
during sepsis. Muscle pyruvate did not decrease during sepsis in naïve
metabolism. During cytochrome oxidase blockade, there was a de-
crease in muscle pyruvate, independently of sepsis. Lactate to pyruvate
ratio increased during sepsis and was further accentuated during cyto-
chrome oxidase blockade. Muscle glycerol increased during sepsis and
decreased slightly without sepsis regardless of N+/K + -ATPase or cyto-
chrome oxidase blocking. There were no significant changes in muscle
glutamate or urea during sepsis in absence/presence of N+/K + -ATPase
or cytochrome oxidase blockade.
Conclusions
These results indicate increased metabolism of energy substrates in
muscle tissue in experimental sepsis. Our results do not indicate
presence of energy depletion or mitochondrial dysfunction in muscle
and should similar physiologic situation be present in other tissues,
other mechanisms of organ failure must be considered.© The Author(s). 2017 Open Access This artic
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Pilot study showing reduced bone strength at 96 hours in rodent
sepsis
ME Cove1, NS Chew2, LH Vu2, RZ Lim2, Z Puthucheary3
1National University Hospital, Singapore, Singapore; 2Yong Loo Lin
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Introduction
Bone mineral density (BMD) is reduced in critical care survivors [1], and
long-term follow up has shown increased fracture risk [2]. It is unclear if
these changes are a consequence of acute critical illness, or reduced ac-
tivity afterwards. Bone health assessment during critical illness is challen-
ging, and direct bone strength measurement is not possible. We used a
rodent sepsis model to test the hypothesis that critical illness causes early
reduction in bone strength and changes in bone architecture.
Methods
20 Sprague-Dawley rats (350 ± 15.8g) were anesthetised and rando-
mised to receive cecal ligation and puncture (CLP) (50% cecum
length, 18G needle single pass through anterior and posterior walls)
or sham surgery (cecum mobilised, no CLP), and then returned to
their cages. 10 rodents (5 CLP, 5 sham) were sacrificed at 24 hours,
and the remaining 10 at 96 hours. Femur bones were harvested and
bone strength testing was conducted using the Instron 5543 (Instron
Corp, USA). Trabecular bone strength was measured using a femoral
neck break and cortical bone strength tested using a femoral shaft 3-
point bending test. Bone architecture was assessed using micro-
computerised tomography (microCT) imaging (PerkinElmer, USA),
and images analysed with BoneJ [3].
Results
All 20 rats survived to the end of the protocol. The load required to
fracture the femoral neck and shaft was not significantly different for
CLP and sham groups at 24 hours (97 ± 19N vs 81 ± 10N p = 0.12 and
127 ± 8N vs 119 ± 18N p = 0.35, respectively). However, at 96 hours
there was a significant reduction in the fracture force at both the fem-
oral neck and shaft in the CLP group, compared to sham (75 ± 11N vs
97 ± 13N p = 0.02 and 102 ± 20N vs 139.9 ± 28N p = 0.04). In contrast,
there were no bone architecture differences, as measured by bone vol-
ume/total volume, trabecular thickness/separation, connectivity density,
anisotropy and BMD (all p > 0.20) using microCT at 24 or 96 hours.
Conclusions
In this rodent model of sepsis, there is a significant reduction in tra-
becular and cortical bone strength at 96 hours. In the absence of
changes in bone architecture, these findings suggest sepsis may in-
duce early biochemical changes affecting bone strength. We plan
further rodent experiments to confirm these results, increase our
power, assess nano-mechanics and complete a histological analysis.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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Endotoxin clearance by the spleen is unaffected by pre-existing
systemic inflammation in porcine septic shock
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Critical Care 2017, 21(Suppl 1):P351
Introduction
As part of the mononuclear phagocytic system, the spleen partici-
pates in bacterial and endotoxin clearance. In our previous study we
saw decreased endotoxin clearance by the liver in pigs with pre-
existing systemic inflammatory response (SIR). We therefore hypothe-
sized that immunosuppression induced by SIR may also lead to
decreased trans-splenic endotoxin clearance, and set out to investi-
gate this in a porcine model of sepsis.
Methods
15 anesthetized pigs received an [i]E. coli[/i] infusion intravenously
(i.v.) for 3 hours (h). In group Pre-existing SIR (n = 6), SIR was induced
by 24 h of i.v. endotoxin infusion prior to the [i]E. coli[/i] infusion.
Group Non-Pre-existing SIR (n = 6) received the bacterial infusion
without prior endotoxin exposure. To study the effects of 24 h of
anesthesia alone, “Controls” (n = 3) received saline instead of endo-
toxin for 24 h prior to the bacterial infusion (not included in the pri-
mary analysis). The kinetic chromogenic LAL-test was used to analyze
endotoxin in arterial and splenic venous blood samples.
Results
All animals receiving endotoxin developed SIR prior to the [i]E. coli[/i]
infusion. The amounts of [i]E. coli[/i] given to the groups were com-
parable. Endotoxin levels were similar at 3 h, just before the end of
the [i]E. coli[/i] infusion, in the Pre-existing SIR and Non-Pre-existing
SIR groups in arterial (Fig. 1) and splenic venous blood (2.40 (1.94-
2.60) vs. 2.81 EU/mL (2.73-2.91) median (IQR)). Furthermore, endo-
toxin levels at 4 h, one hour after completed [i]E. coli[/i] infusion,
were lower in Pre-existing SIR vs. Non-Pre-existing SIR group both in
arterial (Fig. 1) and splenic venous blood (0.38 (0.31-0.42) vs. 0.51 EU/mL
(0.47-0.71); p < 0.05). There was no difference in the ratio of splenic
venous to arterial endotoxin levels between Pre-existing SIR and Non-
Pre-existing SIR groups.
Conclusions
In our model, the endotoxin clearance by the spleen is not affected by
pre-existing inflammatory response in porcine [i]E. coli[/i] septic shock.Fig. 1 (abstract P351). See text for descriptionP352
The role of autophagy in critical illness-induced organ failure
I Derese, S Thiessen, S Derde, T Dufour, L Pauwels, Y Bekhuis,
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Introduction
Increasing evidence implicates mitochondrial dysfunction and endo-
plasmic reticulum (ER) stress, which activates the unfolded protein
response (UPR), as contributors to critical illness-induced organ
failure. Both can be alleviated by autophagy, a cellular defense mech-
anism. However, a phenotype of insufficiently activated autophagy
has been observed during critical illness. We hypothesized that insuf-
ficient hepatic autophagy during critical illness aggravates liver dam-
age/failure, hallmarked by mitochondrial dysfunction and ER stress.
Methods
In a centrally catheterized mouse model of critical illness, induced by
cecal ligation and puncture, the effect of genetic inactivation of hep-
atic autophagy (via inducible deletion of autophagy gene 7 in liver)
on survival, markers of organ damage, apoptosis, UPR and mitochon-
drial content and function was evaluated in the acute (30 hrs) and
prolonged (3 days) phase. For each time point, 2 groups of critically
ill mice and 2 groups of healthy pair-fed mice were included (at least
10 surviving mice per group), where each time autophagy was inacti-
vated in one group but not in the other.
Results
Hepatic autophagy deficiency during critical illness did not affect sur-
vival, but increased hepatic damage/dysfunction. In the acute phase,
this was illustrated by higher plasma ALT (P = 0.0001), and by ele-
vated markers of apoptosis (P = 0.001) and more mitochondrial dys-
function (Complex V activity, P = 0.02) in liver. In the prolonged
phase, hepatic autophagy inactivation increased apoptosis (P = 0.01)
and aggravated mitochondrial dysfunction (Complex V activity, P =
0.005) in liver. Autophagy deficiency did not affect mitochondrial
DNA content (day 1 P = 0.98, day 3 P = 0.57). Autophagy deficiency
time-dependently modulated several branches of the UPR in liver.
On day 1, it decreased activation of the IRE1alpha-XBP1s (P = 0.003)
and ATF6-CREB3L3 pathway (P = 0.003), coinciding with a diminished
inflammatory response as shown by lower C-reactive protein
gene expression (P = 0.006), but did not affect the p-eIF2alpha
pathway (P = 0.26). At day 3, autophagy deficiency increased the
activation of the p-eIF2alpha pathway (P = 0.03), but not the
IRE1alpha-XBP1s (P = 0.37) or ATF6-CREB3L3 (P = 0.14) pathway.
Conclusions
Insufficient hepatic autophagy during critical illness aggravates liver
damage, coinciding with more mitochondrial dysfunction and a
time-dependent modulation of the UPR, hereby likely aggravating
liver failure.P353
Role of leptin and proprotein convertase subtilisin/kexin type 9 in
modulating pulmonary inflammation in a murine model of early
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Introduction
Obesity increases the risk of sepsis but how obesity shapes the
immune responses to infection is unknown. Similar to patients, we
previously demonstrated that Western diet fed obese mice have re-
duced lung inflammation during early sepsis. In this study we explore
the potential mechanisms to explain this finding. Proprotein Conver-
tase Subtilisin/Kexin Type 9 (PCSK9) is a protein involved in choles-
terol homeostasis that is implicated in sepsis survival. Leptin is a
hormone produced by adipocytes that regulates energy homeostasis
and is increased in obesity and sepsis. We hypothesized that either
Critical Care 2017, 21(Suppl 1):58 Page 3 of 70PCSK9 and/or leptin contributes to the obesity-associated lung pro-
tection in sepsis.
Methods
PCSK9 deficient, PCSK9 overexpressing and wild type mice on a C57/
Bl6 background were fed either a high fat Western diet (WD) or a
normal chow diet (NCD) for 15 weeks (n = 5/group). Sepsis was in-
duced by cecal ligation and puncture (CLP). Tissues were harvested
six hours post surgery. For the leptin studies mice were housed in
static cages for 10-12 weeks. Mice were injected with recombinant
leptin protein (1mg/kg)) one hour prior to CLP, then re-anesthetized
and tissues collected at 6 hours. All mice were resuscitated with 2ml
of lactated Ringers SQ pre surgery, and 1ml IV post surgery. Lung in-
jury was assessed by myeloperoxidase (MPO in U/mg of tissue) assay
of lung tissues and histopathology scores. Data are expressed as
mean ± SEM and analyzed using ANOVA or t-test.
Results
Septic PCSK9 over expressing mice fed NCD had greater lung MPO
levels (46.5 ± 4.5) compared to PCSK9 deficient mice (31.1 ± 1.7) on
NCD (p < 0.01). In mice fed the WD for 15 wks the protection from
the loss of PCSK9 was no longer present, however the injury was re-
duced. Septic PCSK9 deficient (14.4 ± 1.4), wildtype (17.6 ± 0.9) and
overexpressing (17.9 ± 1.0) mice on WD had no significant differences
in lung MPO levels. This correlated with histopathology scores for
PCSK9 deficient (0.7 ± 0.2), wildtype (1.1 ± 0.2) and PCSK9 overex-
pressing (1.3 ± 0.7) septic mice. We found that leptin treated septic
mice had lower lung MPO (32.6 ± 1.6) levels compared to saline
treated septic mice (46.6 ± 3.5) (p < 0.001). Sham operated mice had
significantly lower MPO levels (12.7 ± 1.7 for leptin and 11.8 ± 1.2 for
saline) compared to septic counterparts.
Conclusions
Our data suggests that both lack of PCSK9 and increases in leptin
contribute to the lung protection in early sepsis. However, when ex-
posed to a WD the potential benefits of PCSK9 deficiency to further
reduce lung injury are no longer evident. These findings have impli-
cations for potential therapeutic strategies to reduce sepsis-induced
lung injury.
P354
The role of oxygen delivery on plasma lactate and organ failure in
experimental septic shock
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Introduction
The concept resuscitation of patients with septic shock, aiming at
normalization of oxygen delivery (DO2), to limit tissue dysoxia and
organ failure has not been confirmed in recent trials. Elevated plasma
lactate in septic shock is considered as a key marker of inadequate
DO2. We hypothesized that, apart from severely decreased levels,
DO2 is not associated to plasma lactate in a model of septic shock.
Methods
We investigated the effects of circulatory shock and inflammation on
plasma lactate in a retrospective analysis of 105 anesthetized endo-
toxemic (N = 61) or bacteremic (N = 44) piglets in shock. Tumor Ne-
crosis Factor alpha (TNF-α) and Interleukin-6 (IL-6) were measured
hourly during 6 hours (h) of shock. Muscle metabolism was moni-
tored by microdialysis. The animals were stratified per degree of
shock by DO2. The primary analysis was the breakpoint of insufficient
DO2 to yield an elevated plasma lactate. ANOVA and regression
models were used.
Results
All animals developed macrocirculatory shock, elevated plasma and
muscle lactate levels, elevated levels of cytokines in plasma, as well
as renal and pulmonary failure. At 3 h, DO2 was 289 ± 68 mL x min-1
x m-2 (mean ± SD) and plasma lactate levels were 2.7 (2.0-3.6) mmol
x L-1 (median(IQR)). Mixed venous saturation (SvO2) decreased and
oxygen extraction increased linearly with DO2 (p > 0.001). Oxygen
consumption (VO2) was not DO2 dependent.
Plasma lactate increased at DO2 < 250 mL x min-1 x m-2 (p < 0.001).
Urinary output decreased at DO2 < 250 mL x min-1 x m-2 (p < 0.01),but static lung compliance was not DO2-dependent. Muscle glucose,
lactate and pyruvate, urea and glutamate were not DO2-dependent.
Muscle glycerol was DO2-dependent without breakpoint.
Plasma lactate correlated to Mean Arterial Blood Pressure (MAP), DO2
and peak IL-6, but not Systemic Vascular Resistance Index (SVRI) and
peak TNF-α.Urinary output correlated to DO2 and MAP. Static lung
compliance did not correlate to any parameters above.
Over time, muscle pyruvate increased and muscle glycerol and glu-
cose decreased but no changes in muscle lactate and glutamate
were seen. Muscle pyruvate correlated to MAP. Muscle glycerol corre-
lated to MAP and to TNF-α.
Conclusions
In porcine experimental sepsis, elevated plasma lactate was only
associated with very low DO2 while oxygen consumption was
unaffected by low DO2 despite development of organ failure. Tissue
metabolism was associated with both inflammatory and circulatory
changes. Our findings suggest that the current concepts of resuscita-
tion focusing on restoration of oxygen delivery must be combined
with measures to limit the inflammatory response.
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Introduction
We used a porcine sepsis model to investigate pulmonary hypoxia as
an explanation for lactate elevation in sepsis. We measured the pul-
monary lactate production and shunt fraction during bacteremia.
Sepsis is a condition characterized by severe organ failure as a result
of a dysregulated response to infection. Central in many patho-
physiological theories is the decreased delivery or utilization of oxy-
gen by tissues. Normal physiology dictates that hypoxia leads to
lactate production, a prognostic marker in sepsis. Thus, hypoxia has
been used as an explanation for both organ dysfunction and ele-
vated plasma (p-)lactate in sepsis. However, new research has im-
plied other mechanisms. Previous studies have reported increased
pulmonary lactate production in sepsis [1], the lungs being a gener-
ally well-oxygenated organ. However, these studies have not mea-
sured pulmonary shunt fraction and hence cannot estimate if the
entire lung is ventilated.
Methods
We used 13 anesthetized pigs where 9 were randomized to a sepsis
group and 4 were randomized to a sham group. All pigs received a
pulmonary artery catheter and an arterial line. Pigs in the sepsis
group were infused with live Escherichia coli for 3 hours (h) and in
the sham group with NaCl. Blood cultures were used to confirm
bacteremia. Blood gases, blood tests and physiological parameters
were collected hourly. Lactate production was calculated by the p-
lactate gradient from pulmonary artery to systemic artery and cardiac
index. Shunt fraction was estimated at 3 h after ventilation with
100% O2 for 5 minutes.
Results
Sepsis occurred in all pigs in the sepsis group, according to the criteria
from Sepsis-3, and in no pigs in the sham group (p = 0.03). Global oxy-
gen delivery (DO2) remained equal in both groups. Arterial lactate was
higher (p = 0.003) in the sepsis group after 1 hour with a median value
of 2.3 mmol/L vs. 0.95 mmol/L. Negative and positive lactate produc-
tion occurred over the lungs in both groups (Fig. 2). There was no dif-
ference in pulmonary lactate production or pulmonary shunt fraction
between groups. Neither group had significant shunt formation.
Conclusions
In this study we found a high p-lactate in septic pigs despite a high
DO2. In absence of pulmonary shunts, the lung was not a major
source, nor a major scavenger, of plasma lactate.
Reference
1. Garcia-Alvarez, M. et al. Sepsis-associated hyperlactatemia. Crit. Care Lond.
Engl. 18, 503 (2014).
Fig. 2 (abstract P355). See text for description
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Introduction
Systemic lactate clearance (LaCl) higher than 10% during the first hours
of sepsis resuscitation is associated with better outcomes, but the mech-
anisms are unclear. We aimed to investigate the relationship between
lactate clearance, inflammatory response, and mitochondrial respiration.
Methods
Original data from two previously published studies were re-analyzed
[1,2]. In cohort 1, pigs were randomized to be resuscitated for 48h
starting 6, 12 and 24h, respectively, after fecal peritonitis induction
(n = 8, each) [1]. Hemodynamics, inflammatory parameters, and mito-
chondrial function were analyzed. In cohort 2, 16 pigs with fecal peri-
tonitis were immediately resuscitated for 24h [2]. Regional lactate
exchange was measured. Animals of both groups were categorized
according to LaCl > =10% or <10% during 6h of resuscitation.
Results
Overall mortality was 20% (4/20) for animals with LaCl > =10% and
60% (12/20) for animals with LaCl > =10% (p = 0.022). In cohort 1, sys-
temic hemodynamics were similar in LaCl > =10% (n = 13) and LaCl <
10% (n = 11) groups. Plasma interleukin-6 levels were lower at study
end in LaCl > =10% [45 (37-204) vs. 166 (128-310; median, IQR), p =
0.047]. Complex 1 state 3 [586 (386-688) vs. 353 (242-483), p = 0.026]
and state 4 [157 (117-247) vs. 122 (89-151), p = 0.045], and Complex
2 state 3 [1156 (828-1401) vs. 761 (664-932), p = 0.041] and state 4
[376 (281-451) vs. 269 (225-326), p = 0.032] isolated brain but not
hepatic, myocardial or skeletal muscle mitochondrial respiration were
higher at study end in LaCl > =10% compared to LaCl < 10%. In co-
hort 2, mesenteric, total hepatic and renal blood flows were higher
at study end in LaCl > =10% (n = 7) vs. LaCl < 10% group (n = 9), des-
pite similar cardiac output. Hepatic lactate influx and uptake were
approximately 1.5 and 3 times, respectively, higher in LaCl > =10%
vs. LaCl < 10% (p = 0.066, both).
Conclusions
Systemic lactate clearance > =10% vs. <10% during early resuscita-
tion after abdominal sepsis was associated with lower plasma
interleukin-6, and higher brain mitochondrial respiration. Blood flow
redistribution to abdominal organs in animals with high systemic lac-
tate clearance increases the potential to deliver and extract lactate.
References
1. Correa TD et al. Effect of treatment delay on disease severity and need for
resuscitation in porcine fecal peritonitis. Crit Care Med 40:2841–9, 2012.2. Brandt S et al. Effect of fluid resuscitation on mortality and organ
function in experimental sepsis models. Crit Care 13:R186, 2009.
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Introduction
Endotoxin released during Gram-negative bacterial infections induces
the production of pro-inflammatory cytokines and may accentuate
the development of septic shock [1]. Gram-negative bacteria exposed
to â-lactam antibiotics in vitro release endotoxin but in a minor ex-
tent when the â-lactam antibiotic is combined with an aminoglyco-
side [2]. The primary purpose of the study was to investigate the
dynamics in endotoxin and interleukin-6 (IL-6) concentration as well
as leukocyte activation and subsequent organ dysfunction in a large
animal intensive care sepsis model in order to explore the relevance
of antibiotic-induced endotoxin liberation and inflammatory re-
sponse in vivo. Whether the addition of an aminoglycoside to a â-lac-
tam antibiotic results in a reduced endotoxin release and systemic
inflammation constituted a secondary aim.
Methods
A prospective placebo-controlled study was conducted on anesthe-
tized pigs in an intensive care setting. All pigs were administered
Escherichia coli as a 3h intravenous infusion. At 2h the animals were
subjected to antibiotic treatment (n = 18) receiving either cefuroxime
alone (n = 9) or the combination of cefuroxime and tobramycin (n = 9),
whereas controls received saline (n = 18). During 4h after administration
of antibiotics/saline, plasma endotoxin, IL-6, leukocytes and organ dys-
function variables were recorded hourly and differences to the values
before treatment were calculated.
Results
All animals developed sepsis. Antibiotic-treated animals demon-
strated a higher IL-6 response (p < 0.001), stronger leukocyte activa-
tion (p < 0.001) and more pronounced deterioration in pulmonary
static compliance (p < 0.01) over time in comparison with controls.
Animals treated with the combination demonstrated only a trend to-
wards less inflammation in comparison with animals treated with
cefuroxime alone. In plasma no differences in endotoxin concentra-
tion were observed between the groups.
Conclusions
Treatment with antibiotics elicits an inflammatory IL-6 response
which is associated with leukocyte activation and pulmonary organ
dysfunction, whereas no observable differences were seen in plasma
endotoxin concentration. The reduction in cefuroxime-induced endo-
toxin release after the addition of an aminoglycoside in vitro could
not be reproduced in vivo.
References
1. Bozza FA et al.: Crit Care 2007; 11: 1.
2. Goscinsky G et al.: Scand J Infect Dis 2003; 35: 40–6P358
Persisitent shift of th1 to th2 in one week after diagnosis of
community-acquired severe sepsis predicts mortality
M Xue, JY Xu, L Liu, YZ Huang, FM Guo, Y Yang, HB Qiu
Southeast University, Nanjing, China
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Introduction
Recent studies have revealed that inflammation mediated by CD4+ T
cells may contribute to the pathogenesis of sepsis. The role of the
Th(T helper)1/Th2 balance in sepsis remains largely unknown. The
Fig. 4 (abstract P358). Receiver operating characteristics (ROC)
curves comparing the ability of value of th2/th1 on Day0, Day3,
Day7 as well as change of th2/th1 in one week. D3-0, change of
th2/th1 between Day3 and Day0; D7-0, change of th2/th1 between
Day7 and Day0; D7-3, change of th2/th1 between Day7 and Day3.
Legend 2 : Figure 4. Receiver operating characteristic (ROC) curves of
value of th2/th1
Critical Care 2017, 21(Suppl 1):58 Page 5 of 70aim of this study was to investigate the th2/th1 pattern and its im-
pact on disease severity and outcomes in patients with new onset
community-acquired severe sepsis.
Methods
This was a prospective observational study. Patients with
community-acquired severe sepsis admitted to ICU within 24
hours were included. Blood sample was collected on day of
admission(Day0, D0), 3rd Day (D3) and 7th Day (D7) after
admission. Th2 and Th1 in lymphocyte were tested by flow cy-
tometry. The increase of th2/th1 (>0.22) indicated immunosup-
pression. According to the change of th2/th1, patients were
divided into 3 groups: immunosuppression recovered in early
stage (th2/th1 began to decrease on D3, Group 1), immunosup-
pression recovered in late stage (th2/th1 began to decrease on
D7, Group 2), immunosuppression worsened (th2/th1 kept in-
creasing in a week, Group 3). The organ dysfunction, hospital-
acquired infection(HAI) and 28-day prognosis was recorded. All
patients or their legal representatives provided written informed
consent. The study is registered with ClinicalTrials.gov, NCT
02883218.
Results
Seventy-four patients were eligible for study during Sept 18, 2014 to
Sept 30, 2016. There were 34 cases in Group 1, 19 cases in Group 2,
and 21 cases in Group 3. Baseline characteristics(age, sex, source of
bacteremia, presence of comorbidities) of the population in different
groups were similar.
(1) Compared with Group1(11.8%), Group3(52.4%) showed a signifi-
cantly higher 28-day mortality(P = 0.001), while group 2 showed a
higher 28-day mortality of 31.6% with no significant difference (Fig. 3).
(2) There were no significant differences in terms of incidence of HAI
and organ dysfunction among groups.
(3) The areas under the receiver operating characteristic (AUC) curves
of value of th2/th1 on D7 was of great value(0.875)(Fig. 4). Using a
th2/th1 on day7 cutoff value of >2.74 to determine 28-day mortality,
the sensitivity was 76.2% with 96.1% specificity.
Conclusions
Persisitent shift of th1 to th2 in one week after diagnosis of
community-acquired severe sepsis may be a predictor for immuno-
suppression. Patients with persistently increasing th2/th1 have poor
outcome.
References
[1] Leentjens J, Kox M, Rebecca M, et al. Reversal of immunoparalysis in
humans in vivo. Am J Respir Crit Care Med. 2012, 186: 838–845.
[2] Monneret G, Venet F, Pachot A et al. Monitoring immune dysfunctions in
the septic patient: a new skin for the old ceremony. Mol Med. 2008, 14:
64–78.
[3] Inoue S, Suzuki-Utsunomiya K, Okada Y, et al. Reduction of immunocom-
petent T cells followed by prolonged lymphopenia in severe sepsis in
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Genetic variants of intron region of aquaporin AQP5 gene and
development of pulmonary edema in lung infection complicated
by septic shock
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Introduction
Product of AQP5 gene belongs to a family of aquaporins (AQPs),
membrane proteins, responsible for the selective transmembrane
transport of water. However, the value of polymorphic variants AQP5
in the development and progression of pul_monary edema in severe
lung infection was studied so far. The aim of the investigation was to
determine the value of genetic variants of a single nucleotide poly-
morphic site rs3736309 of intron 3 of aquaporin_5 (AQP5) gene in
the course of critical illness in patients with documented pulmonary
infection.
Methods
Patients with critical illness admitted to the intensive care units were
examined during the course of treatment (n = 86, age 27 to 82 years,
mean age 53.20 ± 14.34 years). Main diagnosis included malignancies
(15%), peritonitis (16%) and necrotizing pancreatitis (37%). Patients
developed nosocomi_al pneumonia (55%), acute respiratory distress
syndrome (ARDS) (54%), septic shock (48%), ARDS combined with
septic shock (33%). DNA genotyping was carried out using tetra_
primer polymerase chain reaction (PCR). Statistical processing was
performed using GraphPad InStat program (GraphPad, USA).
Results
The distribution of frequencies of genotypes AA, GA and GG (AQP5,
rs3736309) in cohort of patients corresponded to Hardy_Weinberg
equilibrium (P = 0.923) and was similar to frequencies of the alleles de-
termined in healthy Caucasian individuals (literature data) (P > 0.05). In
a subgroup of patients with septic shock and AQP5 AA
(rs3736309) genotype the lower EVLWI values were found com-
pared to patients with geno_types GG and GA with septic shock
in spite of the same approach to treatment. Genetic variant
AQP5 G+ (rs3736309) contributed to the development of pulmon-
ary edema resistant to treatment (odds ratio, OR = 6,75; P = 0.032).
Only the subgroup of patients with septic shock and geno_type
G + (but not all patients or the subgroup of patients without
Fig. 5 (abstract P362). Effect of vasoprissin & noradrenaline
on second-hit LPS induced monocyte TNF release. n = 4,
**p < 0.01; ***p < 0.001
Critical Care 2017, 21(Suppl 1):58 Page 6 of 70septic shock of the same genotype) were char_acterized by
significantly elevated levels of surfactant protein SP_D in plasma com-
pared to patients of genotype AQP5 AA with septic shock (P < 0.05).
Conclusions
In septic shock, the presence of homozygous variant allele A (AA) of
AQP5 rs3736309 is a favor_able factor for patients developing the
pulmonary edema. The presence of allele AQP5 G (rs3736309) is a
risk fac_tor for developing severe pulmonary edema and unfavorable




Altered T cell repertoire diversity and increased PD-1 expression
predict mortality in patients with septic shock
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Introduction
Sepsis causes impairment of innate and adaptive immunity by
multiple mechanisms, including depletion of immune effector
cells and T cell exhaustion. Although lymphocyte dysfunction is
associated with increased mortality and potential reactivation of
latent viral infection in patients with septic shock, the relation
between viral reactivation and lymphocyte dysfunction is obscure.
The objectives of this study were 1) to determine the relation of
lymphocyte dysfunction to viral reactivation and mortality, and 2)
to evaluate recovery of lymphocyte function during septic shock,
including T cell receptor (TCR) diversity and the expression of
programmed death 1 (PD-1).
Methods
In 18 patients with septic shock and latent cytomegalovirus infection,
serial blood samples were obtained on days 1, 3, and 7 after the on-
set of shock, and immune cell subsets and receptor expression were
characterized by flow cytometry. TCR diversity of peripheral blood
mononuclear cells was analyzed by Multi-N-plex PCR, and cyto-
megalovirus DNA was quantified using a real-time PCR.
Results
Monocytes showed a decrease of TCR diversity and HLA-DR expres-
sion in the early stage of septic shock, while CD4+ T cells displayed
an increase of PD-1 expression. Normalization of TCR diversity and
PD-1 expression was observed by day 7, except in patients who died.
cytomegalovirus reactivation was detected in 3 of the 18 patients
during the first week of their ICU stay and all 3 patients died.
Conclusions
These changes are consistent with the early stage of immune cell ex-
haustion and indicate the importance of normal lymphocyte function
for recovery from septic shock. Ongoing lymphocyte dysfunction is
associated with cytomegalovirus reactivation and dissemination, as
well as with unfavorable outcomes.
P362
Vasopressin alone and with noradrenaline attenuates TNF-α
production in an in-vitro model of monocyte priming and
deactivation
R Davies, KP O´Dea, S Soni, JK Ward, DJ O´Callaghan, M Takata,
AC Gordon
Imperial College, London, United Kingdom
Critical Care 2017, 21(Suppl 1):P362
Introduction
Vasopressin is a safe and effective ‘catecholamine-sparing’ vasopres-
sor in septic shock [1]. It also has anti-inflammatory properties, in-
cluding inhibition of endotoxin-induced inflammatory cytokine
release from macrophages in-vitro [2]. To further assess vasopressin’s
anti-inflammatory effects in sepsis, we developed an in-vitro assay of
monocyte priming and deactivation to model the pro- and anti-
inflammatory responses, respectively.Methods
Healthy volunteer CD14+ monocytes were cultured at 37°C for 20hrs
with lipopolysaccharide (LPS, 100pg/ml) or IL-10 (10ng/ml), in com-
bination with noradrenaline (5000pg/ml) and ‘high’ (300pmol/L) or
‘low’ (100pmol/L) dose vasopressin. Monocytes were analysed for
HLA-DR and CD86 (T-cell co-stimulatory ligand) expression by flow
cytometry, or stimulated with a ‘second-hit’ of LPS (10ng/ml) and
TNF release measured by ELISA.
Results
Pre-treatment of monocytes with LPS resulted in a primed pheno-
type of higher HLA-DR expression and TNF release on stimulation,
whereas IL-10 reduced HLA-DR, CD86, and TNF release indicating a
deactivated phenotype. Under normal and priming conditions, co-
incubation with vasopressin alone or with noradrenaline significantly
reduced TNF release (Fig. 5), but not HLA-DR/CD86 expression. In
contrast, neither vasopressin nor noradrenaline affected the IL10-
induced deactivated phenotype.
Conclusions
The vasopressin-mediated suppression of TNF release in normal or
primed monocytes, but not in deactivated monocytes, suggests a se-
lective immune-modulatory activity that may be beneficial in septic
patients and warrants further investigation.
References
1. Gordon AC et al. JAMA.316:509–18,2016
2. Peng T-C et al. Tzu Chi Medical Journal.25:150–4,2013
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concentrations of pd-1/pd-l1 in sepsis – pilot study
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Introduction
Programmed death antigen (PD-1) and ligand (PD-L1) are inducible
negative regulators on leukocyte surface. The PD-1/PD-L1 pathway con-
tributes to lymphocyte exhaustion and immunosuppression in sepsis
[1]. A clinical trial is currently evaluating the safety of an anti-PD-L1 anti-
body in sepsis patients [2]. However, serum levels and differences in
PD-1/PD-L1 expression by B and T cell subsets are unknown and are
likely to influence the efficacy of this intervention. We tested the
hypothesis that surface PD-1/PD-L1 expression will differ in B and T cell
subsets, and that serum PD-1/PD-L1 levels will be high in sepsis.
Critical Care 2017, 21(Suppl 1):58 Page 7 of 70Methods
A prospective observational cohort study in 22 critically ill adult sep-
sis patients, excluding those with immune deficiency states, was
done with ethics approval and informed consent. Blood was taken
on ICU admission day and PBMCs isolated. Patients (11 survivors &
11 non-survivors) were compared with contemporaneously collected
and analysed samples from 11 healthy controls. Cell surface staining
was performed with antibodies to CD3, CD19 [BD Biosciences], CD4,
CD27, PD-1, PD-L1 and PD-L2 [Biolegend], and live dead stain
Amcyan [Invitrogen]. FACS analyses were performed on a
FACScalibur flow cytometer [BD Biosciences] and using Tree Star
FlowJo software. Serum PD-1 and PD-L1 in the same cohort were
measured by ELISA [Proteintech]. Data was analysed using PRISM.
Results
The percentages of B and CD4+ T cells expressing PD-1 and PD-L1 were
significantly higher in survivors and non-survivors of sepsis compared
to healthy controls. There were no significant differences between sur-
vivors and non-survivors in expression of PD-1 or PD-L1 by any lympho-
cyte subset. CD4 + CD27- memory T cells had significantly higher mean
fluorescence intensity (MFI) and percentage positivity of PD-1 than
CD4 + CD27+ T cells. The PD-1 MFI was significantly higher in CD19 +
CD27+ memory B cells than CD19 + CD27- B cells. Serum PD-1 and PD-
L1 concentrations were not different in sepsis patients compared to
controls and values did not correlate with surface expression of PD-1 or
PD-L1 by any lymphocyte subset in sepsis patients.
Conclusions
We show higher expression of PD-1 and PD-L1 by B cells and CD4+ T
cells in sepsis compared to health, and higher expression of PD-1 by
memory compared to naïve B cells and CD4+ T cells. Further
research to identify patients likely to benefit from PD-1/PD-L1 block-
ade in sepsis is required.
References
1. Hotchkiss R et al. Nat Rev Imm; 13(12):862–74, 2013.
2. https://clinicaltrials.gov/ct2/show/NCT02576457
3. Singer M et al. JAMA; 315(8):801–10, 2016.
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Introduction
Reduced activity of proprotein convertase subtilisin/kexin type 9
(PCSK9), by increasing the density of low density lipoprotein (LDL)
receptors on hepatic cells, may decrease the systemic inflammatory
response to sepsis due to increased clearance of pathogen lipids in-
corporated into LDL [1]. The purpose of this study was to determine
the relationship between PCSK9 loss-of-function (LOF) variants and
the risk of short and long-term death and/or hospital readmission(s)
within a year following an episode of sepsis, in two distinct cohorts.
Methods
This was a retrospective observational study involving two cohorts from
St. Paul’s Hospital in Vancouver, Canada: Cohort 1 was composed by
189 patients with septic shock admitted to intensive care unit between
July 2000 and January 2004 and who survived at least 60 days post-
hospitalization; Cohort 2 included 185 patients admitted to the Emer-
gency Department from January 2011 to July 2013, with clinical diagno-
sis of sepsis. R46L, A53V, and I474V PCSK9 missense LOF SNPs were
genotyped in all patients, who were classified in 3 groups: WT, 1 LOF,
and 2 or more LOF according to the number of LOF alleles.
Results
Cohort 1: Time to event curves for 5-year mortality showed a trend to
statistically lower probability of death within 5 years in patients with
PCSK9 LOF (overall p = 0.062) and the presence of 1 PCSK9 LOF allele
(Cox model) was independently associated with decreased hazard-ratio
for 5-year mortality (0.578, 95% CI = 0.36-0.93, p = 0.024).Cohort 2: Patients from the 2 or more LOF group had lower probability
of death within 90 days in comparison to WT (p = 0.010) or 1 LOF pa-
tients (p = 0.028), and the presence of 1 PCSK9 LOF allele (Cox model)
was independently associated with decreased HR for 90-day mortality
(0.46, 95% CI 0.23-0.92, p = 0.030). Patients from the 2 or more PCSK9
LOF group also had lower probability of death or infection related read-
missions when compared to WT (p = 0.015) or 1 LOF allele (p = 0.002),
and the presence of 2 or more PCSK9 LOF alleles had the lowest ad-
justed HR for this outcome (HR = 0.32, 95% C.I. 0.11-0.92, p = 0.035).
Conclusions
PCSK9 LOF genotype is associated with decreased risk of 5-year and
90-day mortality, and all-cause 1-year death or readmissions due to
infection after an episode of sepsis.
Reference
1. Walley KR et al.: Science translational medicine Sci Transl Med.
6(258):258ra143, 2014
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Introduction
Some critically ill patients are at high risk of severe sepsis due to in-
fections with Pseudomonas aeruginosa (PSA) in the lung or abdo-
men, which is difficult to treat. The present study was performed to
find out whether these critically ill patients on a surgical intensive
care unit with sepsis due to PSA have a characteristic monocyte
surface receptor expression and cytokine secretion patterns.
Methods
The surface markers CD163 (hemoglobin scavenger receptor; clear-
ance of hemoglobin, adhesion to endothelial cells, tolerance induc-
tion, tissue regeneration; soluble form: antiinflammation), CD206
(mannose receptor for mannose on surface on microorganisms),
intracellular levels of IFN-γ, CXCR1 (IL-8α chemokine receptor) and
CXCR2 (IL-8β chemokine receptor) of monocytes of critically ill pa-
tients with PSA sepsis and of healthy controls were analyzed by flow
cytometry. Furthermore, the IL-8 secretion levels in vivo and ex vivo
after LPS stimulation were determined by ELISA.
Results
20 surgical patients with severe sepsis / septic shock with underlying PSA
infections and of 22 healthy controls were monitored. The monocytes of
the patients showed differences in the IL-8 secretion level. In line with
high IL-8 or low IL-8 secretion in serum (965 ± 139 pg/ml vs. 232 ± 15 pg/
ml) as well as in culture after LPS stimulation (2838 ± 259 pg/ml vs. 1097
± 356 pg/ml), the expression of surface markers IFN-γ, CXCR1, CXCR2 and
CD163 was high or low, respectively, however, always above those of the
healthy control group (p < 0.05). CD206, only, showed the opposite be-
havior in that CD206 was highly expressed (3657 ± 279 MFI) on IL-8 low
cells, whereas a low expression (17 ± 6 MFI) could be observed on
IL-8 high cells (p < 0.001). The IL-8 low group had markedly
higher severity of disease scores (SAPSII 34 ± 8) than the IL-8
high group (SAPSII 17 ± 6), and worse outcome (p < 0.001).
Conclusions
Different patterns of monocyte surface pattern expressions are asso-
ciated with low or high IL-8 secretion of monocytes in patients with
PSA sepsis. Low IL-8 expression and the respective surface pattern
on monocytes may be associated with worse outcome.
P366
Identification of a distinct metabolomic profile in acute influenza
infection
M Chase1, E Freinkman2, A Uber1, X Liu1, MN Cocchi1, MW Donnino1
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The goal of this investigation is to characterize the effect of acute
influenza infection on the host metabolome. Metabolomics is an
emerging field of research studying small molecules or metabolites
providing a profile of the physiologic status of an organism at a
point in time. The human metablomic response to acute influenza in-
fection is not well-characterized. We hypothesized that acute influ-
enza infection will induce a distinct metabolic response in the host
which may enable the identification of host mediators in influenza
pathogenesis.
Methods
We are conducting a randomized clinical trial administering atorva-
statin or placebo to patients with acute influenza infection. As an ex-
ploratory aim, we assessed the metabolomic profile of enrolled
patients at baseline, prior to study drug administration, compared to
healthy controls. T-tests were used to compare 117 metabolites. Raw
data were entered into MetaboAnalyst statistical software for ana-
lysis. We report findings based on Partial Least Squares-Discriminant
Analysis (PLS-DA) which uses multivariate regression techniques to
predict class membership based on original variables.
Results
We performed metabolomic analysis on serum samples of 49 statin-
naïve patients with acute influenza and 25 healthy controls. We
found 17 individual metabolites that were significantly different
between groups at a threshold of p = 0.05. PLS-DA score plot demon-
strated a distinct difference between influenza subjects and controls
(Fig. 6) and PLS-DA model validation by permutation tests was highly
significant (p < 5e-04). The most significant discriminating metabo-
lites between influenza patients and controls were phosphocholine,
phosphoethanolamine, nicotinamide, taurine, ADP, tryptophan,
threonine, proline, citrulline (lower in flu samples) and kynurenine,
acetoacetate, 3-hydroxybutyrate, hypoxanthine (higher in flu sam-
ples). Each of these metabolites had a VIP score of >1.4
Conclusions
In our metabolomics analysis of ED patients with acute influ-
enza, we found a statistically significant difference in 17 metab-
olites as compared to healthy controls. We believe these data
represent a potentially unique metabolic fingerprint in influenza
infection. Further study is needed to elucidate potential meta-
bolic pathways and host mediators that may contribute to influ-
enza pathogenesis.Fig. 6 (abstract P366). See text for descriptionP367
Von Willebrand factor and ADAMTS-13 influence the outcome of s.
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Introduction
The size and functionality of the multimeric von Willebrand factor
(VWF) molecule is regulated by its cleaving protease ADAMTS-13.
While VWF and ADAMTS-13 levels correlate with disease course and
outcome in the heterogenous population of septic patients, animal
models have been inconclusive and mainly focused on gram-
negative abdominal sepsis. It is unknown if modulation of the VWF/
ADAMTS-13 balance can modulate the outcome of [i]S. aureus[/i]
sepsis.
Methods
We aimed to study the role of VWF and ADAMTS-13 in [i]S. aureus[/i]
sepsis, using patient data and an animal model.
Results
In patients with [i]S. aureus[/i] bloodstream infection, high VWF levels
correlated with inflammatory parameters and inversely with kidney
function. Low ADAMTS-13 levels were associated with disease sever-
ity and DIC parameters.
In a severe sepsis model, mice deficient in VWF showed improved
survival, compared to wildtype mice. In contrast, [i]Adamts13-/-[/i]
mice had increased mortality. Immediate clearance of bacterial load
in blood was better in VWF deficient mice. The differences in mortal-
ity for the studied genotypes were associated with differential loads
of organ microthrombi in liver and kidneys. Further experiments will
study if administration of ADAMTS-13 can alleviate the course of [i]S.
aureus[/i] sepsis.
Conclusions
In conclusion, this is the first study that consistently shows the rela-
tion of VWF, ADAMTS-13 and their ratio to disease severity in pa-
tients and mice with [i]S. aureus[/i] sepsis. Not only is the balance of
VWF and its cleaving protease implicated in primary adhesion and
bacterial retention, but VWF/ADAMTS-13 ratio also regulates the
amount of organ microthrombi containing platelets, neutrophils and
bacteria – and thus potentially end organ failure.
Targeting VWF multimers and/or the relative ADAMTS-13 deficiency
that occurs in sepsis, should be explored as a potential new thera-
peutic target in [i]S. aureus[/i] endovascular infections.
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Introduction
During infection, there is an activation of the L-arginine-nitric-
oxide pathway, with a shift from nitric oxide synthesis to a deg-
radation of L-arginine to its metabolites, asymmetric and symmet-
ric dimethylarginine (ADMA and SDMA). We investigated the
association of L-arginine, ADMA, and SDMA with adverse clinical
outcomes in a well-defined cohort of patients with community-
acquired pneumonia (CAP).
Methods
We measured L-arginine, ADMA, and SDMA in 268 CAP patients from
a Swiss multicenter trial by mass spectrometry and used Cox regres-
sion models to investigate associations between blood marker levels
and disease severity as well as mortality over a period of 6.1 years.
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Six-year mortality was 44.8%. Admission levels of ADMA and SDMA
(μ mol/L) were correlated with CAP severity as assessed by the pneu-
monia severity index (r = 0.32, p < 0.001 and r = 0.56, p < 0.001 for
ADMA and SDMA, respectively) and higher in 6-year non-survivors
versus survivors (median 0.62 vs. 0.48; p < 0.001 and 1.01 vs. 0.85; p
< 0.001 for ADMA and SDMA, respectively). Both ADMA and SDMA
were significantly associated with long-term mortality (hazard ratios
[HR] 4.44 [95% confidence intervals (CI) 1.84 to 10.74]) and 2.81
[95%CI 1.45 to 5.48], respectively). No association of L-arginine with
severity and outcome was found.
Conclusions
Both ADMA and SDMA show a severity-dependent increase in pa-
tients with CAP and are strongly associated with mortality. This asso-
ciation is mainly explained by age and comorbidities.Fig. 7 (abstract P368). Metabolism of nitric oxide
Fig. 8 (abstract P368). Kaplan-Meier survival estimates for SDMAP369
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Introduction
Sepsis is a severe systemic inflammatory response to infection that
manifests with widespread inflammation as well as endothelial and
coagulation dysfunction that may lead to hypotension, organ failure,shock, and death. Disseminated intravascular coagulation (DIC) is a
complication of sepsis involving systemic activation of the fibrinolytic
and coagulation pathways that can lead to multi-organ dysfunction,
thrombosis, and bleeding, with a two-fold increase in mortality. Sev-
eral studies have reported that low levels of protein C predict out-
come in patients with severe sepsis. Protein C helps to regulate
coagulation by controlling the activation of factors Va and VIIIa. In
addition, activated protein C has anti-inflammatory functions. The
purpose of this study was to determine the functional protein C
levels in this cohort of patients over the 8 day study period and to
correlate protein C levels with survival.
Methods
De-identified serial plasma samples from patients diagnosed with
sepsis-associated coagulopathy (n = 137) were obtained from the
University of Utah under an IRB approved protocol. The citrated
plasma samples were collected from adult patients in the ICU upon
admission and ICU days 4 and 8. In addition, plasma samples from
healthy volunteers (n = 50) were purchased from George King Bio-
medical (Overland, KS). P). Patients were assigned a DIC score based
on the International Society of Thrombosis and Hemostasis (ISTH)cri-
teria and categorized as having sepsis and no DIC, non-overt DIC and
overt DIC. Plasma samples were analyzed for functional protein C
levels using a clot-based method (Diagnostica Stago, Parsippany, NJ).
Results
The functional protein C levels on day 0 and day 4 were decreased
in the septic patients compared to normal controls (p < 0.0010). In
addition, the functional protein C levels decreased with an increase
in severity of DIC. On day 8, there was a decrease in the functional
protein C levels in both the non-overt and overt DIC groups com-
pared to normal and patients with sepsis and no DIC. There also was
a significant decrease in functional protein C levels in survivors com-
pared to non-survivors (p < 0.010).
Conclusions
These results underscore the importance of functional protein C
levels in the regulation of hemostasis. Furthermore, these studies
demonstrate that decreased functional protein C contributes to the
pathogenesis of sepsis associated coagulopathy as evident by the
observed relationship with the severity of sepsis and decreased pro-
tein C levels. Thus functional protein C levels may be a useful prog-
nostic marker to risk stratify patients with sepsis and DIC.
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Cholesterol is a marker of multiple organ dysfunction syndromes
after abdominal surgeries.
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Introduction
According to the third international consensus sepsis is defined as
life-threatening organ dysfunction caused by a dysregulated host re-
sponse to infection. The aim of the study was to investigate the pos-
sibility of using additional laboratory marker cholesterol for early
detection of multiple organ dysfunction syndromes (MODS) after ab-
dominal surgeries.
Methods
After approval the ethics committee of the Mogilev Regional Hospital
in a prospective observational study included 58 patients aged 18 to
85 years. All patients underwent laparotomy abdominal surgeries
after which hospitalized in the intensive care unit. In R group (n = 30)
of patients in the postoperative period was followed by the develop-
ment of MODS, in the C group (n = 28) - patients without MODS. De-
termination of cholesterol produced daily by AU 680 biochemistry
analyzer.
Results
Patients on the R group marked decrease in the level of cholesterol
on the 4th day after surgery with 158.7 (96.8; 189.6) mg / dL to 127.7
(112.2; 174.1) mg / dL (Wilcoxon test, p = 0.0035). In group C was no
significant differences in cholesterol levels. In R group value of
cholesterol on 4th day was significantly higher in patients (n = 17)
with recovery 147.1 (112.2; 170.3) mg / dL, than in patients (n = 13)
Critical Care 2017, 21(Suppl 1):58 Page 10 of 70with a fatal outcome 116.1 (100.6; 127.7) mg / dL (Mann-Whitney U
test, p = 0.034). In the surviving patients reduced cholesterol level
normalization was observed after 14 days after the operation.
We performed ROC-analysis to determine the diagnostic significance
of cholesterol as a marker MODS. The area under the curve was
0.726 (p <0.001) 95% confidence interval from 0.684 to 0.769, sensi-
tivity 73.6%, specificity 63.8%. The optimal threshold level of choles-
terol as a predictor of MODS was determined of 130.0 mg / dL.
Conclusions
Determining the level of cholesterol, together with an assessment of
clinical symptoms and blood formula, will provide early diagnosis of
MODS after abdominal surgeries.Fig. 9 (abstract P372). NLR and mortalityP371
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Introduction
Antibiotic therapy is a very important treatment for critically ill pa-
tients, but long-term administration can lead to antimicrobial resist-
ance. Procalcitonin (PCT) has been used as a biomarker to monitor
the effectiveness of antibiotic therapy with the aim of shortening the
administration period. This study aimed to clarify the relationship of
WBC counts to sepsis-related biomarkers (procalcitonin [PCT], endo-
toxin activity assay [EAA], interleukin-6 [IL-6], and presepsin) and 28-
day mortality rate in critically ill patients.
Methods
We studied 422 patients (L-group with WBC counts <4000: 79 pa-
tients; H-group with WBC counts >12,000: 343 patients). Blood bio-
chemistry and PCT, EAA, IL-6, and presepsin were measured
immediately after ICU admission. Results were expressed as the
mean ± SD (median). The Mann-Whitney U-test and chi-square test or
Fisher’s exact test were used for statistical analysis. A p-value of
<0.05 was considered to indicate a statistically significant difference.
Results
Regarding background factors, the APACHE2 scores in the L-group
and H-group were 24.9 ± 9.2 (23.5) and 22.4 ± 9.1 (23.0), and the
SOFA scores were 9.3 ± 3.9 (9) and 12.9 ± 3.4 (8), respectively. These
values showed no significant differences between groups. PCT levels
in the L-group and H-group were 65 ± 96 (25) and 20 ± 51 (3.2) re-
spectively; EAA levels in the L-group and H-group were 0.59 ± 0.26
(0.62) and 0.36 ± 0.22 (0.32), respectively. IL-6 levels in the L-group
and H-group were 61,728 ± 10,8417 (15,150) and 2440 ± 3422 (217),
respectively. All of these values in the L-group tended to be higher
than in the H-group. On the other hand, presepsin levels in the L-
group and H-group were 1277 ± 943 (882) and 2440 ± 422 (1210), re-
spectively. The 28-day mortality rate in the L-group was 34%, and
14.7% in the H-group. There was a significant difference between
groups (p < 0.05).
Conclusions
In critically ill patients who entered the ICU, most sepsis-related bio-
markers (PCT, EAA, IL-6) tended to be higher in the low leukocyte
count (WBC < 4000) group, but only presepsin tended to be higher in
the high WBC (>12,000) group. Further study to explain this differ-
ence is necessary.P372
Neutrophil-lymphocyte ratio and mortality during critical illness
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Introduction
Immunologic alterations are common during critical illness and may
determine outcome. We evaluated whether lymphopenia (lympho-
cyte count <1000*106/mmc) or a higher neutrophil-lymphocyte ratio(NLR, as a marker of inflammation) were associated with mortality in
critically ill patients.
Methods
Prospective observational study on 221 consecutive adult patients
admitted to our 14-bed Intensive Care Unit (ICU). Neutrophil and
lymphocyte counts were recorded every day. Receiver operating
characteristics (ROC) curves and binary logistic regression analysis
were used to test the association between lymphopenia/NLR and
ICU-mortality.
Results
83% of patients showed lymphopenia at least once in the ICU stay.
The mean lymphocyte count was a weak discriminant of ICU-
mortality (area under the ROC curve: 0.63 [95% confidence interval
0.52-0.74]). A mean NLR [>=] 12 was able to discriminate Non-
survivors with a sensitivity of 64% and specificity of 71% (ROC: 0.71
[0.61-0.80], Fig. 9). A mean NLR [>=] 12 was associated with higher
mortality independently of age, presence of infection, days of mech-
anical ventilation and the Simplified Acute Physiology Score (ad-
justed odds ratio: 3.597 [1.760-7.354]).
Conclusions
A higher mean NLR was independently associated with mortality.P373
Leukocyte activity assessment using magnetic levitation in septic
patients
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Introduction
In sepsis, chemotactic factors induce swelling and activation of leuko-
cytes. We have invented a novel portable bedside device based on
the principles of magnetic levitation (two opposing magnets with a
capillary tube in between that suspend cells) to image and quantify
morphological properties of circulating leukocytes using whole
blood. The device separates blood cells based on their mass and
magnetic properties. Our aim was to determine whether magnetic
levitation technique, by measuring leukocyte size and morphology
parameters can accurately identify Emergency Department(ED) pa-
tients with sepsis.
Fig. 10 (abstract P374). Clusters of cytokine patterns after
tracheostomy.
Critical Care 2017, 21(Suppl 1):58 Page 11 of 70Methods
Single-center, prospective, observational cohort study of a con-
venience sample of adult (>17y) patients from a 56.000 visit ED
or affiliated out-patient lab between 3/2016-11/2016. Inclusion
criteria: Sepsis: patients admitted to the hospital with suspected
or confirmed infection. Non-infected Controls: ED or outpatient
clinic patients without infection or acute illness. Procedures:
Half a microliter of whole blood collected in EDTA tube, mixed
with a paramagnetic gadolinium solution, transferred to a capil-
lary tube, and placed between magnets for imaging and data
analysis. Primary analysis: comparison of sepsis patients vs non-
septic controls. Covariates of interest: leukocyte area, length,
width, roundness, standard distribution(SD) of levitation height
(measure of mass/charge dispersion). Means reported with t-test
comparisons and calculation of area under the curve for assess-
ment of diagnostic accuracy.
Results
We enrolled 41 non-infected controls and 21 sepsis patients: sep-
sis(6), severe sepsis(9) and septic shock(6). Our analyses identified a
significant increase in the size of the circulating leukocytes in sepsis
patients versus controls, as seen by the following morphology pa-
rameters: mean cell area, 570 pixels (SD) (±115) vs 411 (±46), p <
0.0001 with AUC = 0.89(0.80-0.99); cell length, 30 pixels (±2.5) vs 25
(±1.9), p < 0.0001, AUC = 0.89(0.81-0.98); and cell width, 27 (±2.4) vs
23 (±1.5), p < 0.0001, AUC = 0.93(0.86-1.00). Cell roundness was 2.2
(±1.1) vs 2.2 (±1.2), p = 0.9, AUC = 0.55(0.40-0.71). For mass:charge,
levitation height SD was 71 (±26) vs 47 (±16), p = 0.0012, AUC =
0.80(0.67;0.93).
Conclusions
Septic patients had increased area, length, and width with strong
diagnostic accuracy. Sepsis patients had leukocytes with a pattern of
more variable mass and magnetic properties. Cell roundness was less
promising. Trends towards these differences were associated with in-
creased severity. This bedside technique shows promise as a novel
diagnostic test for infection.P374
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Introduction
Bedside tracheostomies are standardized, repeated procedures per-
formed on relatively stable patients. The effects of tracheostomies at
the biochemical level have not been studied before.
Methods
5 blood samples were obtained from patients undergoing bedside
tracheostomies at t = 0, 4, 8, 12 and 24 hrs. Vital signs and clinical lab
measures were also recorded. The blood samples were assayed for
analytes shown in Fig. 10.
Results
We report results for 23 patients from this ongoing study. Parametric
and nonparametric tests showed few statistically significant changes
between the time points. Clearly discernible patterns of response
were observed, which were different between patients. Using a self-
organizing map clustering algorithm, we were able to cluster the re-
sponses over time, for every analyte eg GCSF showed 3 possible pat-
terns of response: peak at t = 2 and then a steady decrease (4 pts);
peak at t = 2 and then a plateau starting at t = 3 (12 pts); and peak at
t = 2 with an increase at t = 4 (5 pts; 2 pts were excluded by the algo-
rithm). The other cytokines showed between 3 to 5 clusters of re-
sponse patterns each.
Conclusions
Results were not amenable to parametric or non-parametric ap-
proaches. We could classify the patients according to response pat-
terns. This highlights the need for the development of individual-
level measures and the personalization of clinical careP375
The h3 haplotype of the EPCR gene determines high sEPCR levels
in critically-ill patients
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Introduction
The endothelial protein C receptor (EPCR) is a protein that regu-
lates the protein C anticoagulant and anti-inflammatory path-
ways. A soluble form of EPCR (sEPCR) circulates in plasma and
inhibits activated protein C (APC) activities. The clinical impact
of sEPCR and its involvement in the septic process is under in-
vestigation. This study investigated possible association of EPCR
haplotypes with sEPCR levels in critically-ill patients with sus-
pected infection.
Methods
Two polymorphisms in the EPCR gene were previously genotyped in
239 Caucasian critically-ill patients, hospitalized in the intensive care
unit (ICU) of &#8220;Evangelismos&#8221; Hospital, Athens, Greece.
The old [1-2] and new [3] sepsis definitions were used to divide pa-
tients in groups. Patients were further divided according to their
genotype. Plasma sEPCR levels were measured using a dedicated
ELISA assay in all patients at the time of admission to the intensive
care unit (ICU).
Results
Patients were categorized using both old and new sepsis defini-
tions. With the old definitions patients were divided in two
groups: severe sepsis/septic shock-positive (SS/SS + ve) and severe
sepsis/septic shock-negative (SS/SS-ve). sEPCR levels were slightly
higher in the SS/SS-ve group (p < 0.05). The patients were also di-
vided according to their qSOFA score. In the three groups of pa-
tients, sEPCR levels were comparable (p > 0.05). However, when
patients were divided according strictly to their genotype, plasma
levels of sEPCR differed between genotypes (p < 0.0001) and be-
tween H3 and non-H3 carriers (p < 0.0001), with higher sEPCR
levels in the H3 carriers.
Conclusions
Frequencies of SNPs determining EPCR haplotypes were in concord-
ance with Caucasian frequencies. Critically-ill patients carrying at least
one H3 allele had significantly higher levels of sEPCR than patients with
no H3 alleles. Using both classification systems, sEPCR levels were not
associated with sepsis severity.
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Introduction
Copeptin (pro-vasopressin) is a hormone derived from the same precur-
sor protein as Vasopressin (AVP). Both hormones are secreted equimolar
in response to physical stress and correlate with adverse clinical out-
comes. In contrast to AVP, copeptin can be easily quantified by a sand-
wich immunoassay. Therefore, it serves as a surrogate marker for AVP
and has emerged as a new prognostic marker in different settings includ-
ing cardiovascular and infectious disease. The aim of this study was to
evaluate the association between copeptin plasma concentrations and
adverse outcomes in a large unselected study population seeking for
emergency department (ED) care like under “real life” conditions.
Methods
This multicenter, observational cohort study consecutively included
adult medical patients seeking for ED care in Switzerland, France and
the USA during March 2013 to October 2014. We recorded initial clin-
ical parameters and batch-measured the copeptin levels in a study
population involving 7039 patients with available copeptin measures.
We used logistic multivariate regression models (expressed in odds
ratio, OR; 95% confidence interval, CI) and area under the receiver
operating characteristic curve (AUC) to investigate the association of
copeptin Plasma concentrations and different adverse outcomes (30-
day all-cause mortality, intensive care unit [ICU] admission, initial
treatment priority, main diagnoses and abnormal vital signs).
Results
During a 30-day follow-up 329 (4.7%) participants reached the primary
endpoint of death. In our logistic regression models adjusted for age and
gender copeptin levels (log transformed with a base of ten) significantly
predicted the 30-day risk of death (OR 3.35, 95%CI 2.78-4.04, AUC 0.78),
ICU admission (OR 2.89, 95%CI 2.48-3.36, AUC 0.69) and high initial treat-
ment priority (OR = 2.23, 95%CI = 2.04-2.43, AUC= 0,66). Furthermore we
found significant associations between copeptin levels and abnormal
vital signs including low blood pressure (OR = 2.71, 95%CI = 2.35-3.11,
AUC= 0.70). Stratifying by main admission diagnoses, subgroup analyses
showed best performance of copeptin levels for 30-day mortality predic-
tion in metabolic disorders (OR 11.00, 95%CI 2.46-49.20, AUC 0.87) and
acute infections (OR 6.90, 95%CI 4.13-11.53, AUC 0.80).
Conclusions
Based on our findings copeptin serves as a strong prognostic marker
on ED admission and might help to improve risk stratification in un-
selected medical ED patients.
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Introduction
Although Procalcitonin (PCT) has been extensively studied in
infectious conditions, the clinical relevance of PCT in unselectedemergency department (ED) patients remains incompletely under-
stood. We investigated association of admission serum PCT levels
and adverse clinical outcomes in a large ED cohort from a previous
multicenter study.
Methods
We prospectively enrolled 7132 adult medical patients seeking ED
care in three tertiary care hospitals in Switzerland, France and the
United States. We used adjusted multivariable logistic regression
models to examine association of admission PCT levels and 30-day
mortality, stratified by principal medical diagnoses and concomitant
comorbidities. We calculated regression models across different
clinically-established PCT cut-offs (0.05, 0.1, 0.25 and 0.5ng/ml).
Results
During a 30-day follow-up 328 (4.9%) participants died. Mortality rate
in the cut-off stratified groups were 1%, 3%, 7%, 14 and 17%, re-
spectively. PCT had a high prognostic power for 30-day mortality
with an area under the receiver operating characteristic curve of 0.74
(95%CI 0.72- 0.77; SE 0.0133). After adjustment for age, gender and
main diagnoses, PCT cut-off levels were associated with a step-wise
increase in risk of 30-day mortality with an adjusted odds ratio of 1.9,
4.5, 8.6 and 11.0 for pulmonal disease; 1.9, 4.7, 8.7 and 11.0 for
cardiovascular disease and 1.9, 4.6, 8.8 and 11.4 for infectious dis-
ease, respectively. These associations were similar among different
types of patients in regard to main diagnoses, comorbidities and age
of patients.
Conclusions
In this large medical ED patient cohort, admission PCT was a strong
and independent outcome predictor for 30-days mortality across dif-
ferent medical diagnoses. PCT may help to improve risk assessment
in undifferentiated medical ED patients.
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Introduction
Infections due to K.Pneumoniae carbapenemase (KPC) are increasing
[1]. Trials analyzing the levels of Procalcitonin (PCT) in KPC infections
are lacking. Aim of this study was to evaluate the levels of PCT in
KPC infections compared with other Gram negative and verify if PCT
levels correlate with sepsis severity.
Methods
From March 2012 to May 2013 133 adult patients with documented
Gram negative bacteria infection, admitted to intensive care depart-
ment were observed. In 53 patients KPC was isolated (KPC Group,
KPCG), while in 80 patients other Gram negative bacteria caused the
infection (Control Group, CG). All the patients were classified daily ac-
cording to sepsis severity. Organ dysfunction was evaluated daily ac-
cording to the SOFA score. PCT levels were detected daily by means
of a quantitative method (Liaison). Microbiological coltures and im-
aging exams were performed according to clinicians decision. Statis-
tical analysis was performed by means of the SPSS11.0 software.
Results
As regards demographic data significant differences were showed
except ICU LOS that was longer in KPCG. The main site of isolation of
KPCs was the respiratory tract. According to the different sepsis se-
verity diagnosis we found the following PCT levels (ng/ml). Sepsis:
KPCG 0.9 ± 1.9, CG 6.6 ± 11.1 (p < 0.01); Severe Sepsis: KPCG 3.4 ± 6,
CG 11.6 ± 19.8 (p < 0.01); Septic Shock: KPCG 8.9 ± 15.9, CG 30.5 ±
35.7 (p < 0.01) In KPC Group the mean PCT level in non-survivors was
7ng/ml, while in survivors was 2.7 ng/ml (p < 0.01). PCT mean values
increased according to SOFA score increases.
Conclusions
Our data demonstrated that in septic patients with KPC infection PCT
levels were significantly lower that those in septic patients with infec-
tion due to other Gram negative species. As regards outcome PCT
levels confirmed to be related to severity of the disease with a mean
level significantly higher in non-survivor compared to survivor.
Critical Care 2017, 21(Suppl 1):58 Page 13 of 70Mortality rate was higher in KPC Group compared to Control Group,
but the difference was not significant.
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KPCG (53pts) CG (80pts) p
AGE (years) 63.1 ± 18.3 65.3 ± 16.4 NS
Gender (M/F) 35/18 46/34 NS
ICU LOS (days) 30.9 ± 33.4 16 ± 15.7 <0.01
SOFA 6 ± 4.4 6.9 ± 4.6 NS
Mortality (%) 25 (47.2) 33 (41.2) NS
Legend : demographic data
Fig. 11 (abstract P379) Kaplan-Meier curve over 30-days stratified
by score.P379
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Introduction
Several prognostic scores and biomarkers have been assessed
for risk stratification in septic patients in intensive care units
(ICUs). Serum lactate is a routinely used biomarker for the man-
agement of patients with sepsis and correlates with hypoperfu-
sion and fluid resuscitation. Procalcitonin (PCT) is a bacterial
infection marker and kinetics indicates the response to anti-
microbial management. There is insufficient data comparing
these two markers regarding outcome prediction. Herein, we
compared the prognostic accuracy of lactate and PCT kinetics,
and the combination of them, in a large, well defined US sepsis
patient population.
Methods
This is an observational cohort study of adult patients with confirmed
severe sepsis or septic shock included in a sepsis database from 14
different BayCare hospitals (Florida). All patients had PCT and lactate
measurements on admission and during follow-up based on the
treatment protocol. We used logistic regression and area under the
curve (AUC) as a measure of discrimination of lactate and PCT with
in-hospital mortality.
Results
The in-hospital mortality rate of the 1075 included patients
(mean age 66.9 years) was 18.8%. Concerning prognosis, the ini-
tial lactate level was a better mortality predictor (AUC 0.64)
compared to PCT (AUC 0.55). For follow-up measurements, PCT
(AUC 0.75) showed a better discrimination than lactate (AUC
0.73). When looking at biomarker kinetics, PCT increase was
more strongly associated with fatal outcomes compared to ini-
tial levels alone (AUC 0.74) and was a better predictor com-
pared to lactate kinetics (AUC 0.63). A joint logistic regression
model combining follow-up measurements of lactate and PCT-
kinetics showed a superior prognostic accuracy (AUC 0.82) com-
pared to these markers alone.
Conclusions
Both biomarkers, PCT, and lactate, provide prognostic informa-
tion in ICU patients with sepsis, particularly when looking at
kinetics.P380
Impact of CRP, procalcitonin and CRP on mortality related with
sepsis in ICU
D Mandaci, G Eren, F Ozturk, N Emir, O Hergunsel
Bakirkoy Dr.Sadi Konuk Training and Research Hospital, Istanbul, Turkey
Critical Care 2017, 21(Suppl 1):P380
Introduction
Sepsis is known to be the leading cause of morbidity and mortal-
ity of ICU patients. APACHE 2, SAPS 2 ve SOFA scores are most
frequently used for predicting mortality. Herein, it’s aimed to
search for the effect of C-reactive protein (CRP), procalcitonin
(PCT) and mean platelet volume (MPV) on mortality of sepsis in
the ICU.
Methods
Retrospectively, 25 sepsis patients admitted to our ICU on May 2016
with at least 5 days of stay in the ICU were searched for APACHE 2,
SAPS 2 and SOFA scores. The effect on mortality of CRP, procalcitonin
and MPV values on the 1st, 5th and 10th days were analyzed with
SPSS version 15 through receiver operating characteristic (ROC) curve
analysis. Sensitivity, specificity, positive and negative predictive
values were calculated.
Results
Patients were between the ages of 18-79 years with a median
of 53 and a female-male ratio of 56-44%. ROC analysis revealed
that the last day MPV values were highly predictive for mortal-
ity (AUC: 0.99, p < 0.01). The cut-off for this value was calculated
as 7.73, with a sensitivity of 90%, specificity of 100%, and posi-
tive predictive value as100%, negative predictive value as 53%.
CRP values on the last day of ICU stay were predictive for mor-
tality as well (AUC: 0.85, p < 0.01) with a cut-off value of 7.55,
sensitivity of 92.3% but a specificity of 87.5% (positive predict-
ive value: 92.3% and negative predictive value: 63.6%). Procalci-
tonin values of neither the first nor the last day of ICU stay
were predictive of mortality. APACHE 2, SAPS 2 and SOFA were
found to be well correlated with MPV values and the last day
CRP values, but not with any of the procalcitonin values.
Conclusions
Together with APACHE 2, SAPS 2 and SOFA scores, CRP and MPV
values are good predictors of mortality of sepsis in ICU. We consider
a further study with a larger sample size to evaluate better the effect
of procalcitonin in this issue.
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Introduction
Bacterial infection often leads to decompensated liver cirrhosis in
cirrhotic patients. Its diagnosis should be swift, otherwise it is associ-
ated with a poor prognosis.
Our aim is to quantitate the various inflammatory markers in cir-
rhotics with and without obvious infectious disease.
Methods
A total of 80 patients admitted due to decompensated liver cirrhosis
were included in this study. We explored the key epidemiologic, clin-
ical and biological features of these patients.
Results
54 patients (67,5%) were assigned to the infection group of which
nine patients (16,6%) had positive blood culture. In this group, the
following diagnoses were made : 34 lung infections, 11 spontaneous
bacterial peritonitis, nine urinary tract infections, three skin infections,
and two gastroenteritis. Three patients had an infection without an
identified source.
The mean age for the infected patients (group 1) was 62.8 years and
for the uninfected ones 63.4 years (group 2). There were higher
levels of C reactive protein (CRP) and procalcitonine (PCT) in group 1
than in group 2 (a mean of 52.7 mg/ L and 1.3 ng/ mL versus 13,3
mg/l and 0,1 ng/mL respectively). The median of CRP for group 1
was 43,15 mg/ L. Infection at admission was associated with signifi-
cantly higher levels of these proteins (p = 0.000). Leucocyte count
was also higher in group 1 (p = 0.04).
49 patients had CRP levels below 43.15 mg/ L, wherein 25 (51%) had
infections. In this particular group, CRP was significantly higher in in-
fected patients (p = 0.000), unlike PCT (p = 0,06) and leucocyte count
(p = 0.23).
Conclusions
Elevated PCT appear only in inflammations of an infectious etiology
with systemic signs. Therefore in cirrhotic patients, procalcitonin de-
termination seems appropriate for the diagnosis of severe infections
but does not seem more reliable than CRP in other situations.
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Introduction
Development of new microbial load biomarkers proceeds, but still -
there is no perfect one. Procalcitonin (PCT) is commonly used and its
level correlates with the extent of microbial invasion. Earlier it was
found that aromatic microbial metabolites (AMM) - are associated
with the severity and mortality of ICU patients [1, 2]. Also the effect-
iveness of the treatment can be evaluated by the AMM level [1]. Ex-
perimental studies have shown their biological activity [3,4]. The aim
of this work is to analyze different criteria of bacterial load in ICU pa-
tients with nosocomial pneumonia.
Methods
In prospective study 46 patients with nosocomial pneumonia admitted
to ICUs were observed in the first day. After liquid-liquid extraction from
serum samples 9 phenylcarboxylic acids (benzoic (BA), phenylpropionic,
cinnamic, phenyllactic (PhLA), p-hydroxybenzoic, p-hydroxyphenyllactic,
p-hydroxyphenylacetic (HPhAA), p-hydroxyphenylpropionic and homova-
nillic (HVA)) were measured using GC-MS (Trace1310-ISQ, Thermo). DNA
was extracted from bronchoalveolar lavage (BAL) samples from 5 of 46
patients for the quantitative detection of nosocomial bacteria by the
PCR-real time (IQ5, BIORAD), PCT and presepsin were measured on the 1,
3, 7-9 days after the diagnosis of pneumonia. Spearman’s correlationcoefficient was found, data presented as medians with interquartile range
(IR, 25-75%) using STATISTICA 10.
Results
In serum samples of 46 patients the total concentration of 9 AMM
was 3.4 (2.2-17.4) μ M that was higher (p < 0.05) than in healthy do-
nors - 1.59 (1.46-1.85) μ M (n = 20). It correlated with APACHE II - 10
(6-18), SOFA - 3 (1-8) scores and mortality (41%): rs = 0.645, 0.666
and 0.717 respectively, p < 0.01. A closer analysis of 5 patient sam-
ples revealed the following correlations: the total concentration of 9
AMM correlated with PCT - 0.580, HVA with PCT and presepsin –
0.810 and 0.709, respectively, PhLA with presepsin-0.770, p-HPhAA
with total DNA of bacteria and DNA Enterobactereacea in BAL– 0.635
and 0.724, p < 0.01.
Conclusions
The level of aromatic microbial metabolites in blood serum of ICU
patients with nosocomial pneumonia reflects the microbial load as
well as the quantity of bacterial DNA, PCT and presepsin.
Supported by Russian Science Foundation Grant 115-15-00110
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Introduction
According to in vitro data, levels of pro- and anti-inflammatory medi-
ators can be markedly decreased in septic shock by hemoperfusion
using a novel cytokine adsorbent therapy (CytoSorb). However, the
capacity and performance of the absorber over time has not yet
been investigated. Our aim was determine elimination of procalcito-
nin (PCT) by the adsorbent in vivo, in patients with septic shock
treated with CytoSorb for 24 hours.
Methods
The current study is a spin-off part of the ongoing “Adsorption Cyto-
kines Early in Septic Shock”, the ACESS-trial. CytoSorb therapy was
commenced early (<48h) after the onset of septic shock and per-
formed for 24 hours. Blood samples were taken from the systemic
circulation in every 6 hourly from the beginning (T0) to the end of
CytoSorb therapy (T6, T12, T18, T24). Serum PCT, CRP, IL-1, IL-1ra, IL-
6, IL-8, IL-10, TNF-α levels were measured. PCT levels were deter-
mined from blood taken simultaneously from the pre-, and post-
adsorbent samples. The efficacy of PCT elimination was defined at
every step by subtracting post-adsorbent (PCTpost) values from pre-
adsorbent (PCTpre) values: Δ PCT = PCTpre-PCTpost.
Results
Data were obtained from 7 patients and 8 treatments. Pre-adsorbent
PCT levels showed a significant decline throughout the study (T0 =
12.2 [5.6-84.2], T6 = 6.8 [4.8-36.5], T12 = 6.7 [4.8-33.2], T18 = 5.9 [4.5-
27.3], T24 = 5.1 [3.5-15.7] ng/ml; p = 0.011). Post-adsorbent PCT levels
showed a similar pattern (p = 0.012). The efficacy of net PCT
elimination (Δ PCT) was most effective at T0 = 11.7 [5.3-78.1] ng/ml,
and showed a significant decline over time: T6 = 2.5 [1.4-14.9] ng/ml;
T12 = 1.2 [0.3-6.1] ng/ml; T18 = 1.2 [0.5-4.8] ng/ml; T24 = 0.5 [-0.9-3.5]
ng/ml; p = 0.004. This corresponded of a median of 90% elimination
at T0, 30% at T6 and only 10% at T12 with no further change from
T12-T24. This pattern showed consistency in every patient and was
independent of the serum levels of PCT.
Conclusions
This study is the first to examine PCT elimination over time during
CytoSorb therapy. According to these results, PCT elimination
Critical Care 2017, 21(Suppl 1):58 Page 15 of 70showed an exponential decline from 90% to a negligible degree after
12 hours. This phenomenon, on the one hand, shows the early effi-
cacy of CytoSorb therapy, while on the other hand, it raises the ques-
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Introduction
The SOFA score is associated with an increased probability of mortal-
ity in sepsis. Assessment at admission in the ED requires several
laboratory variables. The Third International Consensus Definitions
for Sepsis and Septic Shock defined the qSOFA, which does not
require laboratory tests and can be assessed at patient admission.
Objective: To compare sepsis biomarkers with SOFA and qSOFA to
discriminate sepsis, severe sepsis or septic shock and to evaluate the
association with increased risk of mortality.
Methods
66 Patients admitted to the ED with signs of sepsis and =/>2 SIRS-
criteria were included. Severe sepsis and septic shock were defined
according to current guidelines. qSOFA score was calculated using
the recommended thresholds: respiratory rate =/>22/min, GCS score
<15, stystolic blood pressure >100mmHG. Presepsin and procalcito-
nin were determined using the POC assay PATHFAST Presepsin
(PSEP), LSI Medience, Japan and the BRAHMS luminescence immune
assay (PCT).
Results
SOFA and qSOFA, differentiated significantly between patients with
sepsis (n = 30, mortality = 6.6%) and the high-risk group with severe
sepsis or septic shock (n = 36, mortality = 36.1%). Discrimination be-
tween the groups revealed AUC values of 0.621, 0.627, 0.731, 0.740
and 0.781 for lactate, PCT, qSOFA, PSEP, and the combination qSOFA
+ PSEP, respectively. 15 patients died during hospitalization. AUC
values of mortality prediction were 0.715, 0.558, 0.734, 0.758 and
0.803 for lactate, PCT, qSOFA, PSEP and qSOFA + PSEP, respectively.
qSOFA scores =/>2 should identify greater risk of death or prolonged
ICU stay. Discrimination between qSOFA <2 and =/>2 revealed AUC
values of 0.756, 0.669 and 0.606 for PSEP, lactate and PCT.
Using the threshold =/>2 of qSOFA and =/>500 ng/L of PSEP, the
combination qSOFA + PSEP detected 14 non-survivors (93%) and 33
(92%) patients of the high-risk group (n = 36), whereas qSOFA alone
detected only 10 non-survivors (67%) and 21 patients of the high-
risk group (58%).
Conclusions
The results demonstrated that the qSOFA score is not a standalone
criterion for risk stratification in sepsis at admission. Simultaneous as-
sessment by combining qSOFA and PSEP improved the validity sig-
nificantly. The POC assay PATHFAST Presepsin showed superior
performance compared to lactate and PCT.
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Early identification of sepsis and its differentiation from non-infective
SIRS are important for sepsis outcome. We intended to evaluate the
use of presepsin in differentiating sepsis from non-infectious SIRS
and its prognostic value compared to CRP.
Methods
We included 31 patients (median age 60 year old, 16 males) admit-
ted with SIRS to El-Sahel Teaching Hospital, Egypt after excluding 21
patients with preadmission corticosteroids therapy, blood transfusion,
immunosuppressive illness, and ICU length of stay (ICU-LOS) less
than 24-hours. Patients were classified into non-infective SIRS group
(13 patients) and sepsis group (18 patients). Presepsin, CRP and SOFA
score were measured on admission and on days 2 and 4 of admis-
sion. The outcome parameters studied were ICU length of stay (ICU-
LOS) and in-hospital survival.
Results
Apart from temperature and AST which were significantly higher in
sepsis group, the two groups were comparable. All the presepsin
levels and CRP on days 2 and 4 were significantly higher in sepsis
than in SIRS groups. The ICU-LOS was positively correlated with all
the presepsin levels and with the CRP levels on days 2 and 4. All Pre-
sepsin values were significantly higher in survivors while none of the
CRP levels were significantly different in survivors and non-survivors.
The decrease of presepsin over time was significantly associated with
better survival. It was found to be 70% sensitive and 91% specific for
predicting survival in SIRS patients. This relation was not found in
CRP levels.
Conclusions
We concluded that the presepsin may be used for early differenti-
ation between sepsis and non-infectious SIRS and predict higher
mortality.P386
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Introduction
Several cumbersome scoring systems were developed for prognosis
and outcome prediction in sepsis. We intended in this study to evalu-
ate the urinary albumin/creatinine ratio (ACR) as a prognostic pre-
dictor in sepsis.
Methods
We included 40 adult septic patients in a prospective observational
study. We excluded patients with preexisting chronic kidney disease
or diabetes mellitus. After clinical evaluation, urine spot samples
were collected on admission and 24 h later for ACR1 and ACR2. Ad-
mission APACHE IV score and the highest recorded SOFA score of
their daily estimation were considered. We also evaluated the need
for mechanical ventilation, inotropic and/or vasoactive support, renal
replacement therapy (RRT), and in-hospital mortality.
Results
In a population with 63 (55–71) year old with 29 (72.5%) males, we
found that the ACR2 is correlated with the SOFA score (r =0.4, P =
0.03). SOFA was higher in patients with increasing ACR [14(4.8–16.8)
vs 5(3–8), P = 0.01]. None of the ACR measures was correlated with
APACHE IV score. ACR2 was higher in patients who needed mechan-
ical ventilation and inotropic and/or vasoactive support [140(125–
207) and 151(127–218) mg/g respectively] compared to [65(47–174)
and 74(54–162) mg/g], P = 0.01 and 0.009. None of the measured pa-
rameters was related to the need of RRT. ACR1, ACR2, APACHE IV
and increasing ACR were predictors of mortality. The AUC for mortal-
ity prediction was largest for APACHE IV (0.90) then ACR2 (0.88).
ACR2 of 110.5 mg/g was 100% sensitive and 86% specific to predict
mortality.
Conclusions
We concluded that the urinary ACR may be used as a simple test for
prognosis and mortality prediction in sepsis.
Critical Care 2017, 21(Suppl 1):58 Page 16 of 70P387
Syndecan-1 (SDC1) and sphingosine-1-phosphate (S1P) are
inversely associated in sepsis
MS Winkler1, M Holzmann1, A Nierhaus2, E Mudersbach3, E
Schwedhelm3, G Daum4, S Kluge4, C Zoellner1
1Dep. of Anaesthesiology, University Medical Center Eppendorf,
Hamburg, Germany; 2Dep. of Intensive Care Medicine, University Medical
Center Eppendorf, Hamburg, Germany; 3Institute of Clinical
Pharmacology and Toxicology, University Medical Center Hamburg-
Eppendorf, Hamburg, Germany; 4Department of Vascular Medicine,
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Critical Care 2017, 21(Suppl 1):P387
Introduction
Sepsis is characterized by endothelial dysfunction. Crucial for endothelial
function is the glycocalix (GLY), a carbohydrate-rich layer on the endothe-
lial surface, which regulates vascular permeability, microcirculation and
mechanotransduction. The GLY is anchored to the endothelium by glyco-
proteins and proteoglycans including Syndecan-1 (SDC1). Shedding of
SDC1 has been observed in situations when the endothelium is dam-
aged. Another key regulator of vascular permeability is sphingosine-1-
phosphate (S1P) that upon binding to endothelial S1P receptor 1
strengthens barrier function. It has been observed that S1P is able to pro-
tect the GLY by inhibiting matrix-metalloproteinase (MMP) activity. We
have recently observed decreased S1P levels in patients with sepsis, and
here, addressed the question whether decreased S1P levels are associ-
ated with increased concentrations of SDC1 in serum of septic patients in
the cohort we have previously studied for S1P levels [1].
Methods
The local ethics committee approved this study by acceptance of an
amendment to our previous protocol. 59 ICU patients with sepsis or
septic shock were enrolled. Blood samples were drawn at day 1 after
admission and serum was prepared. Soluble SDC1 was measured by
ELISA and S1P by mass spectrometry. The SOFA Score was used to
assess disease severity. Twenty health controls were included.
Results
SDC1 are increased and S1P levels are significantly decreased in sepsis pa-
tients when compared to controls. Highest SDC1 levels and lowest serum-
S1P levels were found in patients with septic shock. The mean serum SDC1
concentration was 33±24 ng/mL in controls, 196± 162 ng/mL in patients
with sepsis and 260±164 ng/L in patients with septic shock. Using linear
regression analyses, S1P and SDC1 were found inversely associated (P<
0.001). The SDC1/S1P ratio was positively associated with the SOFA score
(P< 0.01). By generating ROC curves for the SDC1/S1P ratio and the SOFA
score to indicate septic shock similar areas under the curve (AUCs) were
found with 0.77 for the SDC1/S1P ratio and 0.80 for the SOFA score.
Conclusions
We found increased SDC1 levels, which were associated with decreased
serum-S1P levels in septic patients. SDC1 and S1P are inversely correlated
and the ratio of SDC1/S1P reveals as valuable prognostic marker for septic
shock.
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Postoperative inflammation is associated with a sepsis like syndrome
including endothelial barrier disruption, volume depletion and
hypotension. Postoperative inflammation is especially associated with
surgical procedures which require extracorporeal circulation.
Sphingosine-1-phosphate (S1P) is a signaling lipid regulating perme-
ability and vascular tone. In animal models S1P and S1PR1 specific
agonists were able to limit trauma induced barrier disruption. More-
over in septic humans decreased serum-S1P levels could be identi-
fied as marker for sepsis severity. Low levels were predictive for
septic shock. Here we were interested if S1P levels are altered by sur-
gical trauma induced by cardiac bypass surgery.
Methods
26 patients with coronary heart disease planned for coronary bypass
surgery were prospectively enrolled in this study. Serum samples
were drawn pre-, post- procedure and on day 1 and day 4 after sur-
gery. S1P concentration in μM was quantified by mass spectrometry.
In addition we analyzed potential S1P sources: Red blood cells (RBC)
and platelets. We further quantified levels of other inflammatory
markers: C-reactive protein, procalcitonin, interleukin- 6 and von-
Willebrand antigen.
Results
Mean serum-S1P levels in patients before the procedure were 0.74 ±
0.2μM. S1P post-levels were lowest directly after surgery and
dropped by 50% (0.37 ± 0.11μM). In recovery serum-S1P levels were
increased to 0.60 ± 0.13μM on day 1 and was higher than pre levels
on the fourth day 0.82 ± 0.18μM. There was no difference observed if
patients were operated with or without extracorporeal circulation. In
both groups the serum-S1P kinetics were similar, with significantly
decreasing levels during surgery and increasing levels in recovery. In
a correlation analysis serum-S1P levels correlated with its sources red
blood cell (RBC) and platelet count. We did not observe a significant
correlation of S1P levels with the dosage of vasopressors in the intra-
operative phase or other inflammatory markers.
Conclusions
Cardiac bypass surgery induces a rapid decrease in serum-S1P levels.
S1P might be a marker for early inflammation postoperative systemic
inflammation, which is independent from other commonly used
inflammatory markers.
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Introduction
Early diagnosis of acute posttraumatic osteomyelitis (POM) is of vital
importance to avoid devastating complications. Lack of specific and
sensitive test as in myocardial infarct makes it difficult to diagnose
POM. Serum inflammatory markers are not able to differentiate be-
tween response to infection and the host response to non-infection
insult.
Methods
The prospective nonrandomised cohort study included 115 patients
after high-energy injury to cruris required to be primary surgical
treated. Values of biochemical and immunoinflamatory profile were
measured on admission (ADD), first postoperative day (POD1) and
fourth-postoperative day (POD4). Collected data from laboratory
measurement and inpatient and outpatient medical records were
analysed by descriptive statistics, univariate logistic regression and
multivariate logistic regression with Firth correction and penalized
regression.
Results
The best predictors of PO on admission are T regulatory cells
CD4 + CD25+, CRP and WBC counts, on POD1: WBC counts, CRP
and PCT and on POD4: CRP, albumins, PCT and WBC counts. Per-
forming logistic regression with Firth correction and multivariate
Critical Care 2017, 21(Suppl 1):58 Page 17 of 70penalized regression we found out that we can best predict de-
velopment of PO by measuring CRP on ADD, POD1, POD4, PCT
on ADD and POD4, albumins on POD4 and assessment of extent
of soft tissue damage, transfusion rate, need of conversion pri-
mary external fixation to intramedullary (IM) nailing or locking
plate fixation and patient’s physical status ASA 3-4 according to
the American Society of Anesthesiologists. Our LASSO predictive
model with cross-validated parameters has shown good perform-
ance (AUC = 0,75).
Conclusions
We can improve prediction of POM development by using peri-
operative inflammatory biomarkers PCT and CRP in combination
with postoperative albumins and considering independent risk
factors.
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Introduction
The goal of this investigation was to determine if acute influenza in-
fection is associated with depletion of Coenzyme Q10 (CoQ10) and
to determine any associations between CoQ10 levels and severity of
illness and inflammatory biomarkers. CoQ10 is a key cofactor in the
mitochondrial respiratory chain and may be depleted in acute critical
illness. Prior investigations have found a correlation between de-
pleted CoQ10 levels in patients with both septic shock and post-
cardiac arrest and the inflammatory cascade. Statin medications have
also been associated with decreased CoQ10 levels.
Methods
We analyzed serum CoQ10 concentrations of patients with acute in-
fluenza infection who were enrolled in a randomized clinical trial ad-
ministering atorvastatin or placebo. Patients were enrolled at a single
urban tertiary care center over 3 influenza seasons (12/2013 to 5/
2016). Blood samples were obtained at enrollment prior to adminis-
tration of any study drug. Healthy adult controls were used for com-
parison. We used Wilcoxon rank sum test to compare CoQ10 levels
between influenza patients and controls. Correlations between
CoQ10 levels and other inflammatory biomarkers and patient-
reported severity of illness were assessed using Spearman correlation
coefficient.
Results
We analyzed CoQ10 from 50 patients with influenza and 29
healthy controls. Overall, patients with acute influenza infection
had lower levels of CoQ10 compared to controls (0.61 ± 0.31 vs
0.77 ± 0.23 ug/mL, p = 0.004). There were significantly more pa-
tients in the influenza group with low CoQ10 levels compared to
controls (48% vs 7%, p = 0.0001). There were significant correla-
tions between CoQ10 levels in influenza patients and several in-
flammatory biomarkers: interleukin-2 (IL-2) (r = -0.297, p = 0.038),
tumor necrosis factor alpha (TNF-α) (r = -0.352, p = 0.013) and vas-
cular endothelial growth factor (VEGF) (r = 0.381, p = 0.007). There
was no correlation between influenza severity of illness score at
time of enrollment and CoQ10 levels.
Conclusions
We found that CoQ10 levels were significantly lower in patients with
acute influenza infection as compared to controls and that CoQ10
levels had a significant correlation with several inflammatory bio-
markers. Further study is warranted to define these relationships and
identify potential targets for therapy in acute influenza.
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Sepsis is the body’s systemic inflammatory response to infection and
can progress to severe sepsis, septic shock and ultimately multiple
organ failure. Rapid detection of severe sepsis and septic shock is
crucial for good outcome. Heparin- binding protein (HBP) is a multi-
functional inflammatory mediator. HBP has been demonstrated in
various infectious diseases caused by a wide array of bacteria. Procal-
citonin and heparin -binding protein value may be useful for early
diagnosis in sepsis, severe sepsis and septic shock patients in inten-
sive care unit. The present study was conducted to determine the
heparin- binding protein, procalcitonin level at early diagnosis in pa-
tients with sepsis, in comparison with C-reactive protein, IL-6 and
TNF-alfa.
Methods
This was a prospective, observational of ICU patients with suspected
infection, conducted Health Sciences University, Kocaeli Derince Tran-
ing Hospital’s ICU. The study was conducted aver a 7- month period
between January and July 2016. Blood samples were taken on the
first and second day of hospitalization, and the seventh day, on day
of discharge or on the day of death.
Results
Heparin-binding protein, PCT, TNF-alaf- IL-6 and C-reactive protein
levels increased in parallel with the severity of the clinical condi-
tion of the patient. Heparin binding protein exhibited a greatest
sensitivity and specificity in differentiating patients with sepsis.
Also, when comparing all the data; HBP was the best predictor of
early diagnosis sepsis and organ dysfunction (Our sturdy
continues).
Conclusions
In the present study heparin binding protein was found to be a
more accurate diagnostic parameter for differentiating sepsis and
organ dysfunction.Heparin binding proetin may be helpful in the
follow up of sepsis patients. HBP measurement in the ICU may
help monitor treatment in patients with sepsis, severe sepsis and
septic shock.
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Introduction
Ventilator-associated pneumonia (VAP) is the most common noso-
comial infection in critically ill patients and associated with in-
creased mortality and morbidity, and prolonged mechanical
ventilatory support and length of stay in the intensive care unit.
The Clinical Pulmonary Infection Score (CPIS) based on chest X-
ray has been developed to facilitate clinical diagnosis; however,
this scoring system has a low diagnostic performance. In this
study, the authors developed a new scoring system for early
diagnosis of VAP called “Lung Ultrasound and Pentraxin-3 Pul-
monary Infection Score (LUPPIS)” which is based on pentraxin-3
(PTX-3) levels and lung ultrasonography and evaluated the per-
formance of this new scoring system.
Methods
This single center, observational, prospective study included 78
patients, who received therapy as an inpatient in the Intensive
Care Unit between January 2015 and April 2016 and who were
suspected of having VAP. At the day of study, an endotracheal
aspirate was obtained for Gram staining and culture. PTX-3, pro-
calcitonin (PCT), and other biomarkers were recorded. The
Table 2 (abstract P393). See text for description
Percentage 1 week mortality Percentage 1 year mortality
NEWS ≤ 6 4 26
NEWS ≥ 7 13 25
Legend : Difference in percentage mortality based on NEWS
Critical Care 2017, 21(Suppl 1):58 Page 18 of 70diagnosis of VAP was confirmed according to either culture posi-
tivity or in culture negative patients, all clinical criteria and initi-
ated or modified antibiotic regimen within 48 hours.
Results
No significant differences were found between groups with re-
spect to age, mechanical ventilation time, APACHE II score, and
SOFA score (p > 0.05). PCT and PTX3 levels were significantly
higher in the VAP (+) group (p < 0.001 and p < 0.001, respect-
ively). The threshold for LUPPIS in differentiating VAP (+) patients
from VAP (-) patients was >7 according to the highest Youden
Index. In predicting VAP, LUPPIS > 7 (sensitivity of 84%, specificity
of 87.7%) was superior to CPIS > 6 (sensitivity of 40.1%, specificity
of 84.5%).
Conclusions
Early diagnosis of VAP currently remains challenging due to lack
of a validated gold standard diagnostic method. The diagnosis
and follow-up of pulmonary infections rely on the chest x-ray,
although this is not feasible for critically ill patients in daily
practice. Lung ultrasound (USG) is an important, simple, non-
invasive, and cost-effective technique used in the diagnosis and
differentiation of lung pathologies. Considering the overlap be-
tween sensitivity analysis and confidence intervals in the
present study, LUPPIS appears to provide better results in the
prediction of VAP compared to CPIS, and the importance of
lung USG and PTX-3 is emphasized, which is a distinctive prop-
erty of LUPPIS.Fig. 12 (abstract P393). Difference in organ support requirements
during ICU stay based on NEWSP393
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Introduction
The National Early Warning Score (NEWS) is a UK-wide system meas-
uring physiological variables to standardise evaluation of acute ill-
ness. We hypothesise that the NEWS may provide novel prognostic
information for patients admitted to ICU.
Methods
We retrospectively assessed the NEWS and outcomes of emergency
admissions in ward-based patients to the critical care unit in a UK
tertiary care hospital. Data was obtained via patient notes and elec-
tronic records over a 6-month period. We evaluated: the NEWS trig-
ger, the seniority of ward doctor reviewing the patient prior to ICU
admission, Medical Emergency Team (MET) involvement, organ sup-
port requirements and mortality outcomes. in two distinct cohorts,
NEWS > =7 versus NEWS < =6.
Results
50 sets of notes were analysed. In the NEWS > =7 group, 65% of
patients were seen by a ward registrar or above prior to critical
care involvement. Only 42% of patients admitted to the ICU with
NEWS > =7 triggered a MET alert, below the national standard.
Over 90% of patients in both groups required at least one form
of organ support, with a preponderance of basic cardiac and
renal support in the NEWS < =6 group. The one-week mortality
was higher in the NEWS > =7 group at 13% versus 4%, but 1-year
mortality difference was negligible.
Conclusions
The RCP guidance for triggering an emergency review is poorly ad-
hered to in our hospital. The necessity for organ support and one-
year mortality were similar in both groups, suggesting that patients
with NEWS < =6 are as vulnerable as the higher scoring group. This
highlights a need to be identified more accurately. We propose the
NEWS is combined with a nurse led observational “level of concern”
score, supporting earlier referral to a senior physician.
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Introduction
Several scoring systems are used to risk stratify patients and alert
staff to clinical deterioration. In the UK, the most widely used of
these is the NEWS, a scoring tool based on physiological observa-
tions. There is increasing evidence that NEWS may be a useful diag-
nostic and prognostic tool in sepsis [1]. A novel biochemical
extension to the NEWS, using parameters from a blood gas (the
metabolic score) was found to predict organ failure and death within
48 hours of admission [2].
We compared the predictive ability of NEWS with metabolic score for
morbidity and mortality outcomes in patients with sepsis.
Methods
This retrospective observational study involved adult patients pre-
senting to the emergency department of University Hospital Lew-
isham (UK) from September 2015-August 2016 with sepsis
requiring inpatient care. Demographic data was gathered from
the hospital electronic patient record system. NEWS was calcu-
lated from physical observations taken during the patients’ triage.
The presence of co-morbidities and metabolic score were col-
lected using a pro forma (completed by the clinician managing
each case).
The primary outcomes were evidence of organ failure, escalation of
care and death within 48 hours of admission. This information was
gathered from the electronic patient record system.
Results
Data was gathered from 140 patient attendances (mean age = 65
years [SD = 19.98], male = 65). 61 patients were identified as having
evidence of organ failure, 12 patients required escalation of care and
22 patients died.
After controlling for demographic data, NEWS score at triage was
predictive for the development of organ failure (p = 0.002) and death
(p = 0.003) however it held no predictive value for escalation of care
Critical Care 2017, 21(Suppl 1):58 Page 19 of 70(p = 0.045). Metabolic score was predictive for death (p = 0.013) and
the need for escalation of care (p < 0.001), however it was not
predictive for the development of organ failure (p = 0.65).
Conclusions
Neither the NEWS or metabolic score can accurately predict the
development of organ failure, escalation of care and death. We suggest
that a combination of these scores should be used to aid risk stratifica-
tion of septic patients presenting to the emergency department
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Introduction
We compared the new criteria of sepsis (Sepsis-3) with the previous
criteria (Sepsis-2) to predict hospital mortality in oncological patients
of a Brazilian Cancer Hospital. Any improvement on sepsis treatment
shall begin with the early detection, especially in high-risk popula-
tions as the oncological patients in developing countries. Any diag-
nosis criteria that delay the diagnosis will impact on patients’
outcomes, especially in mortality.
Methods
Retrospective study conducted between 2009 and 2014 in a 55-
bed ICU of a tertiary and teaching Cancer Hospital. We included
all oncological patients admitted in the ICU that received the
diagnosis of sepsis, severe sepsis or septic shock at the ICU ad-
mission by the attending physician. Mortality was compared
across categories of both Sepsis-2 (sepsis, severe sepsis, shock
septic) and Sepsis-3 definition (infection, sepsis, septic shock). A p
value < 0.05 was considered statistically significant.
Results
The medical records of 487 patients were collected from a prospect-
ively recorded database. Mean age was 60 + 14 years, median SOFA
was 7 + 7, respiratory tract infection was the most common cause of in-
fection (21%, 101 patients), 398 patients (82%) presented solid tumor,
89 (18%) hematological malignancies and 297 (62%) had metastasis,
median ECOG was 2 + 1.3 and 285 patients (59%) died in hospital. The
mortality rate was progressively higher across categories of sepsis de-
fined by Sepsis-3 consensus: infection with no organ dysfunction (28%);
sepsis (55%) and septic shock (69%) (p < 0.001). There was no statisti-
cally significant difference among the categories of Sepsis-2 definitions,
neither when they were analyzed separately: sepsis (50%); severe sepsis
(57%) and septic shock (62%) (p = 0.2). One-hundred and fifteen pa-
tients (24%) did not meet sepsis criteria according to the Sepsis - 2 con-
sensus but were diagnosed by ICU physicians as such. This group also
showed a high mortality rate (49%).
Conclusions
In oncological patients of a Cancer Hospital located in a developing
country, Sepsis 3 criteria were accurate in stratifying hospital mortal-
ity and in some aspects superior to the definitions previously used.
References
1. Kaukonen K et al.: N ENG JMED 2015; 371 (17): 1–10
2. Seymour et al.: JAMA 2016; 315 (8): 762–774
P396
Combining usage of national early warning score (NEWS) and
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Patients with early stage of post hematopoietic stem cell
transplantation (HSCT) have a great risk of infectious complica-
tion. Sepsis contributes to morbidity and mortality in those
patients. Therefore, it’s crucial to early detect sepsis and to treat
with rapidly proper management. Our hypothesis is national
early warning score (NEWS) and rapid response team (RRT) is
useful to early detect and resuscitate sepsis in HSCT patients.
Methods
All post HSCT adult patients in sterile room unit who developed
persistent fever for 3 days in our university hospital from January
to December 2014 were included in this retrospective observa-
tional study. Patients were divided into two groups, 1) the con-
trol group and 2) the intervention group. Patients in the control
group were treated with a local routine protocol. Patients in the
intervention group had a local routine protocol treatment and
were further evaluated with NEWS and RRT was activated simul-
taneously. RRT was activated when total NEWS score was
exceeded 7 or individual item score was exceeded 3. The 90-day
mortality, the number of ICU patients, SOFA score at ICU admis-
sion, the number of patients with vasopressor, the number of pa-
tients required mechanical ventilation, and days in post HSCT
sterile room unit were compared between two groups. Values
were expressed as mean ± SD. Data were analyzed by Mann–
Whitney U-tests or Χ test. A p < 0.05 was considered as statisti-
cally significant.
Results
There were 66 patients (35 men, 31 women; age median 37 (18-
62)) in this study. The number of patients who admitted to ICU
(6 vs. 3), SOFA score at ICU admission (7.6 ± 1.3 vs. 5.2 ± 1.2), the
number of patient who required vasopressor (8 vs. 4) and the
number of patient who required mechanical ventilation (6 vs. 3)
were statistically higher in the control group than in the interven-
tion group (p < 0.05). There were no significant differences in sex
in 90-day mortality (17.6% vs. 15.6%) and days in post HSCT ster-
ile room unit (17.4 ± 2.4 vs. 16.7 ± 2.8).
Conclusions
The NEWS monitoring and RRT did not statistically improved 90-
days mortality in this study. However, the strategy using NEWS
and RRT could contribute to early detect deteriorations and to
timely ICU care in post HSCT patients who admitted in a special
sterile room.
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Introduction
Following publication of the Sepsis-3 review [1], we aimed to
evaluate the awareness and use of the new qSOFA criteria for
assessing patients with suspected sepsis and the use of SOFA
scoring for subsequent evaluation. We also aimed to assess the
correlation between MEWS and qSOFA, and the strength of the
24hr/48hr/mean/maximum SOFA and APACHE2 as predictors of
mortality when compared to patient outcome.
Methods
This is a retrospective cross-sectional study over a period of 3
months. The patients’ electronic records were reviewed for the
use and documentation of qSOFA, SOFA, or any other clinical pa-
rameters to justify sepsis requiring ICU input. If not present, the
SIRS, qSOFA, 24hr, 48hr, mean & maximum SOFA scores were
then calculated. Outcome (discharge vs death) was tested against
the mortality risk scores. Inter-test agreement independent of
outcome was also analysed. Pearson correlation and binary logis-
tic regression analysis was used to assess for statistical
significance.
Results
Of the 214 patients admitted over the three-month period,
81% were admitted with a SIRS score of > =2 regardless of
Fig. 13 (abstract P398). See text for description
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due to sepsis. None had SIRS or qSOFA documented either
prior to or during their ICU admission. All had MEWS, APACHE2
and SOFA scores done only on ICU admission. They all had a
retrospectively calculated admission qSOFA of 2 and their 24hr
SOFA scores ranged between 5 and 16. Two patients admitted
with sepsis had SOFA scores of 10 and 16 respectively, a
qSOFA score of 2, but only 1 SIRS criterion. Three patients had
a MEWS of 2, nine between 4-5 and twenty-two between 6-20;
94% of patients with sepsis admitted to ICU had MEWS of > =4.
The top 5 clinical parameters used to justify ICU input due to
sepsis were: reduced GCS, hypotension, tachycardia, pyrexia
and Type 1 respiratory failure. The strongest correlation for pa-
tient outcome was with 48hr SOFA (p < =0.01), followed by
mean SOFA (p < =0.01) and APACHE-II (p < =0.05). The best
agreement between the mortality prediction scores was with
APACHE2 and the mean SOFA score (p < =0.01), independent of
outcome.
Conclusions
Despite the dichotomy of approach to sepsis, clinical judgement
has remained constant. We observed that the 48hr SOFA had
the best correlation with patient outcome. All septic patients
had a qSOFA of 2, correlating well with a MEWS of > =4 seen in
the majority of septic patients prior to their ICU admission,
however we agree with Vincent et al [2] that until qSOFA is val-
idated further, it should be used as a guide and not a replace-
ment of SIRS.
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Introduction
Antibiotic resistance is increasing in frequency due to higher rates of
inappropriate antimicrobial therapy and empiric use of broad-
spectrum antibiotics.
Methods
We employed a real-time multiplexed automated microscopy system
(ID/AST; Accelerate Diagnostics, Tucson, Arizona) capable of evaluat-
ing antibiotic susceptibility and resistance directly from positive
blood culture broth in septic patients using automated phenotypic
growth pattern analysis.
Results
Pathogens included Klebsiella species (N = 17), E. coli (N = 16), En-
terobacter species (N = 7), P. aeruginosa (N = 7), other Gram-
negative species (N = 10), and Candida species (N = 11). Mortality
was greater for patients treated with an inactive initial regimen
(63.2% versus 6.5%; P < .001). Antimicrobial de-escalation occurred
in 41 (63.1%). Time to patient identification and antimicrobial sus-
ceptibility using conventional methods was 51.4 hours [48.0, 54.6]
versus 10.2 hours [8.3, 11.5] for ID/AST (see Fig. 13). For patients
receiving an inactive regimen, ID/AST would have potentially
allowed appropriate therapy to be administered a median of 35.8
hours sooner; while de-escalation could potentially have occurred
41.1 hours sooner.
Conclusions
The ID/AST system provided accurate pathogen identification and
susceptibility more than 1 day sooner compared to standard blood
culture processing.P399
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Introduction
Catheter-related bloodstream infection (CRBSI) requires a positive blood
culture and a positive result by the semiquantitative culture method
(SQC) or the quantitative sonication method (SON). Our aim is to com-
pare the yields of both techniques to detect the colonization and infec-
tion, in short and long term catheters in ICU patients.
Methods
We prospectively studied central venous antimicrobial catheter. Both
methods were performed on tips cut into 2 equal segments each, to
avoid loss of microbial colonies during serial examination and con-
tamination. SQC method was performed by rolling the tip on a
Columbia agar plate. Sonication was applied by placing the tip in 5
ml of 0.9NaCl, sonicating for 5 min, vortexing for 15s and culturing
0.1 mL of the fluid on a Columbia agar plate too. The cutoff for tip
colonization was 15 cfu for SQC and 100 cfu for SON.
Results
112 catheter tips (81long, 31short term) from 73 patients were included.
The overall catheter tip colonization was 38.4% (43/112). The SON
method detected colonization in 39/43 (90.6%) and SQC in 25/43 (58.1%)
catheters p < 0.01). 18/112 patients (16%) had a definite CRBSI according
to the current guidelines. 17/18 (94.4%) were detected by SON method
and 9/18 (50%) by SQC method. Most commonly bacteria were Entero-
bacteriaceae, isolated by SON in 54.5% and by SQC in 45.5%, followed by
coagulase-negative staphylococci in 22.7% and 11.4% respectively. SON
detected Candida spp. in 8.1% while SQC failed.
Conclusions
Our findings, unlike previous studies, imply superiority of the SON
method over SQC, in detection of catheter colonization and CRBSI. A
hypothetical explanation is based on the prolonged sonication time
of 5 min (instead of the usual 1 min), which probably enhances de-
tachment of gram (-) bacteria that as endoluminal bacteria are more
difficult to isolate by SQC. Especially for long term catheters, where
colonization by gram (-) bacteria is most often, according to the lit-
erature, the sonication method may be prove particularly useful for
colonization detection and CRBSI diagnosis. Further investigation is
envisaged to explore the potential of the method.
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Introduction
Hospital-acquired (or nosocomial) infections are important causes of
morbidity and mortality despite improved antimicrobial therapy, sup-
portive care, and prevention. However, due to aging, comorbidities
and repeated contact with healthcare facilities, many patients are
already infected with multidrug-resistant (MDR) pathogens at the
time of ICU admission.
Methods
Retrospective analysis of microbiologic exams taken at admission in
a ICU over one year, using data obtained from microbiology labora-
tory. Characterization of positive samples regarding pathogens iden-
tified and clinical setting (community vs hospital acquired).
Results
2788 samples were obtained in 510 patients admitted to the ICU dur-
ing 2015. Regarding the type of sample, 23.6% were tracheal aspirate
cultures, 57.6% blood cultures and 18.7% urine cultures. We collected
560 positive samples, obtained from 280 patients. From the tracheal
aspirate cultures, 38.3% were positive. The most frequent pathogen
was S. aureus, found in 74 samples – 15 of which were oxacilin resist-
ant. 8 of these patients were admitted from the ER. The other were
transferred from wards: 3 from medical wards and 4 from surgical
wards, with an average lenght of stay (LOS) before ICU admission of
5 days. 9 samples were positive for A. baumanii, 1 admitted from ER,
3 from surgical and 5 from medical wards. In 7 samples were found
ESBL positive pathogens, 5 coming from surgical wards, 1 from ER
and 1 from medical ward. From the blood cultures, 11.6% were posi-
tive. The most common pathogen was S. epidermidis in 46 samples.
Regarding MDRs, we found 9 MRSA, 5 ESBL positive germens and 4
A. baumanii. The MRSA positive samples were obtained from patients
coming mostly from surgical wards (5), followed by medical wards
(2) and ER (2), with an LOS before ICU admission of 9.4 days. The
ESBL positive pathogens were found in 3 patients admitted from ER
and 2 patients from surgical wards, with average LOS previous to ad-
mission of 4.6 days. A. Baumanii was identified in 2 patients coming
from medical wards, 1 from surgical and 1 from ER. In urine samples
the most frequent germen was E. coli, found in 7 samples; and K.
pneumoniae, found in 5. From these, 3 were ESBL positive, 2 coming
from surgical wards and 1 from ER. The average LOS before ICU ad-
mission was 5.0 days. 2 samples were positive for A. baumanii. MDR
Pseudomonas aeruginosa were found in 2 samples.
Conclusions
MDRs were found at ICU admission in 54 samples (9.6% of all posi-
tive samples). 44.4% came from surgical wards and 33.3% from ER.
The number of MDR found in patients admitted from ER probably
results from repeated contact with healthcare facilities. Surgical
patients are more prone to MDR infections.
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Introduction
Whilst bronchoalveolar lavage (BAL) in the context of adult extracor-
poreal membrane oxygenation (ECMO) has been shown to be safe
[1], there is a paucity of data regarding the microbiological yield and
microbiota of BAL in this setting. In community acquired pneumonia
(CAP), BAL may be of additive diagnostic value in around 50% of pa-
tients [2], with a similar yield in ventilator associated pneumonia
(VAP) [3]. The aim of this study was to describe the positive micro-
biological BAL results and the yield of BAL in the context of adult
veno-venous ECMO (VV-ECMO) at a large UK ECMO centre.Methods
A retrospective analysis was conducted of all BAL microbiological re-
sults of patients supported with VV-ECMO at a UK specialist centre
for severe acute respiratory failure. Data were collected for the period
April 2014 to July 2016, restricted to the initial diagnostic BAL done
on admission to this centre.
Results
Of the 85 patients treated with VV-ECMO, BAL was performed on ad-
mission in 71/85 cases (84%). The vast majority (83/85) were on anti-
biotics for suspected bacterial pneumonia. A total of 58 positive
microbiological results were obtained from 45/71 patients, giving an
overall BAL yield of 63%. The bacterial yield from BAL was 18%.
Fungi were isolated from 23 patients (32%), respiratory viruses from
19 patients (27%), and bacteria from 13 patients (18%). The most
commonly isolated fungi were species of Candida (predominantly C.
albicans), found in 18 patients. Aspergillus was isolated from 4 pa-
tients (6%), but in no case was it the only organism identified. Influ-
enza A, found in 11 patients (15%), accounted for more than half of
all the positive virology results. Staphylococcus aureus was the most
common bacterium isolated (7%), closely followed by Pseudomonas
aeruginosa (6%).
Conclusions
BAL on admission to a specialist centre provides an acceptable over-
all microbiological yield in the context of VV-ECMO (as compared
with previous data for CAP and VAP). The bacterial yield is low. The
finding of a positive BAL fungal result should be correlated with the
clinical context.
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Introduction
The aim was to estimate the rate of urinary tract infection in bacteri-
uria, duration of urinary tract infection treatment and length of stay
also associated factors with poor outcome in Coronary Care Unit
patients.
Methods
Retrospective analysis of 57 patients data with bacteriuria treated in
Coronary Care Unit in Hospital Kaunas Clinics of Lithuanian University
of Health Sciences during 5 years was carried out.
Results
Urinary tract infection was revealed in 52 patients (91.2%) of 57 with
bacteriuria, p < 0.05. Mean length of stay in Coronary Care Unit in
case of bacteriuria as colonisation was 3.6 ± 1.8 days, in bacteriuria as
urinary tract infection was 10.67 ± 3.9 days, p < 0.05. Length of stay in
Coronary Care Unit was 10.68 ± 5.3 days if urinary tract infection was
caused by bacteria, 27.75 ± 12.3 days by fungi, p < 0.05. Duration of
urinary tract infection in 24 patients with adequate empirical antibac-
terial treatment was 9.9 ± 4.7 days, but 15.7 ± 3.3 days in 28 patients
with inadequate antibacterial treatment, p < 0.05. Length of stay in
Coronary Care Unit was 3.3 ± 2.1 days in case of adequate empirical
antibacterial treatment, 14.7 ± 5.3 days when inadequate, p < 0.05.
Twenty – one patient (40.4%) of 52 with urinary tract infection has
died in Coronary Care Unit. Seventeen patients (39.5%) of 43 have
died in group > = 65 years, 4 patients (44.4%) of 9 in group 50 – 64
years, but all 5 patients < 50 years have survived, p < 0.05. 5 patients
(45.5%) of 11 with diabetes mellitus have died (95%; OR 1.3; CI 0.33 –
4.99; p < 0.05). Twenty – one patient (42.9%) has died of all 49 with
urinary bladder catheterization, 8 patients (25%) of 32 with short –
term urinary bladder catheterization, 13 patients (76.5%) of 17 with
Critical Care 2017, 21(Suppl 1):58 Page 22 of 70long – term urinary bladder catheterization, but none of 8 patients
without of it, p < 0.05.
Conclusions
Rate of urinary tract infection in bacteriuria was 91.2%. Length of stay
in Coronary Care Unit was longer in case of bacteriuria due to urinary
tract infection and fungi as pathogens of it. The length of urinary
tract infection treatment as well as stay in Coronary Care Unit was
shorter in case of adequate antibacterial treatment. The mortality
rate of urinary tract infection in Coronary Care Unit was 40% related
to age > = 50, diabetes mellitus, urinary bladder catheterization, es-
pecially long – term.
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Introduction
Ventilator-associated pneumonia (VAP) is an infection related to high
mortality, high costs for antibiotic therapy and long hospital stays
and rehabilitation programs. Our retrospective and observational
study aims to evaluate the prevalence of bacterial colonization of the
airways in tracheostomized and ventilated patients, affected by
motoneuron disease [1, 2].
Methods
22 tracheostomized patients, ventilated for 24 hours a day, at home,
affected by motoneuron disease, followed in the period 2015-2016,
tracheostomic cannula change every 90 days, tracheobronchial sam-
ple and chest X-ray performed every year in absence of VAP. In the
considered period, no patients was hospitalized nor has received tar-
geted antibiotic therapy. It was compared the prevalence of bacterial
colonization in 2015 compared to 2016.
Results
In 2015 the prevalence of Pseudomonas Aeruginosa was 64%, of
MRSA (Stafilococcus Aureus methicillin resistant) 35%, of Klebsiella
Pneumoniae 5% and of Enterobacteriacee (Providencia, Serratia, Pro-
teus, Enterococchi) 52%. 52% of patients have polymicrobial infec-
tions. In 2016 the prevalence of Pseudomonas Aeruginosa was 63%,
of MRSA 45%, of Klebsiella Pneumoniae 9% and of Enterobacteriacee
54%. 54% of patients have polymicrobial infections. In any of the 2
periods are found colonizations by totiresistant bacteria.
Conclusions
Comparing the 2 periods, we found that there aren’t substantial per-
centage differences of prevalence of bacterial colonization by Gram
negative bacteria; on the contrary there is an increase of bacterial
colonization by Gram positive bacteria - MRSA. Our study shows that
tracheostomized patients, ventilated for 24 hours a day at home do
not develop totiresistant colonization.
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Introduction
Endotoxin tolerance leads to an attenuated inflammatory response
at a second hit [1]. From this it was hypothesized that bacterial killing
might be affected similarly. If so, studies whether this might be of
importance for the choice of antibiotics are warranted. In a previous
study it has been shown that bacterial elimination and killing inbacteraemic animals occur in the spleen and liver [2]. Therefore, the
objective of this study was to compare the killing of bacteria in the
spleen and liver in animals made endotoxin tolerant by a 24h-
endotoxin infusion with that in animals not exposed to endotoxin.
Methods
The endotoxin exposed group (Exp) (n = 18) were, prior to the bac-
terial exposure, given 0.063 μg/kg/h endotoxin during 24 h. There-
after, an Escherichia coli intravenous infusion of 8.3 log10 Colony
Forming Unit (CFU)/h was administered for 3 h. The endotoxin unex-
posed group (Unexp) (n = 18) was given an identical bacterial chal-
lenge but without the preceding exposure of endotoxin. The animals
were observed for signs of sepsis and inflammatory response and
treated in accordance with an intensive care protocol [2]. Blood cul-
tures were obtained hourly. After 6 h the animals were killed by a
potassium chloride injection. Biopsies for quantitative culture were
taken from the liver and spleen immediately post mortem.
Results
All animals developed signs of sepsis. Peak TNF-α levels 1 h after
start of the bacterial infusion were 2.27 ± 0.13 and 4.17 ± 0.13 log10
pg/ml (mean ± SE) in the Exp and Unexp groups, respectively. Clear-
ance of bacteria from the blood was rapid and within 1 h. The Exp
group demonstrated a significantly increased killing and attenuated
growth of bacteria in the spleen and a similar trend in the liver.
Mean bacterial growths in the spleen of the Exp and Unexp groups
were 3.16 ± 0.13 and 3.73 ± 0.17 log10 CFU/g (mean ± SE), respectively
(p = 0.01). Mean bacterial growths in the liver of the Exp and Unexp
groups were 2.01 ± 0.18 and 2.40 ± 0.23 log10 CFU/g (mean ± SE), re-
spectively (p = 0.20).
Conclusions
Contrary to the hypothesis the reduced cytokine response character-
istic for endotoxin tolerant animals was not associated with a re-
duced bacterial killing in the spleen and the liver. This indicates that
these processes do not run in parallel in vivo. The effect on bacterial
killing after more prolonged activation of inflammatory and anti-
inflammatory responses needs further investigation.
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Introduction
Klebsiella pneumoniae (KP) infection is associated with high morbid-
ity and mortality in different clinical settings. Multi-drug resistance
associated with extended spectrum beta-lactamase (ESBL) among KP
is endemic worldwide. Our study aims to evaluate the clinical charac-
teristics and outcomes of patients with KP bacteraemia in the critical
care and general ward settings.
Methods
Adult patients admitted to a regional hospital in Hong Kong from 1
January 2009 to 30 June 2016 (7.5 years) with KP bacteremia were in-
cluded. Demographics, disease severity, clinical features, microbio-
logical characteristics and outcome were analyzed.
Results
Among the 853 patients, 178 (20.9%) required critical care and 176
(20.6%) died within 30 days of hospital admission. 30-day survivors
were younger (p < 0.001), had lower disease severity (defined by
SOFA score) (p < 0.001), presented with hepatobiliary sepsis (p <
0.001) or urosepsis (p < 0.001), less septic shock (p = 0.013) or require-
ment of invasive organ support (p < 0.001) and received appropriate
empirical antibiotics (p < 0.001). Cox regression analysis showed that
Critical Care 2017, 21(Suppl 1):58 Page 23 of 70respiratory tract (HR = 2.99; 95% CI = 2.061-4.337;p = <0.001), gastro-
intestinal tract (excluding hepatobiliary system) infection (HR = 2.763;
95% CI = 1.761-4.337; p = <0.001), use of mechanical ventilation (HR
= 2.202; 95% CI = 1.506-3.221; p = <0.001), medical case (HR = 1.830;
95% CI = 1.253-2.672; p = 0.002), inappropriate empirical antibiotics
(HR = 1.716; 95% CI = 1.267-2.324; p = <0.001), female (HR = 1.699, CI
= 1.251-2.307, p < 0.001), age >65 (HR = 1.692; 95% CI = 1.160-2.467;
p = 0.006) and presence of solid tumor (HR = 1.457; 95% CI = 1.056-
2.009; p = 0.022) were independent risk factors for 30-day mortality.
Unexpectedly, presence of diabetes mellitus was associated with a
better 30-day survival (p = 0.002). ESBL-producing strains were identi-
fied in 102 patients (12.0%). Non-hepatobiliary sepsis, use of systemic
steroid within 30 days before positive blood culture, presence of
solid tumor and use of central venous catheter independently pre-
dicted the occurrence of ESBL KP bacteremia. However, presence of
an ESBL strain was not associated with higher 30-day mortality.
Conclusions
KP bacteremia is associated with high 30-day mortality. Site of infec-
tion, patient’s comorbidities and appropriate use of empirical antibi-
otics are important predictors of patients’ outcome. Early empirical
antibiotics in high-risk groups is warranted.
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Introduction
Several studies have shown that the use of tigecycline, especially in
ventilator associated pneumonia (VAP) patients, was significantly as-
sociated with increased risk of all-cause mortality. However, tigecyc-
line is one of the options for multidrug resistant Acinetobacter
baumannii which is a growing problem in Thailand. Moreover, there
have not been any studies showing such correlation at a University
Hospital, Thailand. The purpose of this study was to investigate the
mortality rate and the length of hospital stay of Acinetobacter bau-
mannii VAP patients receiving tigecycline compared with other anti-
bacterial agents.
Methods
A retrospective study chart review was performed in patients admit-
ted to Intensive Care Units, University Hospital during 2007 and 2015
and received the treatment for Acinetobacter baumannii VAP. Pri-
mary outcome, mortality rate, and secondary outcome, ventilator
days, in both groups were collected.
Results
There were 126 patients; 80 patients in tigecycline group and 46 pa-
tients in non-tigecycline group. We selected only 41 Acinetobacter
baumannii VAP patients in each group with matched baseline char-
acteristics. The mortality rate of tigecycline group was significantly
higher than non-tigecycline group (73.20% and 46.30% respectively,
P = 0.013). The median length of hospital stay was also significantly
higher in tigecycline group than non-tigecycline group (46.99 days
and 30.24 days respectively, P = 0.004).
Conclusions
The use of tigecycline in Acinetobacter baumannii VAP patients in-
creased the mortality rate and the length of hospital stay compared
with the use of other antibacterial agents. However, a prospective co-
hort study with larger sample size is necessary.
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Introduction
The incidence of carbapenem resistant enterobacteriacae (CRE) has
been steadily rising [1]. The morbidity, mortality and financial impli-
cations of such patients are significant. We recently had few reports
of colistin resistance in our centre. This prompted us to analyse the
risk factors for the outbreak of pan drug-resistant (PDR) organism.
Methods
We did a retrospective analysis of the case records of the patients
who had any culture report positive for pan drug resistant (PDR) or-
ganisms. Cultures were done in our centre using VITEK 2 compact for
all specimens. We followed the report of VITEK-2 and EUCAST break-
points were followed (S < = 2, R > =2) for Enterobacteriacae. Pseudo-
monas and Acinetobacter isolates were considered resistant to
colistin if the MIC > = 8 and 4 respectively. Their APACHE II score on
admission, all culture reports, antibiotics received, length of stay in
ICU and hospital along with outcome were scrutinized.
Results
There were total 10 isolates of PDR organisms in 8 patients. Five
patients had received prior colistin therapy due to growth of car-
bapenem resistant bacteria isolates while 3 cases had no prior
colistin treatment. Two out of 5 such cases had colistin mono-
therapy. Among 10 such isolates, there was Klebsiella pneumonia
in 7, Pseudomonas aeruginosa in 2 and Acinetobacter baumanii
in one case. Among these 7 isolates were considered to be col-
oniser and three were infective pathogens. These PDR isolates
were associated with CAUTI (5), tracheitis (2), bacteremia (1),
meningitis (1) and soft tissue infection (1). Average APACHE II
score was 24 indicating sicker patients with multiple co-
morbidities and organ dysfunction. Mean age of the patients was
50.4years. Average length of hospital stay was 42.8 days. Four of
these patients died while other 4 were discharged home. Six of
the 8 patients belonged to neurosciences (stroke and traumatic
brain injury) and had overall poor status with Glassgow coma
scale (GCS) <8 with long hospital stay.
Conclusions
Critically ill patients with longer hospital stay are more likely to get
affected by PDR organisms. Patients requiring long-term rehabilita-
tion should be cared for in dedicated centers. Culture reports should
be judiciously interpreted to differentiate between colonizer and in-
fective pathogen before treatment. Widespread indiscriminate use of
colistin to treat CRE and other gram negative organisms can lead to
emergence of PDR organisms. Strict implementation of antibiotic
stewardship programme are essential to limit use and prevent abuse
of colistin.
References
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Introduction
The aim of study was to analyze multidrug-resistant (MDR) and ex-
tended spectrum beta – lactamases (ESBL) producing E. coli strains
of monobacteremia also associated factors with length of stay in
Intensive Care Unit (ICU) > =7 days and mortality.
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The retrospective data analysis of patients (pts) treated in surgical
and medical ICU of Kaunas Clinics with E. coli positive blood culture
during 2005-2015 was carried out.
Results
There were found 87 (70.7%) MDR strains among 123 cases of E. coli
monobacteremia (P = 0.046). Rate of MDR strains during study period
was: 6 (42.9%) cases in 2005, 12 (66.7%) in 2010, 12 (85.7%) in 2015
(P = 0.027, RR = 17.324).
There were found 57/87 (65.5%) cases of ESBL producing strains
among E. coli MDR strains (P = 0.04). Rate of ESBL producers during
study period was: 2 (16.7%) cases in 2005, 7 (58.3%) in 2010, 10
(76.0%) in 2015 (P = 0.03, RR = 14.856).
28/57 (49.1%) pts with both MDR and ESBL E. coli strain stayed in
ICU > =7 days. All 28 (100%) pts had SOFA score > =13, were
mechanically ventilated > =3 days and were in shock, respectively (P
= 0.001), 25/28 (89.3%) were admitted from emergency department
(P = 0.03).
79/87 (90.8%) pts with E. coli MDR strain have died. All 79 (100%) pts
were mechanically ventilated (P = 0.04), 78 (98.7%) were in shock (P
= 0.001, OR = 5.909, CI95% = 2.176–16.049), 68 (81.0%) had diabetes
mellitus (P = 0.03), 66 (78.6%) had renal dysfunction (P = 0.046), 59
(70.2%) had SOFA score > =13 (P = 0.032, RR = 12.00) and 54 (65.5%)
pts had ESBL strain (P = 0.04).
54/57 (94.7%) pts with ESBL producing E. coli strain have died. All
these 54 (100%) pts were mechanically ventilated (P = 0.001), were in
shock (P = 0.001), 50 (92.6%) had SOFA score > =13 (P = 0.01), 45
(83.3%) had diabetes mellitus (P = 0.02) and 35 (64.8%) pts had renal
dysfunction (P = 0.04).
Conclusions
MDR E. coli was found in 2/3 of all E. coli monobacteremia
strains, 2/3 of them were ESBL producers. During 11 year rates of
both MDR and ESBL strains were constantly increasing: MDR dou-
bled, ESBL have increased in 4.5 times. Associated factors for stay
in ICU > =7 days were admission from emergency department,
ESBL producing strain, mechanical ventilation > =3 days, shock,
SOFA score > =13. Very high mortality rate of E. coli monobacter-
emia due to MDR or ESBL strain was associated with diabetes
mellitus, ESBL producing strain, mechanical ventilation, shock,
renal dysfunction, SOFA score > =13.
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Introduction
The aim of study was to analyze antimicrobial resistance of E. coli in
monobacteremia and associated factors with length of stay in Inten-
sive Care Unit (ICU) > =7 days and mortality.
Methods
The retrospective data analysis of patients (pts) treated in surgical
and medical ICU of Kaunas Clinics with E. coli positive blood culture
during 2005-2015 was carried out.
Results
There were found 123 cases of E. coli monobacteremia, and this
group was homogenous in point of gender, age, comorbidities,
source of bacteremia (P > 0.05).
104 (84.6%) strains of E. coli were resistant to ampicillin, 94 (76.4%) -
ampicillin/sulbactam, 90 (73.2%) - gentamicin, 88 (71.5%) –
cefotaxim, 57 (46.3%) – ciprofloxacin, 56 (45.5%) - piperacillin, 34
(27.6%) - piperacillin/tazobactam, 29 (23.6%) - amikacin. Resistance to
carbapenems was 0/123 (0%). 87/123 (70.7%) E. coli strains were
found to be multidrug-resistant (MDR) (P = 0.046). 57/87 (65.5%) E.
coli MDR strains were producers of extended spectrum beta-
lactamases (ESBL) (P = 0.04). 32/123 (26.0%) pts stayed in ICU > =7
days. 30 (93.6%) pts among them were on mechanical ventilation >
=3 days (P = 0.004, RR = 23.097), 29 (90.6%) had SOFA score > =13 (P= 0.036, RR = 18.762), 28 (87.5%) were in shock (P = 0.019, RR = 2.956),
25 (78.13%) were admitted from emergency department (P = 0.049,
RR = 19.987), 23 (71.9%) had MDR strain (P = 0.049, RR = 15.085), 19
(59.4%) had ESBL strain of E. coli (P = 0.049, RR = 12.476). 88/123
(71.5%) pts with E. coli monobacteremia have died. Mortality rate’s
dynamic during study period was: 12 (66.7%) cases in 2005, 13
(72.2%) in 2010 and 13 (92.9%) in 2015 (P = 0.012). 84 (95.5%) pts had
MDR strain (P = 0.001, OR = 3.215, CI95% = 1.176–5.095), 82 (93.2%)
were on mechanical ventilation (P = 0.04), 80 (90.9%) were with shock
(P = 0.001, OR = 5.909, CI95% = 2.176–16.049), 68 (77.3%) had dia-
betes mellitus (P = 0.03), in 66 (75.0%) hemotransfusion was used
(P = 0.03), 66 (75.0%) were with renal dysfunction (P = 0.0046), 59
(67.0%) had SOFA score > =13 (P = 0.032, RR = 12.00) and
57(64.8%) had primary type of bacteremia (P = 0.001).
Conclusions
High resistance of E. coli to aminopenicillins without and with beta-
lactamases inhibitor, gentamicin, cefotaxim, ciprofloxacin and no re-
sistance to carbapenems was estimated. Stay in ICU > =7 days was
associated with admission from emergency department, MDR and
ESBL strain of E. coli, mechanical ventilation > =3 days, shock, SOFA
score > =13. Mortality rate of E. coli bacteremia 71% is significantly
increasing and associated with diabetes mellitus, primary type of
bacteremia, MDR strain, mechanical ventilation, shock, renal dysfunc-
tion, hemotransfusion and SOFA score > =13.
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Introduction
The objective of this study is to determine the incidence of ESKAPE
pathogens, their antimicrobial resistance and association with inva-
sive devices in the ICU of a public hospital during its inaugural year.
Worldwide, most ICU-infections are caused by ESKAPE pathogens,
whose high rates of antibiotic resistance are an active threat to pub-
lic health.
Methods
A retrospective, cross-sectional analytical study was conducted, in-
cluding all patients admitted to this ICU during 2014. Statistical ana-
lysis was performed using SPSS 20.0, Graph Pad Prism 6, and Open
Epi 3.01.
Results
150 cases were evaluated. The average age in the non-infectious,
ESKAPE and non-ESKAPE cases was homogenous (Kruskal-Wallis Test,
p = 0.053). 54% of cases were infectious. 13.3% of cases were ESKAPE
cases. 46.4% (n = 26) of cultures isolated ESKAPE pathogens. Of these,
Acinetobacter baumannii was the most common (50%). The most
frequently prescribed antibiotics were ceftriaxone, imipenem and
vancomycin, reporting resistance in 83%, 56.7% and 11.1% of the cul-
tures respectively. 86.5% (n = 32) of the cases with pneumonia were
associated with the use of endotracheal tube (ETT) (Xi2 Test, p =
0.0005). The cases with mechanical ventilation presented pneumonia
5.2 times more frequently than cases without it (OR 5.2, IC 95%, 1.9-
14.4). 53% (n = 17) of the cases with pneumonia and ETT were
caused by ESKAPE pathogens (p = 0.0711). 11.5% (n = 16) of the cases
with UTI had a urinary catheter, and 2.8% were caused by an ESKAPE
pathogen. The average ICU stay was 7.8 days, 4.9 days for the non-
infectious cases, 7.3 days for the non-ESKAPE cases, and 19.5 days for
the ESKAPE-cases (Kruskal-Wallis Test p < 0.0001). A moderate posi-
tive correlation between the days of mechanical ventilation and days
of stay in ICU was established (Pearson r 0.59, p < 0.0001). The mor-
tality rate was 45% in ESKAPE cases and 49% in non-ESKAPE cases.
The infectious cases were lethal 3 times more frequently than the
non-infectious cases (OR 3.052, IC 95%, 1.512-6.33).
Conclusions
Almost half of the cultures isolated ESKAPE pathogens. Ceftriaxone
and Imipenem were most frequently prescribed antibiotics. Antibio-
grams reported high rates of resistance to these two antibiotics. All
Critical Care 2017, 21(Suppl 1):58 Page 25 of 70of the ESKAPE cases had at least two invasive devices. Pneumonia
was more frequently diagnosed in patients with ETT. In average, the
ESKAPE-cases stayed hospitalized 2.6 times longer than the non-
ESKAPE-cases, and 4 times longer than the non-infectious-cases.
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Introduction
The incidence of Acinetobacter infections has steadily increased, and
now lately, has become a major threat with the emergence of
multidrug-resistant strains. Acinetobacter are notorious for their abil-
ity to spread amongst hospitalized patients. This study attempts to
identify ICU care variables predictive of Acinetobacter sepsis.
Methods
In this case-control study, we extracted data from a prospectively col-
lected ICU database on all patients admitted with a diagnosis of sep-
sis from 2010 to 2015. Identification data on all Acinetobacter
isolates was obtained from the Section of Microbiology database.
Patients with Acinetobacter sepsis were compared with control
patients. The institutional Research Ethics Committee approved the
protocol.
Results
431 patients were studied, 43 (10%) developed Acinetobacter sepsis.
Mean APACHE II score was 26 ± 7.7; median procalcitonin level was
3.9 (IQR 1.1, 18.4). Mean age was 52.5 ± 21.4 years with median ICU
length of stay 6 (IQR 4.43) days. ICU mortality was 23% (99 patients)
with mortality rate of patients with Acinetobacter sepsis at 60.5% (26
patients of 43). Patients who developed Acinetobacter sepsis had a
mean SOFA score 14.1 ± 3.7 with 46.5% in septic shock, 9% organ do-
nors, and 7% post-solid organ transplant. Most common site of isola-
tion was the respiratory tract, 34.6%, followed by bloodstream/line
sepsis, 30.8%, 32.5% had a single site infected. Median duration on
mechanical ventilation was 15.3 (IQR 7, 15.3) days. On univariate re-
gression analysis Acinetobacter sepsis was predicted by vasopressor
dependence, OR 4.1 (95% CI 1.6,9.9, p =0.002), blood-stream infec-
tion, OR 6.3 (95% CI 3.2,12.4, p < 0.001), single site of initial sepsis OR
0.4 (95% CI 0.2, 0.9, p = 0.02), APACHE II score, OR 1.05 (95% CI 1.01,
1.1, p = 0.01), malignancy OR 6 (95% CI 2.2,15.7,p < 0.001) and appro-
priate empiric antibiotics OR 0.04 (95% CI 0.01,0.15, p < 0.001).On
multivariate regression, appropriate empiric antibiotics OR 0.04 (95%
CI 0.01,0.13, p < 0.001), vasopressor dependence, OR 3.1 (95% CI
1.07,9.2, p =0.03), blood-stream infection, OR 7.5(95% CI 3.2,17.4, p <
0.001), single site of initial sepsis OR 0.1 (95% CI 0.07, 0.4, p < 0.001)
remained significant predictors of Acinetobacter sepsis.
Conclusions
Acinetobacter sepsis remains a frequent and hazardous ICU acquisi-
tion with a higher risk imposed by continued vasoplegia and septi-
cemia and protective effects from appropriate initial antibiotic
coverage and limited sites involved.
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Introduction
Community-acquired pneumonia (CAP) by Streptococcus pneumo-
niae could result into acute respiratory distress syndrome (ARDS). In
patients with severe pneumococcal CAP, we characterized preva-
lence, risk factors and clinical outcomes of ARDS.Methods
We prospectively enrolled adult patients admitted into a pulmonary
intensive care unit (ICU). Patients were clustered based on ARDS oc-
currence, according to the Berlin definition. Characteristics, risk fac-
tors and outcomes were compared between groups.
Results
Among 6439 patients with CAP, 1307 (20%) had pneumococcal CAP;
of those, 282 (23%) patients were admitted to the ICU and 115 re-
quired ventilatory support (70%, invasive mechanical ventilation and
30% non-invasive mechanical ventilation). Thirty-six out of 115 (31%)
ventilated patients met the Berlin ARDS criteria. ARDS was mild,
moderate and severe in 36, 44 and 20% of the cases, respectively.
Multivariate analysis indicated that previous corticosteroid therapy
decreased risk of ARDS (odds ratio (OR), 0.33; 95% confidence inter-
val (95% CI), 0.11-0.94). Patients with ARDS presented less
ventilation-free days (p = 0.047), higher ICU mortality (39% vs. 18%;
p = 0.014) and higher in-hospital mortality (22% vs. 42%; p = 0.025).
ARDS was an independent risk factor for ICU mortality (OR, 2.60;
95%CI, 1.04-6.53).
Conclusions
ARDS develops in a minor proportion of patients with pneumococcal
CAP. Yet, ARDS highly increases mortality risks. Previous treatment
with inhaled corticosteroids is the only ARDS protective factor.
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Introduction
The aim of study was to evaluate antimicrobial resistance of Gram-
negative bacteria (GNB) as pathogens of ventilator-associated pneu-
monia (VAP) and to determinate predictors of in-hospital mortality.
Methods
Retrospective data analysis of patients treated in ICU with multidrug-
resistant strains of GNB as pathogens of VAP during 2015 was carried
out.
Results
In 77 VAP pts 98 multidrug-resistant strains of GNB were revealed: 37
(37.8%) of A. baumannii, 16 (16.3%) of Klebsiella spp., 11(11.2%) of
Enterobacter spp., 10 (10.2%) of P. aeruginosa and others 24 (24.5%)
as S. marcescens, Morganella spp., Citrobacter spp., E. coli, Proteus
spp. In 34 (34.7%) of GNB strains multidrug-resistance (MDR), in 63
(64.3%) extensive drug-resistance (XDR) and in 1 (1%) pandrug-
resistance (PDR) was ascertained. MDR was found in 7 (63.6%) of En-
terobacter spp. and 7 (70%) of P. aeruginosa (p < 0.001), XDR - in 36
(97.3%) of A. baumannii strains (p < 0.001). One (10%) of P. aerugi-
nosa strains was found to be PDR. 37 (48%) pts with multidrug-
resistant pathogens of VAP have died. Statistical significant differ-
ences of survivors vs nonsurvivors were found in means of hospital-
isation days prior of VAP 53.8 (SD = 34) vs 29,1 (SD = 17), p = 0.001,
neutrophils percent 81 (SD = 8.9) vs 85 (SD = 6.3), p = 0.045, and be-
tween proportions of internal disease 7 (33%) vs 14 (67%), p = 0.042,
co-infection 13 (30%) vs 30 (70%), p = 0.001, shock 16 (36%) vs 28
(64%), p = 0.03, multiple organ dysfunction syndrome 17 (40%) vs 25
(60%), p = 0.039, inappropriate initial antimicrobial treatment 18
(40%) vs 27 (60%), p = 0.02. OR for in-hospital mortality was: 8.9 (95%
OR CI 2.24; 33.72) for co-infection, 4.67 (95% OR CI 1.7; 12.6) for
shock and 3.3 (95% OR CI 1.27; 8.59) for inappropriate initial anti-
microbial treatment.
Conclusions
A. baumannii and Klebsiella spp. were found to be predominating
multidrug-resistant pathogens of VAP. 1/3 of all multidrug-resistant
GNB of VAP were MDR and 3/5 were XDR. 2/3 of Enterobacter spp.
and P. aeruginosa strains were found to be MDR. A. baumannii strain
were found to be exclusively of XDR type. In-hospital mortality of
VAP was 48%. Longer hospitalisation prior of VAP, neutrophilosis,
Critical Care 2017, 21(Suppl 1):58 Page 26 of 70internal disease, co-infection, shock, multiple organ dysfunction syn-
drome, inappropriate initial antimicrobial treatment were found to
be associated with in-hospital mortality. Co-infection, shock and in-
appropriate initial antimicrobial treatment were found to be signifi-
cant predictors for in-hospital mortality in ICU patients with
multidrug resistant GNB in VAP.P414
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Introduction
Over the last decade, the prevalence of strains of Klebsiella Pneumo-
niae Carbapenemases (KPC) producing K. pneumoniae (Kp) has dra-
matically increased worldwide and has become a significant problem
in terms of public health, especially in some countries.
Methods
In this retrospective observational study conducted in Intensive Care
Units (ICU) of the the Italian teaching Hospital of Pisa, we recruited
critically ill patients with a diagnosis of bloodstream infections (BSI)
caused by KPC-Kp. 30-days mortality from the first positive blood cul-
ture, septic shock diagnosis, steroid therapy, SOFA, SAPS II, Charlson
Score, antibiotics therapy, previous hospitalization were compared
between Survivor and Non-Survivor groups.
Results
We enrolled 42 patients admitted in ICU between January 2012 and
December 2015. The overall 30 days mortality rate was 52,4%. A sig-
nificantly higher rate was observed among patients with a diagnosis
of septic shock at BSI onset, steroid therapy, higher SOFA and SAPS II
score. Gentamicin used in combination therapy was associated with
lower mortality, regardless of meropenem use. Furthermore, in colo-
nized patients the digestive decontamination with oral Gentamicin
decreased BSI mortality. Previous use of meropenem was associated
with increased mortality. Additionally, the intravenous admistration
of Fosfomicin resulted in a lower mortality rate. Charlson score and
optimal empirical therapy seemed not to have a significant influence
on survival.
Conclusions
KPC-Kp BSI was associated with high mortality. We found that a re-
gime therapy including gentamicin is associeted with lower mortality.





3 Months previous hospitalization 2/19 (10.5%) 9/23 (39,1%) P = 0.054
Steroids use 3/19 (15.8%) 14/23 (60.9%) P = 0.024
Septic shock 11/19 (57.9%) 15/23 (65.2%) P = 0.045
SOFA (day 1) 8.65 ± 3.37 11.9 ± 3.37 P = 0.015
SAPS II (day 1) 57.58 ± 17.70 67.59 ± 20.99 P = 0.034
Charlson Score 3.05 ± 1.87 4.00 ± 1.87 Ns
Optimal empirical therapy 17/19 (89.5%) 20/23 (87%) Ns
Previous carbapenems therapy 2/19 (10.5%) 9/23 (39.1%) P = 0.081
Oral gentamicin decontamination 2/19 (21.1%) 0/23 (0%) P = 0.093
Gentamicin therapy 6/14 (42.9%) 1/23 (4.3%) P = 0.023
Fosfomycin therapy 5/14 (35.7%) 3/23 (13%) P = 0.066
Gentamicin associated with
other antibiotics
6/19 (31.6%) 15/23 (4.3%) P = 0.072
Legend : Clinical characteristics, therapy and outcomes of study populationP415
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Introduction
Neonates and children under 5 years are at major risk for sepsis, but
knowledge on the global epidemiology of childhood sepsis is scarce.
The aim of this study was to estimate the global burden of and mor-
tality from sepsis in children and neonates based on available evi-
dence from observational epidemiological studies.
Methods
Systematic review and meta-analysis. We searched 13 international
databases for published and grey literature between 1979-2016, sup-
plemented by hand search and expert consultation. Studies reporting
on the incidence of sepsis in children (<20 y) defined according to
the International Consensus Conference on Pediatric Sepsis Defini-
tions [1], ACCP/SCCM consensus criteria [2,3] or related sepsis-
relevant ICD-9/ICD-10 codes on a population level per 100 000
person-years or live births were included.
Results
Of 1270 studies, 23 studies from 16 countries met the inclusion cri-
teria. Sixteen were from high-income-countries, seven from middle-
income-countries. Fifteen studies reported complete data and were
included in the meta-analysis. We found an aggregate estimate of 48
[95% CI, 27-86] sepsis cases and 22 [95% CI, 14-33] severe sepsis
cases per 100 000 child population in high-income-countries. Mortal-
ity ranged between 1-5% for sepsis and 9-20% for severe sepsis. The
population-level estimate for neonatal sepsis was 2062 [95% CI,
1065-3957] per 100 000 live births with a mortality rate between 11-
19% in middle- and high-income-countries. Extrapolating these
figures on a global scale, we estimate 2.9 Mio. cases of neonatal sep-
sis with 319 000-551 000 neonates dying from or with sepsis.
Conclusions
Sepsis is a major contributor to neonatal and childhood mortality.
Further comprehensive studies on sepsis epidemiology especially in
low- and middle-income countries are needed, as well as effective
measures to reduce the burden of sepsis in children globally.
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Introduction
The prevalance and mortality of sepsis in Turkey is largely unknown.
Turkey is among the countries that have a high level of antibiotic re-
sistance. Turkish Society of Intensive Care Medicine, Sepsis Study
Group conducted a national, multicenter, point-prevalance study to
determine the prevalence, causative microorganisms, and outcome
of sepsis in Turkish ICUs.
Methods
A total of 132 ICUs from 94 hospitals participated the study. All pa-
tients (>18 yr old) present on the participating ICU or admitted for
any length of time during a 24 hr period between 08:00 on
Critical Care 2017, 21(Suppl 1):58 Page 27 of 70Wednesday 27 January 2016 and 08:00 on Thursday 28 January 2016
were included the study. The International Sepsis Forum definitions
for common sites of infection were used [1]. The presence of SIRS,
severe sepsis and septic shock was assessed and documented based
on consensus criteria of the ACCP/SCCM (SEPSIS-I) [2]. Data were also
used to define septic shock according to the SEPSIS-III definitions [3].
Demographics, severity of illness, comorbidities, microbiological data,
therapies used, length of stay and outcome (dead or alive through
30 days) were recorded.
Results
Of 1499 patients screened, 165 (11%) had sepsis, 260 (17.3%)
had severe sepsis without shock, and 204 (13.6%) had septic
shock. Mortality rates increased significantly with increasing sever-
ity of sepsis (31.3%, 55.8%, and 71.1%, for sepsis, severe sepsis
and septic shock, respectively; p < 0.05). According to the SEPSIS-
III definitions, 91 (10.5%) patients had septic shock and mortality
rate for septic shock was 75.3%. The respiratory system was the
most common site of infection, accounting for 62.8% of all infec-
tions, followed by the the bloodstream (14.9), and the urinary
system (7%). Acinetobacter species were the most common iso-
lated pathogen (34.5%), followed by Klebsiella species (16.7%)
and Pseudomonas species (14.5%). While colistin was the last-line
therapeutic drug used against multidrug-resistant Gram-negative
pathogens, 5% of Klebsiella spp. isolates, 3.3% of Pseudomonas
spp. isolates, and 2.4% of Acinetobacter spp. isolates were resist-
ant to colistin.
Conclusions
This study found a high prevalance of sepsis and an unacceptable
high mortality rate in Turkish ICUs.
References
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Introduction
In 2016 The Third International Consensus Definitions Task Force
defined sepsis as a life-threatening organ dysfunction due to a
dysregulated host response to infection [1]. Evaluation of new
clinical criteria for this sepsis definition was not done so far in
Low and Middle Income Countries (LMC). The aim of this study
was to evaluate the prognostic ability of new and old clinical cri-
teria for sepsis in LMCs.
Methods
This is a secondary analysis of CERTAIN (Checklist for Early Recog-
nition and Treatmentof Acute Illness and Injury) study data from
15 intensive care units (ICU) from LMC. We included adult pa-
tients with discharge diagnosis of infection. Data on admission
SOFA were collected prospectively. The presence of SIRS was
determinedfrom prospectively collected APACHE II data on admis-
sion. Association with mortality was explored using univariate lo-
gistic regression.
Results
Between October 2013 and July 2016, out of 1398 eligible pa-
tients, 131 patients (9.4%) were included in the study with both
SIRS and SOFA and a discharge diagnosis of infection. There were
51 female (39%) and 80 male (61%) patients from 15 ICUs. Me-
dian SIRS was 2 (IQR 1-3) and median SOFA was 7 (IQR 4-9), 28
days mortality was 47.2%. The SOFA score was higher among
non-survivors (7.84 +/- 3.8 vs. 6.42 +/-3.36, p = 0.03). SIRS score
did not differ among survivors and non-survivors (1.7 +/- 1.2 vs.2 +/- 1.3, p = 0.197).The SOFA score > =2 was predictivefor 28
days mortality (AUC 0.62, p = 0.03), while SIRS > = 2was not (AUC
0.56, p = 0.2).
Conclusions
In a sample of LMCs ICU patients with infection SOFA, but not SIRS
sepsis criteria are predictive for 28 days mortality.
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Introduction
We tested the hypothesis that differences in generic and sepsis-
specific patient characteristics explain the observed differences in
sepsis outcomes between countries [1].
Methods
We studied first ICU episode for adult medical patients with sep-
sis admitted during 2013 using national data sources from Eng-
land (ICNARC Case Mix Programme) and Brazil (ORCHESTRA
study). After harmonizing relevant variables, the datasets were
merged.
Sepsis was defined as infection and > =1 organ dysfunction (OD)
(> = 2 points) using a modified SOFA score to align with Sepsis-3
[2]. The primary outcome was acute hospital mortality. We used
multilevel logistic regression models to evaluate the impact of
country (Brazil vs England) on hospital mortality, after adjustment
for generic (age, sex, comorbidities, admission source, time to
ICU admission) and sepsis-specific (infection site, OD type and
first order interactions) characteristics. We report risk-adjusted
mortality stratified by admission source, time in hospital prior to
ICU admission, infection site, and decile of predicted risk of death
(from our regression model).
Results
Of medical ICU admissions, 30.7% (17,921/58,316) in England and
13.2% (4,505/34,150) in Brazil met the sepsis definition. The Brazil
sepsis cohort was older and had greater prevalence of serious co-
morbidities and dependency when compared with England. Re-
spiratory was the commonest infection site (England 61.8%, Brazil
50.7%). The commonest OD was respiratory in England (85.8%)
and cardiovascular in Brazil (41.2%). Crude mortality was similar
(England 39.3%, Brazil 41.4%). After adjusting for generic charac-
teristics, Brazil had lower odds of mortality (OR 0.88 [0.75-1.02], p
= 0.089). However, after adding sepsis-specific characteristics,
Brazil had higher risk-adjusted mortality (OR = 1.22 [1.05-1.43]; p
= 0.01; AUROC = 0.78; Brier Score = 0.18). We observed statistically
significant interactions in the full model when stratifying by time
in hospital prior to ICU admission, infection site and deciles of
predicted risk of death.
Conclusions
We show for the first time that generic and sepsis-specific patient
characteristics explain observed differences in sepsis outcomes be-
tween countries.
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Introduction
Esophageal heat transfer device (Advanced Cooling Therapy, Chi-
cago, Ill, USA) is a new temperature management device, which has
mostly been used for temperature management in survivors of car-
diac arrest [1]. Our aim was to evaluate the effectiveness of the de-
vice in long-term temperature management in non-cardiac-arrest
patients.
Methods
A retrospective study from January to November 2016 with inclusion
criteria: the device used for >120h in non-cardiac arrest patients.
Results
We included 3 males (age 67, 71 and 74 years) and 1 female (36
years). The duration of treatment with the device was 220, 192, 452
and 168h, respectively. Indications for temperature management
were hyperthermia associated with sepsis (1 patient with meningitis,
2 with pneumonia and 1 with necrotizing fasciitis). Target
temperature was determined by the attending physician (36-37°C in
a patient with meningitis and one patient with pneumonia, 36.5-
37.5°C for one patient with pneumonia, and 37-38°C in patient with
fasciitis). Temperature was in target range for 81% of time, ±0.5°C
outside target range for 11.6% of time, and > =0.6°C outside of target
trange for 7.4%. The greatest temperature fluctuations (>2°C outside
target temperature) were observed in the patient with fasciitis after
return from operating theatre (the device was disconected from the
chiller during surgery) (Fig. 14).
Conclusions
Esophageal heat transfer device can be used for effective long-term
temperature control in non-cardiac arrest patients.
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Introduction
Dysregulated systemic inflammatory response in septic shock often
results an overwhelming &#8220;cytokine storm&#8221;, evolving
into fulminant sepsis, with multiple organ dysfunction and early
death. Attenuating the cytokine storm by adsorbing cytokines via
hemoperfusion (CytoSorb) has pathophysiological rationale. Our aim
was to investigate the effects of CytoSorb therapy on organdysfunction and inflammatory response when started early (<48 h) in
septic shock.
Methods
Patients fulfilling septic shock criteria were randomized into CytoSorb
and Control groups. CytoSorb therapy lasted for 24 hours. Blood
samples were taken to determine IL-1, IL-1ra, IL-6, IL-8, IL-10, TNF-α,
PCT, CRP levels. At this stage of the study only PCT and CRP levels
were analyzed. Organ dysfunction was evaluated by the Sequential
Organ Failure Assessment (SOFA) score. Data were recorded on en-
rollment (T0) then at T12, T24, and T48 hours.
Results
Within the first 2 years of the study 14 patients were randomized
into CytoSorb (n = 7), and Control-groups (n = 7). Both SOFA scores
and mortality risk showed significant decrease between T0 and T48
the CytoSorb group: T0 = 12.7 ± 3.5, T48 = 9.4 ± 6.2, p = 0.028; T0 =
55.4 ± 26.2, T48 = 34.0 ± 30.8%, p = 0.013. Dose of the required nor-
epinephrine also showed a significant reduction by T48 as compared
to T0 and T24 (T0 = 51.4 ± 53.0, T24 = 40.7 ± 45.4, T48 = 11.9 ± 18.1μg/
min, p = 0.035). Regarding the inflammatory response PCT and CRP
levels were grossly elevated at T0, but there was no difference be-
tween the CytoSorb-, and Control-groups within the first 48 hours.
Conclusions
According to our interim results CytoSorb therapy resulted in better
SOFA scores, and also proved to be safe without significantly affect-
ing PCT and CRP changes within the first 48 hours of septic shock.
Based on the results of this current pilot study we are planning to
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Introduction
Unfractionated heparin (UFH), antithrombin (AT), and recombinant
thrombomodulin (RT) represent two distinct anticoagulant/anti-
thrombotic agents with different targets in the hemostatic process to
produce their therapeutic effects. Both of these agents are widely
used in various hematologic indications in mono and poly thera-
peutic approaches. Currently, a recombinant version of thrombomo-
dulin, ART-123 (Recomodulin) is undergoing clinical trials to validate
its efficacy in sepsis-associated coagulopathy. Recomodulin is a
novel, recombinant and soluble thrombomodulin, and is a human
protein with both thrombin inhibiting and protein C stimulating ac-
tivities. In comparison to both UFH and AT, this agent has relatively
weaker anticoagulant activities related to bleeding risk at therapeutic
concentrations of < = 1.25 ug/mL. Supratherapeutic concentrations of
this agent may occur in some patients with renal dysfunction. The
purpose of this study is to compare the anticoagulant and platelet
modulatory effects of ART-123, UFH, and AT.
Methods
UFH of porcine origin was obtained from Medefil Inc. (Glendale
Heights, IL) in powdered form with a specific activity of 175 U/mg. A
working concentrations of this agent was made at 100 ug/mL in ster-
ile saline. AT was commercially obtained from Baxter Healthcare Cor-
poration (Deerfield, IL). A working concentration of AT was prepared
at 100 U/mL in sterile saline. Recomodulin was commercially ob-
tained and was manufactured by Asahi Kasei Pharma (Japan). A
working concentration of Recomodulin at 100 ug/mL was prepared
in sterile saline. The effect of Recomodulin, AT, and UFH on the glass
activated clotting time and thromboelastographic (TEG) profile was
measured at concentrations of 0-5 ug/mL. Global anticoagulant
Table 4 (abstract P422). See text for description
ART-123 n = 119 Placebo n = 107 Total n = 226
Intra-abdominal 97(81.5) 84(78.5) 181(80.1)
Thoracic 6(5.0) 7(6.5) 13(5.8)
GU 2(1.7) 5(4.7) 7(3.1)
Ortho 7(4.2) 5(4.7) 12(5.3)
Cardiac 4(3.3) 4(3.7) 8(3.5)
SSSI 1(<1) 2(1.9) 3(1.3)
Head /Neck 1(<1) 0 1(<1)
UNK 1(<1) 0 1(<1)
Legend : Type of Surgical Operation
Table 5 (abstract P422). See text for description
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whole blood and retrieved plasma. The effect of these drugs on
agonist induced platelet aggregation (arachidonic acid, ADP, colla-
gen, thrombin, and epinephrine) was measured in platelet rich
plasma collected from healthy donors.
Results
In comparison to both AT and UFH, Recomodulin did not pro-
duce any anticoagulant effects in either the TEG or the ACT tests
at concentrations of 1.25 ug/mL. At higher concentrations of 2.5
and 5.0 ug/mL, the relative anticoagulant effects of Recomodulin
were much weaker in comparison to both AT and UFH. In the
TEG profile at 5.0 ug/mL, both the AT and UFH produced
complete anticoagulation. However, Recomodulin did not produce
a complete anticoagulation at 2.5 and 5.0 ug/mL. In the whole
blood global clotting assays, all agents produced a concentration-
dependent anticoagulant effect following the order UFH > AT >
Recomodulin. In the platelet aggregation studies, while heparin
produced a mild increase in the aggregation profile of some of
the agonists, AT and Recomodulin did not produce any effects at
concentrations of up to 10 ug/ml and 5 U/ml for all of the ago-
nists except thrombin.
Conclusions
The circulating levels of Recomodulin for the management of sepsis-
associated coagulopathy range from 0.5-1.5 ug/mL. The therapeutic
levels of UFH for similar indications range from 1.5-5.0 ug/mL (0.25-
1.0 U/mL), whereas the circulating AT levels may range from 1-2.5 U/
mL. The results from this study suggest that Recomodulin is a much
weaker anticoagulant in comparison to both UFH and AT and at
therapeutic concentrations, it does not produce any measurable anti-
coagulant effects. At supratherapeutic concentrations of > 2.5 ug/mL,
Recomodulin exhibits weaker anticoagulant effects which are unlikely
to contribute to any hemostatic deficit resulting in potential bleeding
complications.
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Introduction
We hypothesized that ART-123 is safe for therapy of S + DIC, particu-
larly re: Bleeding risk. S + DIC occurs in 20%-35% of hospitalized pa-
tients with sepsis. Limited safety data exist for surgical patients
receiving ART-123 for S + DIC despite substantial clinical use in Japan
(>160,000 pts treated).
Methods
Retrospective review of a large Phase 2b, randomized, placebo-
controlled trial of therapy with ART-123 to assess safety [1] in
741 treated pts. Data were analyzed for the presence and type
(Table 4) of an operation within 30 d prior to randomization. On-
treatment (during study drug admin or 4 d thereafter) serious
major bleeding events [SMBEs] (any intracranial hemorrhage, any
life-threatening bleeding, any bleeding investigator-classified as
serious by the investigator, or any bleeding that required > 6 U
red cell concentrates over two consecutive days, and 28-d mortal-
ity were compared. Χ2, p < 0.05.
Results
226/741 (30.5%) were surgical patients (SP). Most (80%) opera-
tions were abdominal. Primary infection source is listed in
Table 5. Among non-surgical (NS) patients, SMBEs occurred in
4.8% (12/252, ART-123 group; 3 fatal) vs. 4.2% (11/263, placebo
group; 4 fatal) (p = ns). Among SP, SMBEs occurred in 5.9% (7/
119, ART-123 group; 1 fatal) vs. 5.6% (6/107, placebo group, 0
fatal) (p = ns). 28-day mortality among SP was 21.0% (25/119,
ART-123) vs. 29.0% (31/107, placebo) (p = ns); this compares
with NS mortality of 16.3% (41/252, ART-123) vs. 18.6% (49/263,
placebo) (p = ns).Conclusions
Similar rates of SMBEs exist between ART-123- and placebo-treated
SP; ART-123 appears to be safe regarding bleeding risk after surgery.
Further research is needed for SP with S + DIC to evaluate the effect
of ART-123 on outcomes.
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Introduction
Norepinephrine (N) is the first-line vasopressor in septic shock, Vaso-
pressin (V) is used in catecholamine-resistant shock to reach
intended MAP, however the dosage of N at which V should be added
is unknown and outcome effects are debated. New data suggested
that low dose V is effective in intermediate severity septic shock [1]
and has positive effects on renal function [2].
Methods
We retrospectively analysed all septic shock patients admitted to our
general ICU from 09/2013 to 08/2016 and treated with N or associ-
ation V + N. We identified 3 different groups. In N group (low sever-
ity), patients received only N < 0.4mcg/kg/min to reach MAP >
65mmhg; in VN-L group (intermediate severity), V at a dosage of
0.02-0.03 U/min was added to N at a dosage < =0.4 mcg/kg/min; in
VN-H group (high severity), despite V infusion, N needed to be
titrated > 0.4 mcg/kg/min. We analysed SOFA score at admission,
mortality rate and need for RRT during ICU stay, vasoactive drugs
infusion length, urine output and progression of AKI by RIFLE classifi-
cation during the first week of ICU stay. Patients with end stage kid-
ney disease at admission were ruled out. Data were analysed by
Anova and Fisher’s exact tests.
Results
We enrolled 39 patients; 16 in N group, 16 in VN-L and 7 in VN-H.
SOFA at baseline was 10 in N patients, 12 in VN-L and 14 in VN-H (p
< 0.05). Overall mortality was 39.5%: VN-L patients showed lower
Fig. 15 (abstract P424). See text for description
Critical Care 2017, 21(Suppl 1):58 Page 30 of 70mortality rate (31.1%) than VN-H (71.4%) and N group (37.5%)
(p 0.38). Need for RRT was 18.8% in N and VN-L series and
57.1% in VN-H. Urine output was higher in VN-L patients than N
and VN-H ones without statistical significance (p 0.35). In N
group, 3 patients without AKI at baseline didn’t develop renal
failure; 9 patients (69.2%), 4 in R, 3 in I and 2 in F RIFLE cat-
egories, improved their renal function. In VN-L group, only 1 pa-
tient without AKI were admitted and didn’t worse his renal
function; 12 patients (80%), 5 R, 4 I and 3 F class, improved
renal function. In VN-H series, 1 patient admitted without AKI
didn’t develop renal failure, and 1 I category patient (16.7%) im-
proved, but all F patients worsened to L (p 0.40). Vasopressors
infusion mean length was 5,6 days in N, 4.3 in VN-L and 10.4 in
VN-H series (p < 0.05).
Conclusions
Although, in our analysis, several data do not reach statistical
significance, the association V + N, in the intermediate severity
group, seems to have favorable effects on the urinary flow, on
the progression of AKI and on vasoactive drugs infusion
length.
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Introduction
Recent data of the Hellenic Sepsis Group showed that treatment of
severe infections by the IgM-enriched preparation Pentaglobin de-
layed the advent of breakthrough bacteremia suggesting a probable
trained immune effect [1]. We investigated if Pentaglobin can elicit
such trained immune responses.
Methods
Interleukin(IL)-10 were selectively measured in serial serum sam-
ples from five patients with ventilator-associated pneumonia of a
prospective cohort [2] who received Pentaglobin at the discretion
of the attending physicians. Fresh peripheral blood mononuclear
cells (PBMCs) were isolated from six healthy volunteers and pre-
treated for 24 hours with medium or Pentaglobin so that final
IgM concentration was 50mg/dl. After washing, PBMCs were stim-
ulated for 24 hours with heat-killed 5log10-growth isolates of
Klebsiella pneumoniae producing-carbapenemase (KPC) and
multidrug-resistant Pseudomonas aeruginosa (MDRPA). Isolates
were selected from those infecting already described Greek pa-
tients; isolates were kept frozen and thawed [1]. Tumour necrosis
factor (TNF) alpha was measured in PBMC supernatants by an en-
zyme immnosorbent assay.
Results
Mean IL-10 at baseline was 58.5 +/- 46 pg/ml and on day 3 36.9 +/-
23.1 pg/ml (p: 0.043). IgM pre-treatment did not affect TNFalpha pro-
duction. After stimulation with MDRPA and KPC TNFalpha was signifi-
cantly higher from IgM pre-treated PBMCs (Fig. 15).
Conclusions
Pentaglobin pre-treatment leads to enhanced TNFα responses after
re-stimulation with resistant Gram-negative hospital-acquired patho-
gens simulating enhanced host responses. This corroborates with the
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Introduction
In a recent publication, 100 patients with severe infections by MDR
Gram-negative bacteria were treated for five days with one IgM-
enriched immunoglobulin preparation (IgGAM, Pentaglobin); they
had favorable 28-day outcomes compared to 100 well-matched com-
parators for all infection variables [1]. We re-analyzed regarding long-
term outcomes.
Methods
Patients were sub-grouped by SOFA score; survival on day 90 was
compared by the log-rank test. Serial procalcitonin (PCT) measure-
ments were available for 22 IgGAM-treated patients and 35 compara-
tors and compared by the Mann-Whitney U test.
Results
In the subgroup with SOFA more than 10, survival until day 90 was
prolonged with IgGAM (median 27 vs 8 days, Fig. 16). Although a
trend for prolonged survival was shown with SOFA 10 or less (me-
dian 42 vs 27 days) this was not statistically significant. PCT started
to decrease in the IgGAM group by day 5; median PCT of the IgGAM
group was 0.17 (0.02-0.72) ng/ml and of the comparators 0.67 (0.24-
13.28) ng/ml (p: 0.012).
Conclusions
IgGAM treatment achieved better 90-day outcomes among the more
severe patients. This was associated with decrease of PCT.
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Fig. 16 (abstract P425). See text for description
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Introduction
The use of mobile applications (apps) by healthcare practitioners is
increasing globally [1]. While this has the potential to improve clinical
knowledge translation, it also represents a potential source of med-
ical risk due to a lack of both regulation and validation. In this study,
we attempt to assess the quality of currently available apps relating
to the management of sepsis.
Methods
Between the 15th and 19th of April, 2016 a detailed search was com-
pleted of all apps available on the two largest global app stores relat-
ing to sepsis. Search terms ‘sepsis’, ‘septic’ and ‘septic shock’ were
used. Matching apps were assessed against set inclusion criteria such
as ‘English language only’, “not a game”. Apps meeting these criteria
were then purchased and reviewed for further metrics including
intended audience, and content design. Apps not intended for med-
ical practitioners and those not relating to the management of sepsis
were further excluded. Remaining apps underwent a detailed review
of content including the representation of international sepsis guide-
line information, author metrics, references, legal disclaimers as well
as update and review processes.
Results
Search terms returned 236 unique apps. 19 apps passed all barrier
conditions for final review. Of these, 15 were information references
only and did not modify management information based on user en-
tered patient data. Of the 4 apps that did, only 2 offered a commit-
ment to maintaining privacy. Reference apps were typically not
specific to sepsis management but rather covered a broad range of
diseases. 5 apps were electronic versions of published medical text-
books. Instances of information conflicting with guidelines was com-
mon. Only 12 apps included references. Periodical updates were
evident in the majority of surveyed apps, but only 8 apps had been
updated within 12 months. Legal disclaimers outlining liability were
observed in only 8 of 19 applications. No application explicitly men-
tioned the presence or absence of any conflicts of interest.
Conclusions
The quality of surveyed medical apps concerning sepsis manage-
ment varied greatly. The potential for clinical risk is high due to thelack of regulation governing currently available medical apps. The
development of designer, consumer and market-based processes to
regulate medical app content is important as this technology is in-
creasingly integrated into modern clinical practice.
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Introduction
In this study we assessed the effectiveness of our sepsis simulation
based education (SBE) course using the Kirkpatrick learning evalu-
ation model [1] in a cohort of Emergency Department (ED) physi-
cians. Few simulation articles have demonstrated change in
participant’s behaviour (Kirkpatrick level 3) [2]. Such evidence demon-
strates translation of learning into practice. Delivery of the ‘sepsis 6’
within 1 hour reduces mortality and morbidity of septic patients [3].
At the Royal Cornwall Hospital we have instigated multi-disciplinary
sepsis study days to improve care of septic patients.
Methods
8 ED Drs and 3 nurses received training in sepsis management and
human factors followed by 2 in-situ simulated sepsis scenarios in the
ED. Data was collected relating to Kirkpatrick level. Level 1 data
assessed participant views on delivery, content and relevance using
Likert scales. Improvement of knowledge was assessed using a ques-
tionnaire before & after the course. To assess behaviour change of
the 8 physicians in attendance, time to completion of each of the
sepsis 6 steps was collected for all septic patients they cared for 2
weeks before and 2 weeks after the course. Data was obtained from
the ED management tool ‘Oceano’, and patient electronic records.
Results
Kirkpatrick level 1: Overall satisfaction was high with averages of 4.5/
5 for the sepsis seminar & simulation and 4.3/5 for the human factors
seminar. Kirkpatrick level 2: Knowledge of sepsis improved from pre-
to post test scores by an average of 4.8 marks out of 20. Kirkpatrick
level 3: The 8 ED physicians who attended training treated 37 septic
patients 2 weeks prior to training and 15 septic patients 2 weeks fol-
lowing training. Documented delivery of all sepsis 6 components im-
proved from 32% to 53% (p = 0.17). Documented delivery of all 6
components within 1 hour improved from 8% to 33% (p = 0.0001).
Conclusions
Our course has demonstrated that participants enjoy and gain know-
ledge in sepsis and human factors in the context of SBE. Importantly
it has demonstrated a statistically significant improvement of sepsis
6 delivery within 1 hour.
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It is unclear whether qSOFA also has prognostic value for organ fail-
ure in patients with suspected infection. The aim of this study was to
determine the prognostic value of qSOFA compared to systemic in-
flammatory response syndrome (SIRS) for predicting organ failure in
patients with suspected infection in emergency department (ED).
Methods
We retrospectively reviewed the medical records of 3234 patients
with suspected infection in ED of a university-affiliated hospital
during a 10-year period. We analyzed the ability of qSOFA com-
pared to SIRS for predicting organ failure development (defined
as an increase in the SOFA score of 2 point or more) in patients
admitted at ED using area under receiver operating characteristic
(AUROC) curve.
Results
A total of 1009 patients with suspected infection finally included in
the study, 627 (62.1%) experienced organ failure development within
24 hours after ED admission. The predictive validity of qSOFA for
organ failure was higher than that of SIRS (AUROC = 0.814; 95% CI:
0.72-0.91 vs. AUROC = 0.662; 95% CI: 0.58-0.75; p = 0.02). The qSOFA
was also superior to SIRS for predicting in-hospital mortality (AUROC
= 0.733; 95% CI: 0.64-0.83 vs. AUROC = 0.599; 95% CI: 0.51-0.69; p =
0.04). When qSOFA score was equal to or greater than 1, its sensitiv-
ity and specificity for predicting organ failure were 75% and 82%,
respectively.
Conclusions
qSOFA can predict the occurrence of organ failure in patients with
suspected infection. It has a superior predicting ability than SIRS. Fur-
ther prospective study about the optimal cutoff value of qSOFA for
predicting organ failure is warranted.
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Introduction
Influenza is associated with high morbidity and mortality rates world-
wide. The severity of influenza infections is increasing over the last
years. In this study we aimed to identify risk factors for ICU admission
and mortality for influenza patients during the 2015-2016 epidemic
in The Netherlands.
Methods
We performed a retrospective cohort study in influenza patients
who were hospitalized in two university hospitals during the
2015-2016 influenza epidemic. Cases were identified using data-
bases of the microbiology departments at both medical centers.
Patients admitted to the hospital with clinical symptoms due to
an acute infection with Influenza A or B were included in this
study. Virus samples were obtained from nose/throat swab, spu-
tum collection or bronchoalveolar lavage. A laboratory confirmed
novel influenza infection was defined as a positive polymerase
chain reaction, immunofluorescence assay or simple culture for
either influenza A or B. In patients where a rapid influenza test
was initially used, one of the above laboratory techniques subse-
quently had to be positive before a patient could be included in
the study as a case.Results
We identified 200 cases with influenza type A or B admitted to one
of the index hospitals. Data of 1 patient was of poor quality and ex-
cluded from further analysis. Overall mortality was 9%. 45 patients
(23%) of the patients were admitted to the ICU, either primarily or
later during the disease. Risk factors for ICU admission were smoking
(p = 0.01), a history of OSAS/CSAS (p = 0.03) and myocardial infarction
(p = 0.007). The development of renal failure and secondary (pulmon-
ary) infections were also associated with ICU admission (P < 0.001).
17 of the 45 (38%) patients admitted to the ICU died during admis-
sion. Risk factors for ICU mortality included diabetes (p = 0.04) and
renal failure before and during ICU admission (p = 0.01). In 25 out of
45 patients (55.6%) a secondary pulmonary infection developed. The
most common bacterial pathogens included staphylococcus aureus
(11.1%) and streptococcus pneumoniae (6.7%). Among the secondary
fungal infections, Aspergillus fumigatus was most common (17.8%),
followed by pneumocystis jirovecii (6.7%). Patients with a secondary
infection received oseltamivir more often (100% vs. 65.0%, p = 0.002).
No association was observed between other immunosuppressive
drugs and the development secondary pulmonary infections.
Conclusions
Development of secondary pulmonary infections is a frequent com-
plication in patients with influenza and associated with an increased
risk of ICU admission. Early identification and treatment of these pa-
tients may prevent ICU admission.P430
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Introduction
Several studies showed neuroprotective and immunomodulatory mecha-
nisms of therapeutic hypothermia (TH). TH negatively affects leucocyte
migration and synthesis of cytokines and is therefore thought to enhance
infection rate due to impaired immunosurveillance. However, data for TH
in children is limited. Therefore, we analyzed incidence of infections and
outcome of children treated with TH (TH-group) and compared them to
normothermic patients (NT- control group).
Methods
This study was performed as a retrospective case control study (from
2000 to 2012). All medical records and laboratory files of patients (new-
borns and children until 18 years of age), receiving TH for 24 to 72
hours, were screened and compared to a NT-group (historic control
group with conventional treatment). Both groups were matched ac-
cording to diagnosis and age. Data was analyzed from the day of ad-
mission to ICU until day 6. Indications for TH-initiation were cardiac
arrest, peripartal asphyxia, traumatic brain injury, ischemic stroke, cere-
bral haemorrhage, -edema or –seizures, as well as acute liver failure. Pa-
tients with evident infection, medical history of an immunodeficiency
disorder and / or an immunosuppressive therapy, before onset of TH,
were excluded. TH (32-34°C) was induced by using a non-invasive cool-
ing device. After 72 hours rewarming was started (0.2-0.3°C/hour).
Results
108 patients were included (TH-group n = 27, NT-group n = 81). Sur-
vival rate showed no significant difference (81% of TH and 78% of
NT, p = 0.996). CRP elevation (>1.2 mg/dL) was earlier in the TH-
group and showed a significant difference on day 6 (4.93 mg/dL) to
NT-group (2.36 mg/dL, p = 0.007). 22,2% of patients in the TH-group
had culture proven infections in comparison to 4% within the NT-
group. Five patients in the NT-group showed only clinical signs of in-
fection. Pneumonia was the most commonly culture proven infection
within both groups (TH 14.8% and NT 6.2%).
Conclusions
We report that therapeutic hypothermia did not significantly alter
overall survival and length of hospital stay in our pediatric center.
Similar to previous observations [1], our results showed a significant
increase of CRP levels in TH patients as compared to NT controls,
and had more culture proven infections. This data underlines the
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Legend 2: Colonisation rates of CVCs categorised by their reason for removal
Table 7 (abstract P432). See text for description
WCC + CRP 48-hours
post CVC removal
N= Mean duration (days) Colonised CR-BSI
Increasing trend 9 6.2 2 0
Decreasing trend 12 6.7 3 1
No change 25 6.7 8 0
Legend 2: Comparison of colonised CVCs and biochemical improvement
following their removal
Critical Care 2017, 21(Suppl 1):58 Page 33 of 70necessity of continuous monitoring for possible infectious complica-
tions when TH is used in pediatric intensive care setting.
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Introduction
Nosocomial acquisition of multidrug resistant Acinetobacter baumannii
in the ICU is common. Despite a high fatality rate, over 50% of ICU Aci-
netobacter carriers are discharged alive from ICU to hospital wards
where they continue to represent a source for cross transmission. We
describe an intervention to terminate an ICU Acinetobacter outbreak
and investigate the effect on hospital wide Acinetobacter prevalence.
Methods
ICU Acinetobacter incidence and prevalence were detected from sur-
veillance and clinical cultures. Hospital prevalence was determined
from clinical cultures. The Acinetobacter control intervention included
unit closure with intense environmental cleaning, a hand hygiene inter-
vention, improved cleaning protocols and the use of virtual walls. Data
for the year preceding and following the intervention were compared
for (1) ICU admission prevalence and ICU acquisition of Acinetobacter,
(2) hospital prevalence of Acinetobacter and (3) Colistin use.
Results
In the year prior to the intervention (6/2014 – 5/2015), Acinetobacter
was isolated during 65/513 (13%) ICU admissions. Acinetobacter was
isolated within 48 hours of ICU admission on 32/65 (49%) occasions
and acquired in the ICU thereafter on 33/65 (51%) occasions. Acineto-
bacter positive patients were discharged alive to the wards on 48/65
(74%) occasions. In the year following the intervention (6/2015-5/2016)
Acinetobacter was cultured during 4/516 (0.8%) ICU admissions (p <
0.001 vs preintervention), only one patient acquired Acinetobacter in
the ICU and one Acinetobacter positive patient was discharged alive to
the ward. In the hospital at large, Acinetobacter prevalence decreased
by 58% from 185/39421 (0.5%) to 107/40292 (0.3%) admissions (p <
0.001). ICU and non-ICU hospital Colistin use (in defined daily doses/
1000 patient days) decreased from 250 to 68 (p < 0.001) and 21 to 12
(p < 0.001) respectively.
Conclusions
The ICU intervention decreased ICU acquisition of Acinetobacter and
ICU discharge of Acinetobacter positive patients to the wards and
was associated with a decrease in hospital prevalence of Acinetobac-
ter. Numerically, the decrease in hospital prevalence (from 185 to
107 patients) exceeded the decrease in ICU discharge of Acinetobac-
ter patients (from 48 to 1). This could suggest that decreased ICU dis-
charge of Acinetobacter positive patients leads to a lower
Acinetobacter load in the wards and thus decreased transmission in
the wards. The decreased load of Acinetobacter also facilitated a de-
crease in Colistin use. In conclusion, control of an ICU Acinetobacter
outbreak had positive ramifications throughout the hospital.
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Introduction
Vascular catheters are a ubiquitous tool in the critical care setting; how-
ever their use does not come without risks. Potentially one of the most
serious and preventable complications is catheter-related blood streaminfection (CR-BSI). The aim of this study was to examine the reasons why
central venous catheters (CVC) are removed, whether there is clinical im-
provement following removal, and see how this relates to rates of CR-BSI.
Methods
We retrospectively studied the insertion, care, and reason for removal
of central venous catheters across a single NHS trust. This data was
then matched with the corresponding biochemical and microbio-
logical results for each patient. Suspected CR-BSI was defined as clin-
ical evidence of sepsis and with no apparent source of septicaemia
except catheter tip colonization. Confirmed CR-BSI was subsequently
defined by colonisation of a catheter tip with the same micro-
organism grown from a peripheral blood culture. A routine change
of CVC or arterial catheter was defined as replacement without evi-
dence of sepsis or problems with the functioning of the catheter.
Results
A total of 87 CVCs were studied with an average duration of insertion
of 5.5 days. The most common reason for removal was absence of indi-
cation (28.7%). 17 out of 87 (19.5%) of CVCs were removed due to sus-
picion of CR-BSI, and of these only 1 was confirmed (Table 6). We
further examined the cultured catheters for evidence of biochemical
improvement following removal (Table 7). Of those who experienced
improvement of inflammatory markers following CVC removal, we
found no difference in mean duration of insertion, and similarly they
were no more likely to have colonised CVCs than patients who did not
experience improvement of their inflammatory markers (25% vs 29%).
Conclusions
In the NHS trust studied we found that 16.1% of central venous cathe-
ters were routinely changed after an average of 7.1 days without obvi-
ous indication other than to prevent catheter-related infection.
Although some of these lines were colonised when cultured, we did
not find any biochemical benefit of removing them routinely. This is
consistent with evidence from randomised trials showing that routine
replacement does not reduce rates of catheter-related bloodstream in-
fection compared with changing them when clinically indicated [1][2].
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Fig. 18 (abstract P433). Adhesion of activated neutrophils on the
Alteco hemofilter
Critical Care 2017, 21(Suppl 1):58 Page 34 of 70P433
Elimination of LPS and cytokines from blood of septic patients
with LPS-adsorber
M Kiselevskiy1, E Gromova1, S Loginov2, I Tchikileva1, Y Dolzhikova1,
N Krotenko 2, R Vlasenko1, N Anisimova1
1Russian Cancer Research Center, Moscow, Russia; 2SP Botkin Hospital,
Moscow, Russia
Critical Care 2017, 21(Suppl 1):P433
Introduction
LPS-adsorption by Alteco® devices allows eliminating from
blood endotoxin, inflammatory mediators and activated leuco-
cytes [1].
Methods
20 patients with septic shock were enrolled ingram-negative the
study. The values of IL-4, IL-6, IL-8, IL-10, IL-18 in serum and washout
from LPS-adsorber were measured by ELISA. Concentrations of LPS
were measured by modified micro gel clot test.
Results
LPS level in blood significantly reduced after the hemoperfusion
procedure (equally or more than twofold) in 50% of the patients
with its initially high level (Fig. 17). Significant reduction of serum
LPS level required from 2 to 6 hemoperfusion procedures. We
did not detect any changes in the patients with initially low level
of LPS. IL-6 and IL-8 showed the most prominent concentration
changes among the cytokines under the study. Their level
dropped down from 2 to 10 times after the procedure in many
of the patients with initially high level of the cytokines. Number
of functionally active leucocytes with high phagocytic activity and
enhanced expression of CD11c adhesion molecules decreased
after the hemoperfusion procedure in the patients. Substantial
part of the leucocytes adhered on the Alteco hemofilter plates
(Fig. 18).
Conclusions
Hemoperfusion procedure allows eliminating from the blood
not only LPS, but excess inflammatory mediators as well.
Adhesion of activated neutrophils on the Alteco hemofilter
allows eliminating from the bloodstream of septic patients
the most reactogenic phagocytes releasing cytotoxic free
radicals.Fig. 17 (abstract P433). Changing the concentration of LPS in
patients before and after hemoperfusionReferences
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Introduction
Sepsis is the most common cause of death by infection. In par-
ticular, abdominal sepsis is characterized by the highest death ra-
tio and a complicate management, because of the high variability
of microorganisms involved and the growing problem of anti-
biotic resistance. Therefore, the aim of this study is to identify
potentially modifiable risk factor of death in patients with
abdominal sepsis.
Methods
This is a prospective-observational study conducted in ICU at San-
t’Anna Hospital, Ferrara. All patients >18 years admitted with the
diagnosis of abdominal sepsis, according to 2016 sepsis criteria, were
enrolled. We collected clinical and demographic data for each pa-
tient. Moreover, we recorded laboratory and blood gas analysis data
microbiological investigations, anti-infective treatment (antimicrobial
therapy/source control) and fluid balance. Primary outcome was 90-
days mortality.
Results
Thirty patients were enrolled. Clinical and demographic variable
are shown in Fig. 19. The 61% of isolated microorganisms were
multiresistant (MDR). Mortality in patients affected by MDR bac-
teria was not increase (36% vs 35%; p = 0.91). However, an ap-
propriate empirical antibiotic therapy in the first 12 hours was
found to be associated with a decreased mortality from 70% to
12% (p = 0.01). Moreover, positive fluid balances for more than
72 hours were more frequent in non-survivor patients (47% vs
18% p = 0.04).
Conclusions
In our population, MDR bacteria were highly represented.
However, not the resistance itself, but the failure of an appro-
priate early empirical therapy was strongly associated with in-
creased mortality; therefore, the knowledge of the local
epidemiology of microorganisms and of their drug-resistance is
crucial. Moreover, the inability to get a null or negative fluid
balance after the first 72 hours in the ICU is a risk factor for
90-days mortality.
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Introduction
Health care associated pneumonia (HCAP) ability to identify pneumo-
nia sustained by multi drug resistant pathogens is controversial [1].
We sought to provide a new scoring system addressing the empirical
antimicrobial therapy based on the correct identification of resistant
pathogens in patients with pneumonia.
Methods
In this prospective observational study, we considered 93 adult pa-
tients with microbiological confirmation of pneumonia. We looked
for the prevalence of Community-Acquired Pneumonia-Drug-
Resistant Pathogens (CAP-DRP), among patients classified and
treated as having CAP or HCAP. The primary goal was to assess
whether the appropriateness of initial empiric therapy would affect
the short term mortality and if we could improve it with a new scor-
ing system.
Results: We considered 51 CAP and 42 HCAP patients with
microbiological confirmation of infection. Receiving inappropri-
ate empirical antimicrobial therapy was an independent risk fac-
tor for 30 days’ mortality (P = 0.018, OR 5.32 [95%C.I. 1.26-
22.73]). Among 76 bacteria-sustained pneumonias, 22.3% had
CAP-DRP. After applying HCAP definition, we found 4.7% of
CAP-DRP among CAP, and 44% among HCAP. Previous
hospitalization, residence in nursing home or long-term facil-
ities, non-ambulatory status and usage of PPI/antiH2 were pre-
dictors of CAP-DRP pneumoniae and were turned into an
equation that identifies them with AUC of 0.847 [95%C.I. 0.732-
0.962], performing better than HCAP model (AUC = 0.780,
95%C.I. 0.663-0.898). Figure 20. DRP score: solid line, HCAP
model: dashed line. DRP score = (hospitalization*4.743) + (nursing
home residence*4.31) + (non-ambulatory status*-2.444) + (use of
PPI/antiH2*-2.361). A score higher than 0.933 is a predictor of
CAP-DRP.
Conclusions: HCAP-addressed empirical therapy leads to overtreat-
ment and undertreatment of a considerable percentage of patients
with pneumonia. Among them, the score system we propose may
help to choose the most appropriate empiric antimicrobial therapy,
aiming at reducing inappropriate initial therapy and its associated
mortality.
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Introduction
Antimicrobials are the 51% of the drugs used in intensive care units
(ICUs) [1] and antimicrobial resistance has increased dramatically in
recent years. Antimicrobial stewardship (AMS) programs aims to es-
tablish strategies to improve the use of antimicrobial and reduce re-
sistance, adverse effects, Clostridium difficile infections and cost [2].
International guideline proposes restrictive, persuasive and structural
strategies. In Chile, the feasibility of these programs are not totally
studied. We showed a process of implementation AMS programs in
our ICU.
Methods
We conducted a 3 steps process of implementation of AMS program.
We reviewed the literature to identify AMS strategies published from
2010 to 2016, inclusion criteria were studies in adult patients, high
complexity hospitals or ICU, and have description of the strategies in
their results. A local survey was applied to 8 health care professional
to evaluate the feasibility to implement the strategies found, this sur-
vey consists of positives, neutral and negative answers and if the
strategy counts with a half of positive answers we considered a pos-
sible implementation. A team with clinical pharmacist, intensivist and
infectious diseases physicians worked on the set to develop the opti-
mal way to implement these strategies in our ICU.
Results
We found 362 studies about AMS program, in which 49 included 21
strategies in ICUs. Strategies were classified in restrictive, persuasive
and structural. In our unit 9 of those are already implemented. Ac-
cording to local survey 7 strategies were feasible to implement
(Fig. 21). Implementation was carried out through two processes:
Medical record optimization and local guideline of antimicrobial
treatment.
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With a baseline of 9 strategies we implemented 7 additional. This
study is the first step to establish AMS policy in our ICU. The next
step is made assessment of the clinical impact of our AMS policy.
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Introduction
To better inform infection control and antibiotic stewardship programs,
we investigated carbapenem resistance trends and assessed the mo-
lecular characteristics of β -lactamases (ESBLs, AmpC β -lactamases and
carbapenamases) among Enterobacteriaceae isolates from IAI patients
treated in South African hospitals participating in the Study for monitor-
ing Antimicrobial Resistance Trends (SMART) program 2010 and 2015.
Methods
Cochran-Armitage test was used to examine trends in susceptibility.
Classification and regression trees (CART) were used to identify mini-
mum inhibitory concentration (MIC) thresholds of various drugs as
well as other factors predictive of phenotypic CRE. EUCAST version 6
MIC interpretive criteria were used to identify non-susceptible isolates.
(4) Isolates recovered <48 hours after hospitalization were considered
community-associated infections (CAI); while those recovered > =48
hours were considered healthcare-associated infections (HAI).
Results
Of the 124 isolates 109 (88%) were phenotypically ESBL, 122 (98%) of
these had one or more β -lactamases and ampC genes identified
and 98 (79%) were fully susceptible to the carbapenems (Fig. 22).
Figure 22A shows that K.pneumoniae (68/124) and E coli (42/124)
were the majority isolates contributed most of the drug resistance
genes identified. Carbapenem susceptibility significantly declined by
an average of 35% (2-80), driven in part by increase in resistance in K
pneumoniae isolates (Fig. 22B). On the contrary, susceptibility to ami-
kacin significantly increased, while that of piperacillin/tazobactam de-
creased to 59%. Of the 26 isolates nonsusceptible to carbapenems; 6
(23%) were CAI and were 12 (46%) were HAI; p = 0.468 (Fig. 22C).
CTXM-15 lactamase was the most frequent gene identified I 85/124
(65%) of isolates; but, was found in combination with other genes 67/81 (83%) of the time. In fact, the odds for nonsusceptibility to carba-
penems rose 26-folds (3-245) when 4 genes were present compared to
isolates with only one drug resistance gene was present for all isolates.
Conclusions
CTXM-15 carrying K pneumonia are emerging as causes of CRE asso-
ciated IAI in South Africa. Piperacillin/tazobactam is an unlikely sub-
stitute antibiotic for this patient cohort given declining susceptibility
trends and overall poor activity.P438
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Introduction
Intraosseous (IO) access may be lifesaving in medical emergencies,
when conventional vascular access is difficult to achieve. In life-
threatening infections, early administration of antibiotics is crucial. In
septic shock, the circulation is markedly compromised. We wanted to
elucidate whether sufficient blood levels are reached, when antibi-
otics are administered IO [1].
Methods
A model of endotoxemic shock was used, where 8 anaesthetized, ex-
tensively monitored, pigs were given a continuous infusion of E. Coli
endotoxin over 6 hour period, after which, the animals were sacri-
ficed. The Animal Ethics Committee of Uppsala University, Sweden,
approved the experiment. IO access was achieved in the tibial bone
(EZ-IO®, Teleflex Medical, Morrisville, NC, USA). Cefotaxime at 75mg/
kg and gentamicin at 7 mg/kg, respectively were administered IO or
intravenously (IV). Central concentrations of these antibiotics were
measured at 5, 15, 30, 60, 120, and 180 min.
Results
After starting the endotoxin infusion, most of the animals showed
signs of hemodynamic instability with reduced mean arterial blood
pressure (MAP), cardiac index and markedly elevated mean pulmon-
ary arterial pressure. All animals except one, needed norepinephrine
to keep MAP >60 mm Hg. The plasma concentrations of both cefo-
taxime and gentamicin, when injected IO and IV, respectively, were
nearly identical with similar slopes showing decreasing plasma con-
centration of each antibiotic by time. There were no significant differ-
ences between either antibiotic, regardless of injection site, based on
analysis of variance. The 95% confidence intervals regarding the dif-
ference of means for each antibiotic, were well within the relevant
intervals.
Critical Care 2017, 21(Suppl 1):58 Page 37 of 70Conclusions
This study strongly suggests that IO access may be an appropriate
alternative to IV administration of antibiotics, in some severe infectious
conditions (e.g. septic shock), when venous access is difficult to achieve.
Relevant concentrations of these antibiotics were achieved even in se-
verely circulatory comprised animals. Thus, we deduce that IO antibiotic
administration also may be considered in the prehospital setting, as
early systemic administration of antibiotics may be lifesaving [2].
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Introduction
Our study was carried out to audit aminoglycoside resistant patterns
and assess the need to cycle aminoglycosides. The current trust anti-
microbial policy at Lewisham (UHL) and Greenwich (QEH) NHS Trust ad-
vises the use of gentamicin as a first line agent against gram-negative
organisms except in severe sepsis where it recommends amikacin. Anti-
microbial cycling has a role in critical care due to the increasingly rapid
spread of resistant bacteria, influencing healthcare costs and mortality
[1][2]. Of note, the rotation of gentamicin and amikacin has been found
to reduce gentamicin resistance in some studies [3].
Methods
This was a 3-month retrospective, cross-site study from 1/8/16 – 31/
10/16. Data was obtained from UHL and QEH critical care units. Re-
sistance patterns of samples positive for gram-negative organisms
were analysed using WinPath. The total number of resistant organ-
isms were found, and within this cohort; the number of gram-
negative organisms resistant to both gentamicin and amikacin. The
proportion of extended spectrum beta lactamase (ESBL) and AmpC
positive organisms were also analysed.
Results
4398 samples were obtained; 2822 (64%) from UHL and 1576 (36%)
from QEH. 68% of gram-negative organisms were sensitive to all anti-
microbials. Within the 3 month period 1462 (33.2%) of samples dis-
played antibiotic resistance; of which 4% of organisms were found to
be resistant to gentamicin.
Conclusions
This audit has demonstrated a significant number of gentamicin re-
sistant organisms. However this does not reach the national thresh-
old for cycling. We have noted the need to reinforce the use of
amikacin as a first line aminoglycoside in all critically ill patients.
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ESBL/AMPc Other gram
negatives
Total number of samples 78 4320
Gentamicin sensitive-GS/ Amikacin sensitive-AS 45 4266
Gentamicin resistant- GR/ AS 33 48
GR/ Amikacin resistant-AR 0 6
GS/ AR 0 0
Legend 1: ResultsP440
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Introduction
Linezolid (LZ) is an antibiotic with time-dependent activity. An opti-
mal antibacterial effect is achieved when plasma drug concentrations
are above the MIC (T >MIC) for the entire length of treatment. Critic-
ally ill patients receiving standard doses of LZ, particularly in those
with sepsis and conserved renal function (CRF), are at risk of not
attaining PK/PD targets. LZ clearance (LzCl) is usually increased in
these patients, often due to augmented renal clearance (ARC). Con-
tinuous infusion (CI) could offer advantages in this context [1]. The
objective of this work was to study the benefit of CI of LZ in critically
ill patients with CRF.
Methods
Study developed in two tertiary hospitals in critically ill patients in
the absence of severe renal dysfunction (Creatinine clearance (CrCl)
>40 ml/min). Each patient received a CI of LZ (50 mg/h) preceded by
a 600 mg bolus. Blood samples were taken on days 1, 2, 3 and 4
after infusion onset. CrCl was determined on each day of the study.
Treatment was considered satisfactory if steady state plasma concen-
tration (CSS) was > =2mg/L (MIC90 of most Gram-Positive Cocci in
Europe). The correlation between CrCl and LzCl was calculated. α sig-
nificance level of 0.05.
Results
22 adult patients (64% males) were included in the study (80 sam-
ples). The mean age was 55 years (SD 19), and the average weight
was 81 kg (SD 19). The median and interquartile ranges (IR) were:
CrCl 119 ml/min (IR 85-168), LzCl 13 L/h (IR 6-24) and Css 3.8 mg/L
(IR 2.1-7.9). 55% of patients presented ARC (CrCl > =130 ml/min) and
32% of the patients had CrCl > =165 mL/min, for at least one day.
CSS was > =2mg/L in 84% of the samples. The correlation (Spear-
man’s Rho) between CrCl and LzCl was 0.81 (p < .001). CrCl, with a
cut-off point of 165 ml/min, can predict failure in treatment (CSS
<2mg/L) with a sensitivity of 92% (95% CI 74-100), specificity of 86%
(95%CI 77-95) and AU ROC 0.94 (95%CI 0.87-1.0).
Conclusions
Despite the high CrCl values of the patients, 50 mg/h LZ CI ensures a
high probability of achieving the PK/PD target if CrCl < 165 ml/min.
In the presence of CrCl > =165 ml/min, a higher dose should be
considered.
References
1. Adembri, C., et al., Linezolid pharmacokinetic/pharmacodynamic profile
in critically ill septic patients: intermittent versus continuous infusion. Int
J Antimicrob Agents, 2008. 31(2): p. 122–9.
P441
Pharmacokinetics of tigecycline in liver impairment: quantification
of liver function with maximal liver function capacity test (LiMAx
test)
M Kaffarnik1, R Alraish1, O Frey2, A Roehr2, M Stockmann1, S Wicha3
1Charite Berlin Campus Virchow, Berlin, Germany; 2Pharmacy, Clinic of
Heidenheim, Heidenheim, Germany; 3Uppsala University, Dept. of
Pharmaceutical Biosciences, Uppsala, Sweden
Critical Care 2017, 21(Suppl 1):P441
Introduction
Tigecycline (TGC) is a key antibiotic in the therapy of intra-abdominal
infections in critically ill patients. Liver failure frequently occurs in this
patient collective and may lead to altered pharmacokinetics (PK) of
TGC in these patients. We aimed to (i) determine the PK of TGC in
patients with and without liver impairment and to (ii) compare the
value of the novel maximum liver function capacity (LiMAx) test and
Critical Care 2017, 21(Suppl 1):58 Page 38 of 70conventional liver function markers (ALAT, Bilirubin, INR) as covari-
ates of TGC PK.
Methods
Patients with and without liver impairment were included in this
open, prospective cohort study. All patients received an i.v. TGC load-
ing dose of 100 mg followed by 50 mg twice daily, administered
over 0.5 h. TGC plasma concentrations were determined by HPLC
after >36 h of therapy at 5 time points. On the day of plasma sam-
pling, ALT, BIL, INR and LiMAx were determined. NONMEM® 7.3 was
utilised for the pharmacometric analysis.
Results
23 patients contributed 114 timed plasma samples and supported
estimation of a two-compartment PK model with linear elimination.
LiMAx and BIL were low correlated (r2 = 0.11). Including both was
significant for TGC clearance (CL) (p < =0.005), whereas ALT and INR
were not significant. Parameter estimates (relative standard error) for
a typical patient with LiMAx 187 μg/kg/h and BILI 2.1 mg/dL were:
CL 9.7 L/h (7%), V1 72.4 L (15%), intercompartimental clearance Q
64.9 L/h (16%), V2 137 L (10%). Inclusion of LiMAx and BIL reduced
the interindividual variability of CL from 43.3% to 30.1%. Determined
CL were substantially influenced by liver function (Fig. 23; paired typ-
ical predicted CL (red) and individually determined CL (black) vs.
LiMAx).
Conclusions
PK of TGC was substantially altered in patients with liver impairment.
The observed variability in TGC clearance was partially explained by
LiMAx and BIL. The determined covariate relationships between the
liver function markers LiMAx, BIL and TGC CL sets the basis for PK-
guided dosing in liver failure patients to avoid therapeutic failure or
potential toxic side effects of the drug.Fig. 23 (abstract P441). Impact of liver dysfunction on predicted
and determined TGC-ClearanceP442
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Introduction
Ceftolozane/tazobactam (C/T) is an antibacterial combination consist-
ing of a novel antipseudomonal cephalosporin and a β -lactamase in-
hibitor. C/T was approved by the US Food and Drug Administration
in 2014 and the European Medicine Agency in 2015 to treat compli-
cated urinary tract infections, acute pyelonephritis and complicated
intraabdominal infections. The Program to Assess Ceftolozane/Tazo-
bactam Susceptibility (PACTS) monitors C/T resistance to Gram-
negative (GN) isolates worldwide.
Methods
A total of 3984 GN isolates were collected in 2014-2016 from 39
European hospitals’ intensive care unit (ICU) patients and tested for
susceptibility by broth microdilution method in a central laboratory.The most common source was tracheal aspirate followed by blood-
stream. In addition to C/T, amikacin (AMK), cefepime (FEP), ceftazi-
dime (CAZ), colistin (COL), levofloxacin (LVX), meropenem (MER), and
piperacillin/tazobactam (TZP) were tested. Antibiotic resistant pheno-
types identified using EUCAST (2016) clinical breakpoints included
extended-spectrum beta-lactamase (ESBL), carbapenem-resistant
Enterobacteriaceae (ENT; CRE), ceftazidime nonsusceptible (CAZ-NS),
meropenem nonsusceptible (MER-NS), and multidrug resistance
(MDR).
Results
The 5 most common species isolated from ICU patients were
Pseudomonas aeruginosa (PSA; 887 isolates), Escherichia coli
(735), Klebsiella pneumoniae (674), Acinetobacter baumannii com-
plex (481), and Enterobacter cloacae (181). For 2,402 ENT iso-
lates, 82.7% were susceptible (S) to C/T (MIC of [<=]1 mg/L),
AMK had 94.8% S, FEP 75.0%S, CAZ 69.6%S, COL 79.0%S, LVX
76.4%S, MER 95.1%S, and TZP 74.1%S. For 489 ENT with an
ESBL (non-CRE) phenotype, and the most active drugs were COL
(93.4%S) and MER (99.2%S). C/T had 64.6%S. A total of 571 ENT
were MDR, 42.7% were S to C/T, 78.6%S to AMK, 20.1%S to FEP,
12.1%S to CAZ, 72.6%S to COL, 28.5%S to LVX, 79.5%S to MER
and 21.9%S to TZP. A total of 118 ENT were CRE, and 56.9%
were S to COL, 44.9%S to AMK, other agents were <13%S. For
PSA, 85.9% were S to C/T (MIC [<=]4 mg/L), 80.0%S to AMK,
72.9%S to FEP, 67.8%S to CAZ, 99.9%S to COL, 57.8%S to LVX,
62.1%S to MER, and 64.7%S to TZP. The most active agents
against the 300 MDR PSA were COL 99.7%S and C/T 59.0%S.
Other agents were AMK 43.5%S, FEP 26.3%S, LVX 12.0%S, MER
14.7%S, and TZP 9.7%S.
Conclusions
C/T demonstrated good activity against ICU ENT isolates with
82.7%S. Only AMK and MER were more active. For PSA, C/T demon-
strated potent activity (85.9%S) and was more active than all other
agents tested except for COL.
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Introduction
The objective of this study was to compare clinical outcomes of
ceftriaxone (CTX) vs. nafcillin (NAF) or cefazolin (CFZ) for the
treatment of methicillin-susceptible staphylococcal aureus (MSSA)
bacteremia. Treatment of MSSA bacteremia typically consists of
oxacillin (OXA) or NAF. Retrospective data comparing CFZ to OXA
for the treatment of MSSA bacteremia suggest that CFZ is an ef-
fective alternative agent, while CTX use has yielded mixed results
[1, 2, 3].
Methods
This retrospective chart review included patients with positive
blood cultures for MSSA who received treatment with CTX, NAF,
or CFZ between the months of January 2012 and September
2016. Patients were excluded for the following reasons: receiving
>3 days of non-study antimicrobial agents with activity for MSSA,
age <18 years, polymicrobial blood cultures, therapy for <14
days, or if adequate source control was not achieved. Patients
were assigned to one of two groups: CTX therapy or standard of
care therapy (SOCT) with either NAF or CFZ. The primary out-
come was rate of clinical cure at end of defined therapy for the
CTX group compared to the SOCT group. Secondary outcomes
evaluated were: treatment failure, time to negative blood culture,
time to defervescence, and occurrence of acute kidney injury
(AKI). Demographic data were collected. Clinical cure, treatment
failure, and occurrence of AKI were assessed with the Fisher’s
exact test. Time to negative blood culture and time to deferves-
cence were assessed with the Mann-Whitney U test. Demographic
data were assessed with descriptive statistics.
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Fifty-one patients met inclusion criteria. There were no differences in
clinical cure rates between CTX (81.8%) and SOCT (72.5%) (p =
0.7063). There were no differences in treatment failure between CTX
(9%) and SOCT (7.5%) (p = 0.99). Median time to negative blood cul-
ture was 40 hours for CTX vs. 36.5 hours for SOCT (p = 0.45). Median
time to defervescence was 13 hours for CTX and 22 hours for SOCT
(p = 0.99). AKI occurred in 0 patients treated with CTX and 4 patients
treated with SOCT (p = 0.5726).
Conclusions
In this comparison of CTX vs. SOCT for the treatment of MSSA
bacteremia we found no difference in clinical cure. We also found no
difference in treatment failure, time to negative blood culture, time
to defervescence, and occurrence of AKI.
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Introduction
Ventilator-associated pneumonia (VAP) is a common and serious
problem in intensive care unit (ICU). Several studies have demon-
strated that Gram stain of endotracheal aspirate may be useful for
accurate diagnosis of VAP. However, the effectiveness of Gram stain
on prediction of causative microorganisms has not been elucidated.
The purpose of this study is to evaluate whether Gram stain of endo-
tracheal aspirates can be used as a guide of initial antibiotic therapy
for VAP.
Methods
Data on consecutive episodes of microbiologically confirmed
VAP were collected from February 2013 to February 2016 in our
ICU. We constructed 2 hypothetical empirical antibiotic treat-
ment algorithms for VAP. The first algorithm was the guideline
based algorithm (GLBA) that based on the recommendation of
American Thoracic Society-Infectious Diseases Society of Amer-
ica guidelines. The second one was the Gram stain based algo-
rithm (GSBA) that limited spectrum of the initial antibiotic
therapy according to the results of bed-side Gram stain. Subse-
quently, the GLBA and the GSBA were retrospectively reviewed
in the same VAP episodes. The initial coverage rates and the
recommendation of broad-spectrum antibiotics was compared
between the two algorithms.
Results
During the study period, 219 suspected VAP episodes were ob-
served and 131 episodes were assessed for analysis. Appropriate
antibiotic coverage rates were equivalent in the two algorithms
(GLBA: 94.7% vs GSBA: 92.4%, p = 0.221). The number of episodes
that anti-methicillin resistant Staphylococcus aureus agents were
recommended as an initial treatment was larger in GLBA than
GSBA (70.2% vs 31.3%, p < 0.001). Furthermore, the number of
episodes that antipseudomonal agents were recommended as an
initial treatment was also larger in GLBA than GSBA (70.2% vs
51.9%, p < 0.001).
Conclusions
The GSBA may restrict the administration of broad-spectrum antibi-
otics without increasing risk of treatment failure.P445
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Introduction
Murepavadin (POL7080) represents the first member of a novel
class of outer membrane protein targeting antibiotics, being de-
veloped by Polyphor for the treatment of serious infections by
Pseudomonas aeruginosa (PA). This study investigated the PK,
safety and tolerability of POL7080 (2.5 mg/kg, 2-hour IV-
infusion; TID for 10-14 days) co-administered with standard-of-
care (SoC) in ventilator-associated pneumonia (VAP) patients
with suspected or confirmed PA infection. Efficacy was a sec-
ondary parameter.
Methods
This was a multicenter, open-label, non comparative, phase 2
study of the PK, safety, and efficacy of POL7080 when co-
administered with SoC. Patients whose pneumonia was subse-
quently shown by culture results to be caused by PA sensitive to
SoC antibiotics, were continued on treatment with SoC plus
POL7080. The main efficacy endpoints included all-cause mortality
(ACM) at day 28 and clinical cure at the TOC (7 ± 2 days after
end-of-treatment).
Results
Twelve (48%) out of the 25 enrolled patients were part of the
microbiological intention to treat (mITT) population: at inclusion,
11 had [>=] 105 CFU/mL - PA retrieved in their endotracheal as-
pirate (ETA) and 1 patient had a positive blood culture. The ACM
at day 28 was 92% (11 of 12 patients). Overall, 10 of 12 (83.3%)
patients in the mITT analysis set had a clinical outcome of cure
at the TOC visit, as assessed by the investigator (based on clinical
signs and symptoms, chest x-ray, CPIS and SOFA scores). Only 2
of 12 (16.7%) patients had a clinical outcome of failure at TOC.
One of those two patients died due to shock and multi-organ
dysfunction syndrome, 6 days after completing the full course of
POL7080 treatment. There was no emergence of resistance re-
lated to POL7080 during this study.
Conclusions
The observed efficacy of POL7080 treatment on 28-day ACM and
clinical response in this severely ill patient population underscore the
potential therapeutic value of POL7080 in the treatment of VAP pa-
tients with PA infection.
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Bacterial toxins are responsible for serious complications of infections
and associated with high morbidity and mortality rates despite best
antibiotic treatment. Novel empty liposomes, named CAL02 specific-
ally mimicking domains targeted by bacterial toxins, have shown
synergistic effects with antibiotics and the ability to fully rescue mice
from deadly acute infections by trapping toxins. CAL02 is active
against a broad panel of toxins both from Gram-positive and Gram-
negative pathogens, regardless of their resistance profile. Initial re-
sults of the first-in-man trial with CAL02 in patients with severe
community-acquired pneumococcal pneumonia (CAPP) are pre-
sented herein.
Methods
The first-in-man clinical study with CAL02 is a randomised, multicen-
tre, double-blind, placebo-controlled, trial carried out in ICU patients
with severe CAPP. All patients received standard-of-care antibiother-
apy and treatment recommendations for Sepsis. The study is com-
posed of three arms: CAL02 Low-Dose (4 mg/kg), CAL02 High-Dose
(16 mg/kg), and Placebo. CAL02 is administered twice, on two con-
secutive days, starting within 12 hours of the diagnosis of severe
CAPP, and within 24 hours of intravenous antibiotic treatment.
Endpoints: safety, tolerability, efficacy and pharmacodynamic
characteristics.
Results
The CAL02 Low-Dose/placebo cohort has been completed and the
CAL02 High-Dose/placebo cohort is ongoing. To date, patients char-
acteristics at baseline (mean (min-max)): age: 58 (38-79), CURB65
score: 3.4 (3-4), APACHE II: 20.7 (14-30), SOFA: 8.0 (6-12). 2 cases pre-
sented septic shock at screening. 5 out of 7 patients needed mech-
anical ventilation and 5 were treated with catecholamines due to
septic shock. 6 patients achieved cured pneumonia at Test of Cure
and 1 patient died on day 2. ICU stay was 11.6 days (2-22) and hos-
pital stay 20 days (2-55). CAL02 was safe and well tolerated. Safety
and efficacy data from all patients having participated to this trial will
be gathered and analysed by March 2017.
Conclusions
This clinical study is the first trial assessing the potential of a broad-
spectrum anti-virulence agent, CAL02, and its ability to protect
against clinical deterioration in combination with antibiotics in a se-
verely infected population. CAL02 is a first-in-class non-antibiotic
drug which appears safe and its potential lies nonetheless far be-





Anidulafungin in ascites and pleural effusion of critically ill
patients
R Welte1, I Lorenz1, P Eller2, M Joannidis1, R Bellmann1
1Medical University of Innsbruck, Innsbruck, Austria; 2Medical University
of Graz, Graz, Austria
Critical Care 2017, 21(Suppl 1):P448
Introduction
Echinocandins such as anidulafungin are first choice for treatment of
invasive candidiasis in critically ill patients. The elimination of anidu-
lafungin is independent from renal and hepatic function. However,
data on its target-site penetration are limited so far. Therefore, we
assessed anidulafungin pharmacokinetics in ascites and pleural effu-
sion of critically ill patients treated with standard doses of anidula-
fungin for proven or suspected invasive candidiasis.
Methods
Ascites and pleural effusion samples were drawn during routine para-
centesis or from drains inserted for therapeutic purpose. When a
drainage was in place samples were taken before as well as 1, 4, 8,
12, 18, and 24 hours after start of anidulafungin infusion. Anidulafun-
gin quantification was performed with high pressure liquid chroma-
tography (HPLC) and UV detection after protein precipitation with
acetonitrile. For gradient elution, ammonium acetate and acetonitrilewere applied. The flowrate was 1.0 ml/min. Anidulafungin was de-
tected at 306 nm. The method was validated according to the Euro-
pean Medicine Agency (EMA) guidelines. Its lower limit of
quantification is 0.05 mg/L.
Results
So far, seven critically ill patients with severe sepsis and multi-organ
dysfunction were enrolled into the study. Anidulafungin pharmaco-
kinetics in ascites has been determined in four patients. Kinetics in
pleural effusion has been assessed in two patients. In addition, a sin-
gle ascites sample obtained at paracentesis has been analysed. Ani-
dulafungin peak concentrations in ascites amounted to 0.34-0.98.
Thus, they were lower than the simultaneous plasma levels (peak
levels 3.82-7.70 mg/L) and displayed a slower increase and decline
than the plasma levels. The time to the peak level amounted to one
hour in plasma and to 4-12 hours in ascites. We defined the penetra-
tion ratio as the ratio between the area under the concentration time
curve (AUC) in ascites and the AUC in plasma. It amounted to 0.07-
0.37. In pleural effusion, anidulafungin were slightly than those in as-
cites. The peak concentrations in the two patients were 1.02 and
2.02 mg/L.
Conclusions
Anidulafungin was detectable in ascites and pleural effusion after ad-
ministration of standard doses. Ascites and pleural effusion concen-
trations exceeded the minimal inhibitory concentrations (MICs)
reported for several Candida strains. However, isolates with MICs
above the target-site concentrations have also been described. Inves-
tigation of target-site pharmacodynamics of anidulafungin in ascites
and in pleural effusion is required.
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Introduction
Anidulafungin can be used first-line for invasive candidiasis and test-
ing B-D-glucan (BDG) has been shown to both identify those with
early invasive fungal infection and guide discontinuation of antifun-
gal therapy when invasive candidiasis is unlikely. Despite the cost,
anidulafungin may be started even in those whom invasive candidia-
sis is unlikely or for whom microbiological evidence is scant. We in-
vestigated the appropriateness of anidulafungin prescription and the
cost implication of its use in this manner in our department
Methods
From April 1st - August 31st 2016, patients in whom anidulafungin
was prescribed were identified and their notes analysed. Likelihood
of fungal infection was assessed using the ‘Candida score’ (score < =
3 suggesting invasive candidiasis unlikely). Electronic patient records
were used to determine whether serum BDG was used to confirm
fungal infection, and where negative, whether this was used to dis-
continue anidulafungin.
Results
Anidulafungin was started with a score <3 on 25 occasions, and with
a candida score > =3 on 13 occasions. Only 2 patients had definitive
evidence of invasive candidiasis on blood cultures and both had a
‘Candida score’ > =3 (illustrating low scores identify low-risk of candi-
daemia). All patients with a score of > =3 in whom BDG was tested
had a positive result whilst with a score <3, BDG was negative in 8 of
11 patients (where tested). Of the total anidulafungin prescriptions
(374 days and 412 doses costing £123,595.88), 221 days (246 doses
costing £73,797.54), were prescribed in those with low-risk of inva-
sive candidiasis (Candida score <3), accounting for 59.7% of spend. A
more rigorous strategy (Candida score <3 and negative BDG) would
still save 85 days (93 doses; £27,899.07), representing 70.2% of spend
in the BDG-tested population with a score <3.
Conclusions
Our pilot study corroborates prior data in which BDG testing identi-
fies high-risk of invasive candidiasis, and a Candida score / BDG
Critical Care 2017, 21(Suppl 1):58 Page 41 of 70regimen could both stratify risk of invasive candidiasis and aid dis-
continuation of treatment in low-risk patients [1,2,3]. The potential
cost improvement for rationalization of anidulafungin use is signifi-
cant but requires further work.
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Introduction
The aim of this study is describe and analyse the thyroid function in
the critically ill patient, the different pattern of which of these are as-
sociate with higher mortality.
Methods
We enrolled all the patients admitted in the ICU of a tertiary hospital,
during the period from January 2015 to August 2016, with a length
of stay in the ICU of seven days or more.
Results
A total of 242 patients were included. 158 (65.3%) were male. Aver-
age age: 60. 49 ± 13.858 (20-88). Severity Indexes: SOFA 8.4 ± 4.2 (1-
20); APACHE II 21.6 ± 12 (3-40); SAPS II 53 ± 18 (13-115). The mean
length of stay was 20 ± 15.8 (8-113).
Regarding the thyroid functional test, TSH was recorded in 155 pa-
tients, mean values were 3.83 UI/ml ± 10.9 (0.001-126); T3 (n = 99)
mean values was 1.42 pg/ml ± 0.42 (1-2.6), and T4 (n = 112) with
mean values of 0.88 ng/dl ± 0.26 (0.4-2.1). The overall mortality in the
study population was 22.3% (n = 54). The cause of admission was re-
spiratory failure in 81 up to 242 patients (33.47%), Severe infection in
39 up to 242 of the cases (16.11%), Neurologic disorders in 64/242
(26.44%) and Miscellaneous 58/242 (23.9%)
We found significant differences in the severity scores of the study
population related to mortality during the ICU stay (No survivors vs
Survivors), SOFA (10.45 vs 7.9); APACHE II (24.42 vs 20.71); SAPS II(63.14 vs 50.69). In the patients with TSH analysis the mortality was
18.7% (n = 29) and the mean values in this group were 1.39 UI/ml. In
the survival group we found mean values of 4.39 UI/ml. p = 0.182.
The mean values of T3 in the mortality group were 1.15 pg/ml. In the
survival group the mean of T3 were 1.5 pg/ml. (p = <0.001) IC 95%.
(0.224 ± 0.487). In patients with T4 analysis the mortality was 21.42%
(n = 24) and the mean values were 0.795 and in the survival group
0.91 mg/ml. p < 0.054.
After the subgroup analysis of the cause of admission, we didn’t
found significate differences in the average values of hormones
among the groups. However we found statistically difference in T3
average value in the group of survivors and no survivors in all the
subgroups.
Conclusions
After the perform of the TSH, T3 and T4 analysis, in the survival, and
mortality group, we found a statistical significant difference in the T3
group. We can hypothesize that the decrease of this thyroid hor-
mone is in relation with worst outcome, as the severity scores. After
the subgroup analysis of the cause of admission, we haven’t found
differences in the mean values of hormones among the groups.
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Introduction
Hyperglycemia, increased lipolysis, hypoaminoacidemia and pro-
found muscle wasting are hallmarks of critical illness. Guidelines rec-
ommend amino acid administration to prevent muscle wasting.
Glucagon, a catabolic hormone that affects these metabolic path-
ways and can induce muscle wasting, is increased during critical ill-
ness. Altered nutritional modulation of glucagon is known to
contribute to the catabolic phenotype of diabetes. We assessed
whether glucagon can be modulated by nutrition and investigated
its metabolic role during critical illness.
Methods
In 174 critically ill patients and 20 matched healthy controls, plasma
glucagon was quantified. In patients, the effect of glucose and insulin
infusion and of parenteral nutrition containing amino acids (PN) on
glucagon was documented. In critically ill mice with CLP-induced
sepsis, the effect of amino acid infusion on plasma glucagon was
evaluated and the impact of glucagon immunoneutralization on glu-
cose, lipid and amino acid metabolism and muscle wasting was stud-
ied in the early (10 or 30 hrs) and/or prolonged (3 days) phase of
critical illness.
Results
In patients, plasma glucagon concentrations were elevated from day
1 in ICU onwards up until day 7 and correlated with severity of ill-
ness. Infusing glucose with insulin did not significantly lower gluca-
gon, whereas PN containing amino acids increased glucagon. In
critically ill mice, infusion of amino acids increased plasma glucagon
and up-regulated markers of amino acid catabolism in the liver with-
out affecting markers of muscle wasting. Glucagon immunoneutrali-
zation in ill mice only transiently affected glucose and lipid
metabolism, with a decrease in the illness-induced hyperglycemia
and signs of stimulated rather than decreased lipolysis at 10 hrs. Glu-
cagon immunoneutralization did not affect muscle wasting, but dras-
tically suppressed markers of hepatic amino acid catabolism and
reversed the illness-induced hypoaminoacidemia.
Conclusions
These data suggest that elevated glucagon availability during critical
illness increases amino acid catabolism in the liver, explaining the
illness-induced hypoaminoacidemia, without affecting muscle wast-
ing and without a sustained impact on blood glucose. The data also
suggest that infusion of amino acids, which is done during illness
Fig. 24 (abstract P453). See text for description
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further increasing glucagon availability- merely results in a further
breakdown of amino acids in the liver.
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In vitro administration of ubiquinol and thiamine improve cellular
oxygen consumption in patients with diabetic ketoacidosis
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Introduction
The objective of this study was to investigate the effects of in vitro
administration of ubiquinol and thiamine on cellular oxygen con-
sumption in peripheral blood mononuclear cells (PBMCs) from pa-
tients with diabetic ketoacidosis (DKA). We hypothesized that DKA
patients would have depressed cellular oxygen consumption com-
pared to controls. DKA often requires significant hospital resources, is
characterized by depletion of electrolytes, and may be associated
with subclinical cellular injury with prolonged acidosis. Therefore,
evaluating metabolic components (apart from insulin) that can more
rapidly reverse DKA and protect cells may be beneficial. Thiamine
and ubiquinol are essential for adequate aerobic metabolism.
Methods
We performed a prospective study of DKA patients and healthy con-
trols presenting to the emergency department at an urban tertiary
care center from November 2015 to June 2016. A single blood draw
was performed and PMBCs were isolated from blood samples. Cells
were randomly assigned to in vitro administration of 0.5 ug/mL
thiamine, 1 ìg/mL ubiquinol, or placebo treatment. The complete
mitochondrial respiration profiles were measured using XF Cell Stress
Mito Kit (Seahorse Bioscience) to reveal the key parameters of cellular
oxygen consumption. One-way ANOVA was used to analyze differ-
ences in oxygen consumption rate between groups.
Results
A total of 10 DKA patients and 9 controls were included. Basal (7.0 ±
2.1 pmol/min/μg protein vs. 10.2 ± 2.4, p = 0.005) and maximal oxy-
gen consumption (16.6 ± 4.2 vs 28.3 ± 9.0, p = 0.05) were significantly
lower in PBMCs in DKA compared to controls. We found a significant
increase in basal (10.3 ± 2.4 pmol/min/μg protein vs. 7.0 ± 2.1, p =
0.05) and maximal (27.6 ± 5.2 vs. 16.6 ± 4.2, p = 0.04) oxygen con-
sumption between the ubiquinol and placebo group. Additionally,
we found a significant increase in basal (9.3 ± 2.4 pmol/min/μg pro-
tein vs. 7.0 ± 2.1, p = 0.05) and maximal (25.4 ± 5.0 vs. 16.6 ± 4.2, p =
0.05) oxygen consumption between the thiamine and placebo group.
Neither ubiquinol nor thiamine had a significant effect on basal and
maximal oxygen consumption for controls.
Conclusions
DKA patients had overall lower oxygen consumption compared to
healthy controls. In vitro administration of thiamine and ubiquinol in-
dependently increased oxygen consumption in DKA patients, but not
in controls. These findings suggest thiamine and ubiquinol may have
potential as mitochondrial resuscitators in DKA and potentially states
with similar metabolic stress.
P453
The evaluation of the adherence to and outcome of the blood
glucose monitoring protocol
O Demirkiran, A Byelyalov
Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
Critical Care 2017, 21(Suppl 1):P453
Introduction
This study aims to evaluate the adherence to and outcome of the
blood glucose monitoring protocol amongst adult patients in ICU.
Methods
Patients above 18 years of age, who were admitted to EICU between
March 2012 and March 2015 for longer than 24 hours and put on
blood glucose monitoring protocol, were enrolled in this study.Patients’ demographic data, diagnosis on admission, presence of dia-
betes mellitus diagnosis, APACHE II score, length of stay in ICU and
afterwards in the wards and health state on discharge from ICU and
from the wards were recorded retrospectively. We calculated the
rates of adherence to the timing of measurements and treatment
protocol using patients’ blood glucose recordings, the success rate of
glycemic control using blood glucose levels, and the effect of adher-
ence to monitoring protocol on the mortality rates and length of
hospital stay. We assessed if the disparity in protocol adherence is as-
sociated with diabetes mellitus diagnosis, having surgery, severe sep-
sis/septic shock diagnosis or different APACHE II scores. Total 453
patients in 4447 in ICU stay day 22.220 measurement were recorded.
Results
24% of measurement timings and 57.8% of treatments were accord-
ing to the protocol. Better adherence achieved more effective hyper-
glycemia control and lessened the fluctuations in blood glucose
levels, however it caused significantly increased rates of
hypoglycemia and no change in mortality or length of hospital stay.
The adherence rate was lower for patients with diabetes mellitus
diagnosis, but sepsis or surgery had no effect.
Conclusions
We need to update our protocol according to the current guidelines
in order to improve its efficacy and safety, redesign the parts that
may hinder our adherence, and provide the necessary training to the
staff for improving the adherence to the protocol.
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Introduction
Two insulin receptor (IR) isoforms are responsible for insulin physio-
logical actions. IR primary mRNA after alternative splicing generates
IR-B and IR-A isoforms [1-3]. They activate different signalization
pathways leading to different physiological effects; IR-B is responsible
of metabolic effects. In Metabolic Syndrome, insulin resistance is as-
sociated to changes in IR isoforms ratio expression [4]. There could
exist a similar situation in sepsis, but there is not data yet. The aim of
this study was to assess the effects of serum septic shock on the IR-B
mRNA expression.
Methods
RAW cells, a murine cell line, were cultured in conditioned media –
enriched with 10% of human septic serum (HSS) - or usual culture
Critical Care 2017, 21(Suppl 1):58 Page 43 of 70media (control). HSS was obtained from critical care patients with
less than 24 hours of septic shock diagnosis. Blood samples were
centrifuged and the serum was obtained. Cells were culture by 16h,
mRNA was extracted and quantified, cDNA was obtained by reverse
transcription and using specifics primers, IR-B mRNA was amplified
[5]. The cellular mRNA content was obtained by densitometric ana-
lysis. This same method was uses to assess if LPS (25 ng/mL) could
have a similar effect to HSS. For statics analysis we used non-
parametric test and p < 0.05 was considered significant.
Results
Both HSS and LPS significantly decreased IR-B mRNA content com-
pared to control. The effect of LPS was significantly higher than
observed with HSS to decrease the IR-B mRNA content (Fig. 25).
Conclusions
We demonstrated that HSS induces a significant reduction of IR-B
expression in macrophages; the infective agent could be mediated
this effect. The LPS concentration used here was greater than
reported in clinics and it could explain it greater effect, if the lower
content of mRNA implies decrease of the protein IR-B expression,
then we are in presence of a new pathogenic mechanism for
hypoglycemia in sepsis not reported before.
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Introduction
Retrospective studies showed that high blood glucose variability is
associated with an increased onset of infections and mortality in crit-
ically ill patients. However, a causal link has not been established.
The aim of this study is to evaluate this association in a prospectively
observed large-scale Intensive Care (IC) population.
Methods
Multi-center prospective observational study, involving 11 Italian
Intensive Care Units (ICUs). All the consecutively admitted adult
patients with an expected ICU-length of stay > = 24 hours were
included. Recruitment phase began in February 2016 (sample size3300 patients). All the routinely performed blood glucose measure-
ments are recorded. Glycemic variability is assessed by calculating
the daily glycemic lability index (GLI), standard deviation (SD) and
coefficient of variation (CV). Demographic, clinical, microbiological
and laboratory data are being collected daily from the ICU admission
to the discharge/death.
Results
These are the preliminary data from the first 57 patients admit-
ted to the ICU of “Ospedali Riuniti” di Ancona (Italy). ICU Non-
Survivors (n = 19) showed higher mean GLI (11.6 [6.5-26.2] versus
4.6 [2.7-13.7], p = 0.013), SD (1 [0.9-1.5] versus 0.8 [0.6-1], p =
0.009) and CV (0.14 [0.12-0.19] versus 0.12 [0.09-0.15], p = 0.024)
as compared to Survivors. The mean glycaemia was similar. Mean
GLI, SD and CV were able to discriminate for mortality (area
under the receiver operating characteristic curve: 0.71 [95% confi-
dence interval 0.57-0.82], 0.72 [0.58-0.83] and 0.69 [0.55-0.80], re-
spectively) but not for infections onset. However, glycemic
variability tended to be higher in patients who developed ICU-
acquired infections.
Conclusions
These preliminary data confirmed the association between glycemic
variability and mortality in critically ill patients. A higher blood glu-
cose variability may be associated with a higher susceptibility to
nosocomial infections in the ICU population but data from a larger
sample of patients are needed.P456
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Introduction
Meticulous euglycemia is known to improve outcomes in critically ill
patients [1].
However attempting to maintain a tight glucose control regime does
lead to dangerous life threatening hypoglycemic episodes [2].
Continous blood glucose monitoring (CGM) can potentially improve
euglycemic control by providing immediate feedback to insulin’s ef-
fects and probably reduce the workload of the nurses.
Methods
After obtaining R&D approvals and patient consent, patients under-
going elective cardiac surgery in 2 centres were enrolled. A non-
randomised, non-treatment, open label prospective study was
performed where blood glucose results from Glysure’s CGM was
compared with the conventional blood gas analyser (Siemens RAPI-
DLab 1200 Systems).
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27 patients were monitored for an average duration of 19.9 hrs, 161
samples (average of 6/patient) were obtained. Mean absolute relative
deviation (MARD) was 10.34%. The correlation coefficient (r) between
the GlySure and intermittent measurement was 0.737.
Conclusions
Glysure based CGM is
1.Reliable.
2.Records Glycemic trends accurately.
3.Reduces workload of nurses.
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Introduction
Measuring of hemoglobin A1c (HbA1c) remain the gold standard for
chronic glycemia monitoring in diabetics [1]. High HbA1c following
coronary artery bypass graft could signal higher short- and long-
term mortality rates [2]. We aim to find relation between preopera-
tive HbA1C and glucose control in intensive care expressed through
time in range blood glucose (TIR).
Methods
Two hundred twenty seven patients were involved in this single center
prospective observational study. All patients were assessed by HbA1C
before surgery, the glucose target was set to be 6.0 to 8.1 mmol/L. Glu-
cose control was expressed though TIR, and based on this patients
were grouped into group I who remained within the set target > 80%
of the time and group II who remained < 80% within the target. Both
groups were matched in terms of age, gender, race, Euro score, cardio-
pulmonary bypass time (CPB), aortic cross clamp time (ACC). Outcome
variables were compared in diabetics and non-diabetics.
Results
Failure to maintain target glycemia was significantly more frequent in dia-
betics (p = 0.001) in patients with glycated hemoglobin (HbA1c) > 8%.
Group II had significantly higher HbA1C (8 ± 2.2 vs 6.6 ± 1.7, p = 0.001),
this group was significantly more liable to complications in terms of
wound infection and post operative atrial fibrillation (p = 0.05 and 0.04
respectively). Lengths of ventilation, stays within ICU and hospital stay
were significantly higher in group II (p = 0.03, 0.04, 0.3 respectively).
Conclusions
High HbA1C is likely a good predictor of poor glycemic control and
post-operative adverse events.References
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Introduction
Shorter leukocyte telomeres have been associated with chronic dis-
eases. We investigated whether telomere lengths upon admission to
the paediatric intensive care unit (PICU) predict outcome and
whether telomere length is altered during PICU stay in a different
manner for children who receive or do not receive early parenteral
nutrition (PN).
Methods
Telomere lengths were quantified in leukocyte DNA harvested from
342 healthy children and from 1148 critically ill children who were
randomised to early or late parenteral nutrition from admission to
the last day in PICU. Independent associations of telomere lengths
with outcomes, with PICU mortality as primary outcome, and the im-
pact of early PN on the change in telomere length during PICU stay
were studied via multivariable logistic regression and Cox-
proportional hazard analyses.
Results
Children admitted to PICU revealed shorter leukocyte telomeres
than matched healthy children. A shorter, not longer, admission
leukocyte telomere length appeared independently associated
with better PICU survival (P = 0.01), a finding that was statisti-
cally fully explained by a more activated innate immune re-
sponse (P = 0.04) with a higher fraction of neutrophils that have
shorter telomeres. After adjustment for confounders, including
neutrophil count, early PN shortened leukocyte telomere length
as compared with late PN (estimate early versus late -0.02, 95%
CI [-0.04;-0.004], P = 0.01), an effect that was only partially ex-
plained by its impact on the duration of PICU stay (estimate per
day in PICU -0.14, 95% CI [-0.28;-0.004], P = 0.04).
Conclusions
Shorter leukocyte telomeres in PICU patients than in healthy children
reflected the degree of innate immune response activation which in-
dependently predicted better survival. Leukocyte telomeres were
shortened by early PN during paediatric critical illness. Whether
shortened telomere lengths predispose PICU patients to the long-
term legacy of critical illness remains to be investigated.
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Introduction
Muscle wasting is very common in critically ill patients and can have
a profound effect on long term recovery. We aimed to quantify the
extent of muscle wasting in trauma patients in the ICU. CT imaging
has emerged as a method to assess body composition, with good
correlation to total skeletal muscle volume [1].
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Of 858 trauma patients admitted to ICU over a 30-month period (Jan
2012-14), 81 were identified as having had 2 abdominal CT scans.
The initial trauma CT scan was compared to the subsequent scan.
Two methods were used to measure muscle cross-sectional area
(CSA). In the first, abdominal muscle CSA at L3 vertebrae was mea-
sured using Fig. 28 J software by tracing the abdominal musculature
and applying predefined Hounsfield Units, -29 to +150 for skeletal
muscle. An observer traced each psoas muscle at the L4 basivertebral
vein for the second method.
Results
Of the 81 patients included 83% were male, median age was 39 (IQR:
23.5-53), median admission APACHE-2 was 12 (9-16) and median
new injury severity score was 38 (27-50). When comparing CT scans
on admission to inpatient scans performed at least 5 days later (me-
dian days between scans was 14.5, IQR: 7-28), there was an overall
decrease in psoas muscle of 15.7% (IQR: 8.9-29.0) and L3 CSA of
14.3% (6.5-20.5). There was increasing loss in muscle volume for both
L3 CSA and psoas with increasing time between CT scans (Fig. 28).
Conclusions
Skeletal muscle wasting is common and time-dependent in critically
ill trauma patients.
References
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SNAQ 0-1 SNAQ > =2
Phase angle normal 180 13
Phase angle low 72 34
Legend 1: Two by Two: SNAQ and phase angleP460
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Introduction
Sarcopenia (skeletal muscle depletion) has been suggested to predict
morbidity, especially infection and mortality, in various diseases.
However, it is not well known whether sarcopenia has prognostic
value for predicting poor outcome in sepsis. We hypothesized that
sarcopenia can predict outcome in sepsis in the emergency depart-
ment (ED) assessed by abdominopelvic computed tomography (CT).
Methods
We retrospectively reviewed the medical records of 627 patients with
sepsis in the ED of a university-affiliated hospital during a 10-year
period. We divided the patients into two groups according to 28-day
survival and compared demographic characteristics, clinical features
and presence of sarcopenia assessed by cross-sectional area of the
psoas muscle at the level of the third lumbar vertebra on abdominalCT scans. Multivariate logistic regression analysis was conducted to
examine the independent prognostic value of scarcopenia on the
outcome of sepsis.
Results
A total of 274 patients with sepsis were finally included in the study:
45 (16.4%) did not survive on 28 days since ED presentation, and 77
patients (28.1%) were identified as having sarcopenia. The presence
of sarcopenia could independently predict 28-day mortality on multi-
variate logistic analysis (OR, 2.382; 95% CI, 1.155-4.913, P = 0.019).
Sarcopenia could also predict 6 month mortality (OR, 2.599; 95% CI,
1.345-5.020, P = 0.004).
Conclusions
Sarcopenia evaluated by CT scan can predict poor outcome of sepsis
patients. Further large prospective studies on sarcopenia in sepsis
and the efficacy of nutrition therapy are warranted.
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Introduction
Malnutrition at ICU admission is associated with increased morbidity
and mortality. Prevalence of malnutrition in ICU patients varies from
17 to 78 percent in different patients groups.
Malnutrition can be assessed by questionnaires but also by bio-
impedance analysis. We compared the Short Nutritional Assessment
Questionnaire (SNAQ) with phase angle at ICU admission.
Methods
During 15 weeks consecutive patients were included. Exclusion cri-
teria were age < 18 years, abnormalities of the limbs and ICU stay < 6
hours. Phase angle was measured short after admission, SNAQ was
obtained from the patient or legal representative. Malnutrition is di-
agnosed by SNAQ ¡Ý 2 or phase angle of < 5¡ã for men and < 4.6¡ã for
women. Demographic and clinical variables were collected. The study
was approved by our local ethical committee (MCL, nWMO 77, 2015).
Results
We included 299 patients (66% male, age 66 ¡À 12 yr, BMI 27 ¡À 4
kg/m2, APACHE II 14 [11-17], elective 193 and acute 106). Hospital
mortality was 7.4%. Malnutrition was present in 16% according to
SNAQ and in 34% according to phase angle. There was a fair accord-
ance between SNAQ and phase angle (Table 10). Phase angle was
significantly higher in patients with SNAQ 0-1 (5.5¡ã¡À1.3) in compari-
son to SNAQ ¡Ý 2 (4.4¡ã¡À1.1) (Fig. 29).
Conclusions
Malnutrition was present in 16% according to SNAQ and 36% accord-
ing to phase angle. There was a fair agreement between SNAQ and
phase angle. With the use of phase angle an objective and accurate
assessment of nutritional status can be made in ICU patients.
Fig. 29 (abstract P462). Boxplot: SNAQ and phase angle
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Phase angle is an independent predictor of mortality in ICU patients
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Introduction
Malnutrition is an important determinant of ICU outcome. An object-
ive way to measure body composition and malnutrition is by bio-
impedance analysis and calculation of phase angle (PhA). We ques-
tioned whether malnutrition, according to PhA, is associated with
morbidity and mortality after ICU admission.
Methods
During 15 weeks consecutive patients were included. Exclusion cri-
teria were age < 18 years, abnormalities of the limbs and ICU stay < 6
hours. PhA was measured short after admission, a PhA < 5 ° for men
and < 4.6° for women was considered malnutrition. Demographic
and clinical variables were collected. The study was approved by our
ethical committee (nWMO 77, 2015).
Results
299 Patients were included. Malnutrition was established in 36% (n =
106). Patients with malnutrition were more often female, older, with
lower BMI and higher APACHE II score (Table 11) and more often di-
agnosed with a malignancy (30 vs 14%, p < 0.001). Hospital LOS, ICU
and hospital mortality were higher in patients with a low PhA.
Logistic regression analysis showed a significant relation between PhA
and age, sex, BMI, malignant disease, hospital LOS and hospital mortality.
Conclusions
According to PhA, malnutrition was present in 36% of ICU patients. The
same independent predictors of PhA (age, sex and BMI) were found as in a
general hospital population. Even in this small population of a mixed ICU
patients, a low phase angle was found to independently predict hospital
mortality. The value of phase angle for ICU patients warrants more research.Table 11 (abstract P463) See text for description
PhA normal n = 193 PhA low n = 106 P
Male n 137 61 0.019
Age yrs 63 ± 11 71 ± 10 <0.001
BMI 27 ± 4 26 ± 4 0.034
APACHE II 13 [10-17] 15 [12-19 <0.001
LOS ICU days 0.9 [0.8-1.3] 0.9 [0.8-3] 0.234
LOS Hosp days 9 [5-16] 16 [9-25] <0.001
Mortality ICU % 3.1 9.4 0.02
Mortality Hosp % 4.1 13.2 0.004
Legend 1: Patients characteristicsP464
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Introduction
Ultrasound is a noninvasive method that can measure quadri-
ceps muscle layer thickness (QMLT) and subsequently lean body
mass (LBM) at the bedside,with the validity and reliability
checked and confirmed in previous studies, we correlated the
sarcopenia associated with heart failure in ischemic cardiomyop-
athy patients detected by decrease cross sectional area of
Qudreceps femoris with the clinical and labortatory parameters
of sarcopenia.
Methods
Retrospective observational study including 26 patients with is-
chemic cardiomyopathy admitted to our cardiac ICU were en-
rolled between January 2014 and september 2016 .serial
measurements of quadriceps muscle cross sectional area were
obtained at admission and every 3 days for intial 10 days. Mea-
sures was recorded to assess the trend and correlation between
presence of muscle loss and the clinical and laboratory parame-
ters that indicate the presence of sarcopenia despite effective
feeding protocol, all enrolled patients were hemodynamically
monitored and treated under the same ICU feeding and physio-
therapy protocol.
Results
Completed data sets were obtained from 26 patients, 20 males
and 6 females, mean age of 57 with age range from 43 to 90
years. The following parameters were assessed daily: Body weight,
serum albumin, haemoglobin and CRP, Quadricips femoris for a
total of 260 scans was analyzed and serial measurements com-
pared, it shows statistical significant difference between recorded
measures (P < 0.05) and positive correlation with clinical
assessment.
Conclusions
In our clinical series, Assessment of sarcopenia by serial Ultra-
sound measurements of Quadreceps femoris cross-sectional area
in patient with ischemic cardiomyopathy was correlated with clin-
ical and laboratory assessment of sarcopenia, its an easy and reli-
able technique to assess for nutritional status and to evaluate
our feeding protocol, Further studies needed to confirm these
findings.
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Introduction
Our study aims mainly to identify the prevalence of malnutrition, to
compare elderly patients according to their nutritional status in a
Moroccan AMU; then analyze the prognosis impact of malnutrition at
540 days follow-up.
Methods
This was a prospective cohort study conducted in the AMU; Ibn
Sina University hospital, Rabat; Morocco, from June to September
2014, including patients aged of > =65 years. Demographic, an-
thropometric, comorbid diseases, clinical characteristics and in-
Table 12 (abstract P466). See text for description
Group 1 < 60% of
7 day targeted
calories n = 68
Group 2 60-99% of
7 day targeted cal-
ories n = 16
Group 3 ≥ 100% of
7 day targeted
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Legend : Baseline characteristics and clinical outcome of ARDS patients
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ated at 2 times; in the hospital and at 540 days follow-up. Malnu-
trition was evaluated using the MNA, and the health and
functional status using EuroQol-5D-3L. Cox proportional hazard
univariate analysis identified the factors associated with mortality
at 540 days. Then, multivariable model incorporating 4 conven-
tional risk variables was calculated with Cox proportional hazards
regression analysis, and we assessed the predictive performance
of this model. Statistical analyses were carried out in SPSS Statis-
tics and STATA.
Results
Ninety five patients were included. Mean age was 75 ± 5.9 years;
64.2% were women. The mean ± SD length of stay in AMU was
6.2 ± 5 days. In-hospital and 540 days post-discharge follow-up
mortality were respectively 16.8% and 46.3%.Median [IQR] of
EQ5D-Index before acute illness was 0.29 [-0.17;0.81]. Prevalence
of well-nourished, at risk of malnutrition and malnourished pa-
tients were respectively 46.3%, 27.4%, and 26.3%. Compared to
well-nourished patients, patients at risk of malnutrition and mal-
nourished patients had significantly higher mortality, with re-
spectively (HR:2.5,1.1;5.7, p = 0.02) and (HR:5.5,2.4;12.1, p < 0.001).
Cox proportional hazards multivariate analyses incorporating con-
ventional risk variables without, and with nutritional status,
showed that malnutrition was a predictor of 540 days mortality:
unmarried patient (HR:2.1,1.1;4.1, p = 0.02) ; Lower Mean arterial
pressure (HR:0.97,0.94;0.99, p = 0.02); Lower EQ5D index
(HR:0.5,0.3;0.9, p = 0.04), malnourished patients (HR:3,1.2;7.7, p =
0.01). In addition, for increasing probability thresholds, the model
incorporating nutritional status combined had higher net benefit
than the conventional model, suggesting that this model has po-
tentially higher clinical utility.
Conclusions
Malnutrition has a negative prognosis impact on the long-term
survival status of elderly in an AMU. Therefore, its high clinical
utility should be considered to guide nutrition interventions dur-
ing hospital stay and even after discharge to reduce the poor
outcome of elderly patients.
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Introduction
There are limited data of mortality-benefit from nutritional manage-
ment in ARDS patients. This study aimed to evaluate the impact of
the amount of calorie-intake during the first week of ARDS on 28-day
mortality.
Methods
We retrospectively collected data from ARDS patients admitted in
medical ICUs in our hospital between 2010 and 2014 and divided
into 3 groups, namely patients receiving less than 60% of tar-
geted cumulative calories in the first week of ARDS, those receiv-
ing between 60% and 100% of the 7-day targeted calories and
those receiving at least 100% of the 7-day targeted calories. The
28-day mortalities among 3 groups were analyzed and compared.
Results
Totally, 114 ARDS patients were included. Baseline characteristics and
clinical outcome were shown in Table 12. The 28-day mortality was
significantly higher in group1, compared with groups 2 and 3 with
odds ratio (OR) of 4.96 (95% CI: 1.57 to 15.65), p = 0.006 and 3.86
(95% CI: 1.53 to 9.74), p = 0.004, respectively. However, the 28-day
mortalities in groups 2 and 3 were not different; OR of 0.78 (95% CI:
0.23 to 2.63), p = 0.69.
Conclusions
We recommended to provide at least 60% of targeted cumulative
calories in the first week of ARDS to improve 28-day mortality. How-
ever, due to limited sample size, further studies are needed to con-
firm the results.P467
Effect of gastric residual volume monitoring on incidence of
ventilator associated pneumonia in mechanically ventilated
patients admitted to intensive care unit
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Introduction
Frequency of motility disorders in the upper or lower gastrointes-
tinal (GI) tract is reported to be almost 80% in critically ill pa-
tients, which a delayed passage and delayed gastric emptying
are very common. Impaired gastric motility can lead to regurgita-
tion or vomiting of gastric contents which may cause aspiration
and consequently pneumonia. Enteral nutrition is the preferred
route of nutrient supply in critically ill patients who are not able
to consume oral foods. Monitoring of upper GI function has an
important role in the decision of the continuation of enteral nu-
trition. Measurement of gastric residual volume (GRV) is recom-
mended for monitoring of GI function and avoidance of
aspiration and pneumonia. However, there are some studies
which have not shown any relationship between high GRV and
risk of aspiration and pneumonia in critically ill patients. So, valid-
ity of GRV as a marker for risk of aspiration in mechanically venti-
lated patients is still unclear. The aim of this study was to assess
the effect of GRV monitoring on incidence of ventilator associ-
ated pneumoniain (VAP) in mechanically ventilated patients ad-
mitted to intensive care unit.
Methods
This descriptive study was done on 150 mechanically ventilated adult
patients admitted to intensive care unit and receiving enteral nutri-
tion. GRV was measured every 3 hours and gastric intolerance was
defined as GRV > 250 cc. The incidence of vomiting and VAP, GRV,
length of mechanical ventilation and ICU stay, APACHE and SOFA
scores, and mortality rate were noted. Data were analyzed using
SPSS 18.
Results
The mean age of the patients was 57.79 ± 18.84 years. The incidence of
VAP was 24% (36 patients). Incidence of vomiting was 50% [24 patients
in VAP positive group and 51 patients in VAP negative group (P =
0.022)]. Mean ICU length of stay (LOS) was 11.59 ± 4.91 days and mech-
anical ventilation was 7.54 ± 3.67 days. Mean APACHE score was 25.14
± 5.78 and mean SOFA score was 11.51 ± 2.14. Mean GRV during the
ICU stay was 230.51 ± 52.63. Mortality rate was 22.1%. There was not a
Table 13 (abstract P468). See text for description
Site Treatment group Control group p value
Trachea 1/26 7/36 0.22
Above the ETT cuff 24/110 46/114 0.04
Oropharynx 47/110 104/108 0.0003
Critical Care 2017, 21(Suppl 1):58 Page 48 of 70relationship between GRV and ICU LOS (P = 0.741), and incidence of
VAP (P = 0.329). But, there was a positive relation between GRV and
incidence of vomiting (P < 0.001) and mortality rate (P = 0.001).
Conclusions
This study showed that increased GRV is associated with increased
incidence of vomiting and increased mortality rate; but it is not asso-
ciated with VAP incidence in critically ill patients.Legend : Positive pepsin A samples at each siteP468
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Introduction
Gastro-esophageal reflux (GER) is common in ventilated patients and
is a cause of VAP. We recently described the development of a
unique device called the peristaltic feeding tube (PFT) (Lunguard,
Yavne, Israel) [1]. The PFT (Fig. 30) uses simulated peristalsis to seal
the esophagus to fluid moving retrogradely, whilst allowing normal
drainage of fluid and secretions moving ante-gradely. Here we de-
scribe the first trial of the PFT in ventilated patients.
Methods
There were 10 subjects in the treatment (PFT) group and 10 patients in
the control group, who had all undergone elective cardiac surgery and
were ventilated in the ICU afterwards. The PFT was placed on admis-
sion to the ICU. In the control group a standard nasogastric tube (NGT)
was inserted. Specimens were collected by suctioning from the oro-
pharynx and from above the tracheal tube balloon every hour and from
the trachea twice per eight hour shift. Samples were analyzed by ELISA
for Pepsin A as a marker for secretions of gastric origin.
Results
The two groups were comparable (demographics and duration of
ventilation). There were statistically more specimens positive for Pep-
sin A in the control group in the oropharynx and above the ETT cuff,
but not in the trachea (Table 13).
Conclusions
The PFT reduced the amount of GER in ventilated patients. A larger
study is required to determine whether this translates to a reduction
in VAP.
References:
1) Avitzur Y, van Heerden PV, Dayan L et al. Development of a device to
reduce gastro-esophageal reflux in critically ill patients.Clinical Nutrit Exp
2016;7:1–8Fig. 30 (abstract P468). Peristaltic feeding tubeP469
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Introduction
Failure to detect misplacement and use of a nasogastric tube in the
pleura or respiratory tract prior to commencement of feeding or ad-
ministration of medication has been classified as a “Never Event” by
NHS England. pH testing remains the first line test that a nasogastric
feeding tube is inserted correctly. Gastric pH is often falsely elevated
due to administration of antacids. Chest X-ray serves as a second line
check only, but is often required to ensure correct positioning of
feeding tubes into the stomach. This study aimed to 1. quantify the
need for chest X-rays to confirm position of nasogastric tubes, 2. de-
termine the percentage of patients in whom gastric aspirate with pH
< 5.5 could be obtained, 3. determine the time lag until enteral feed
can be started after insertion of a nasogastric tube.
Methods
All data on insertion of new nasogastric tubes were collected retro-
spectively by research nurses on Intensive Care from August to No-
vember 2016. Data collected included indication for tube insertion,
level of training of person inserting the tube, pH of gastric aspirate
(if obtained), need for chest X-ray request, X-ray results, time lag until
feeding was initiated, and treatment with antacids.
Results
96 events of nasogastric tube insertion were recorded. 90% of tubes
were inserted by junior doctors, 5% by consultants and 2% by nurs-
ing staff. 82 patients (85.4%) received antacids (40.6% ranitidine,
44.8% proton pump inhibitors). A gastric aspirate could be obtained
in 43 patients (44.8%). 14 of these patients (32.5%) had a gastric pH
of 5.5 or above, thus precluding safe initiation of enteral feeding. A
chest X-ray was requested for 76 patients (79.2%), which confirmed
position within the stomach in 70 patients. In 7 patients a chest X-
ray was requested, although the pH of the gastric aspirate was below
5.5. In 17 patients (17.7%) it took more than 4 hours until feed was
started.
Conclusions
A main causal factor for patient harm after initiation of enteral feed-
ing through misplaced nasogastric tubes is misinterpretation of chest
x-rays1. Although chest X-rays should only be used as second line
check, when a gastric aspirate cannot be obtained or pH is inconclu-
sive, in our patient cohort circa 80% of patients required a chest x-
ray to confirm position of nasogastric tubes. A nasogastric aspirate
could only be obtained in about 45% of patients. Devices to facilitate
gastric aspiration may be cost efficient by reducing chest X-ray re-
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In previous studies, parenteral nutrition (PN) was associated with
higher risk for adverse outcomes as compared to enteral nutrition
(EN) [1]. We aimed to test the hypothesis that critically ill patients
receiving PN have higher mortality and infection rates as compared
to those not receiving PN.
Methods
Prospective observational study on 108 consecutive adult pa-
tients admitted to our Intensive Care Unit (ICU) from February
2016. Patients with ICU-length of stay <72 hours were excluded.
We recorded type of nutrition (PN, EN, none or oral feeding),
daily caloric and protein intake, microbiology results, ICU-
mortality.
Results
Thirty-one patients (29%) received PN at least one day during the
ICU stay. Patients receiving PN showed higher ICU-mortality as
compared to those not receiving PN (Fig. 31) and Non-survivors
received PN for a longer time period as compared to Survivors
(71 ± 26 versus 42 ± 25 hours, p = 0.005). The association between
PN and mortality was independent of the Simplified Acute Physi-
ology Score (adjusted odds ratio: 3.389 [95% confidence interval
1.301-8.828]). PN was associated with higher infection rate
(Fig. 32).
Conclusions
PN was associated with higher ICU-mortality and infection rate in a
general population of adult critically ill patients.
References
1- Elke G et al. Crit Care 2016; 20:117.Fig. 31 (abstract P470). PN and mortality
Fig. 32 (abstract P470). PN and infectionsP471
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Introduction
We hypothesize that (1) septic patients with alcohol-use disorders
(AUDs) do not consistently receive thiamine as part of their treat-
ment regimen, and that (2) those not receiving thiamine have in-
creased mortality compared to those receiving thiamine. Previous
studies have shown AUDs to be associated with increased sepsis-
related mortality although the mechanism through which AUDs con-
tribute to worse outcomes has not been fully elucidated. Thiamine
(vitamin B1) deficiency is a common sequela of AUDs and may con-
tribute to impaired mitochondrial aerobic respiration leading to
refractory acidosis/death if untreated.
Methods
We performed at retrospective analysis of all patients presenting with
septic shock between 2008 and 2014 at a single tertiary care center.
Patients were identified based on (1) receipt of antibiotics, (2) use of
vasopressors, (3) lactate levels > 4 mmol/L, and (4) an AUD diagnosis
based on ICD-9 codes. We excluded patients with seizures during the
hospital stay and those with non-index events. Descriptive statistics
were used to calculate the proportion of septic patients with AUDs
receiving thiamine, and mortality between groups were compared
using Fisher’s Exact.
Results
We included a total of 88 patients. The median age was 57 (quartiles:
49, 64), and 67% were male. 59/88 (67%) of all patients received
thiamine and overall mortality was 43/88 (49%). In those receiving
thiamine, 24/59 (41%) died, compared to 19/29 (66%) of those not
receiving thiamine, p = 0.03.
Conclusions
In this study, we found that a considerable proportion of patients
with AUDs admitted for septic shock did not receive thiamine.
Thiamine administration in patients with AUDs and septic shock was
associated with decreased mortality. We suspect that failure to ad-
minister thiamine in this patient population is related to a shift in
clinician focus towards the septic insult and away from the AUD his-
tory, although further studies are needed to better understand this
phenomenon.
P472
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Introduction
Vitamin D deficiency has been repeatedly implicated in regulation of
the innate and adaptive immune system. Evidence from ER studies
investigating the association between vitamin D deficiency and mor-
tality are currently lacking.
Methods
We conducted an interim analysis of a prospective study enrolling
patients presenting with sepsis/septic shock at our ER. Vitamin D was
sampled from patients before any fluid or drug administration. Pa-
tients were considered as vitamin D deficient if < 30 μg/L. Apache II
and Charlson index were calculated for each patient.
Results
At November 15th 2016 96 patients completed the 3 months follow
up. Vitamin D deficiency at ER admission was observed in 65.1% of
patients. 42% were bacteraemic. 34.3% of patients were under
pressor support during ER stay and 62% had an increased lactate.
Apache II was not significantly different between groups while
Charlson Age adjusted comorbidity index was significantly higher in
Critical Care 2017, 21(Suppl 1):58 Page 50 of 70patients with normal levels of Vitamin D (5.34 vs 7.91 p = 0.002).
Mortality was higher in vitamin D deficient patients (34.2% vs 23.1%
p = 0.12) in a non-significant fashion. Multivariate regression analysis
showed that Apache II was independently associated with worse out-
come (p < 0.001) while vitamin D status was not (p = 0.231). Mean
ICU length of stay was longer for vitamin D deficient patients without
reaching statistical significance (6.8 days vs 6.01 days p = 0.64).
Conclusions
Our interim analysis showed a trend towards an increased mortality
for patients admitted to the ER for sepsis with a vitamin D deficiency.
A larger sample will eventually clarify the role of vitamin D deficiency
at ER admission for sepsis.Fig. 33 (abstract P472). See text for description
Fig. 34 (abstract P473). Effect of Vitamin D on mortalityP473
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Introduction
Vitamin D insufficiency is reported in up to 50% of the critically ill pa-
tients and is associated with adverse outcomes as increased mortal-
ity, length of stay (LOS) in ICU and hospital, and development of
respiratory disorders with prolonged ventilation (1). Vitamin D sup-
plementation is an interesting therapeutic strategy in the critically ill
but clinical evidence remains unclear. The aim of this systematic re-
view was to evaluate the clinical efficacy of vitamin D administration
in critically ill patients.
Methods
We searched databases for randomized controlled trials (RCT) in crit-
ically ill patient comparing vitamin D administration to placebo. The
studies had to report mortality, infectious complications, hospital/ICU
LOS or length of mechanical ventilation. Two independent reviewers
assessed eligibility, risk of bias and abstracted data onto a pretested
form. When possible, we pooled data using a random effect model
to estimate the relative risk (RR) for dichotomous outcome and mean
difference (MD) or weighted mean difference (WMD) for continuous
outcomes. Pre-defined subgroup analysis included oral-enteral vs
parenteral administration, high vs low dose and sensibility analysis
restricted to vitamin d deficient patient.
Results
Six RCTs (695 patients) met study inclusion. No overall analysis were
significant. A trend towards a reduction in mortality was found when
vitamin D was administered (RR = 0.84, 95% Confidence Interval [CI]
0.67-1.06; P =0.13, see Fig. 34). A trend was found towards a reduc-
tion in ICU (P = 0.17) and hospital LOS (P = 0.08). No differences ininfection rate and ventilation days existed. In the oral-enteral group,
a significant reduction in hospital LOS existed (P = 0.008) and a trend
towards mortality reduction (P = 0.12) and ICU LOS (P = 0.12). Finally,
doses higher than 300 000 IU were associated with a trend to reduce
mortality (P = 0.12) and ICU LOS (P = 0.12).
Conclusions
In critically ill patients, Vitamin D administration does not affect
overall mortality, ICU/hospital LOS, infection rate and length of
mechanical ventilation. However, many analyses showed trends
and seemed underpowered to detect a clinical difference, thus
prompting further RCTs.
References: 1. Lee P et al. N Engl J Med 2009; 360:1912–14P474
Current pharmaconutrition practices in the ICU: results of the
international nutrition survey 2014-2015
W Manzanares1, C Szwec2, P Langlois3, I Aramendi1, D Heyland4
1University Hospital, Montevideo, Uruguay; 2Hospital Posadas, Buenos
Aires, Argentina; 3Université de Sherbrooke, Sherbrooke, Canada;
4Queen’s University, Kingston, Canada
Critical Care 2017, 21(Suppl 1):P474
Introduction
Over the last few years several randomized controlled trials examin-
ing the role of pharmaconutrition in the critical care setting have
shown controversial results. The purpose of this study was to de-
scribe current pharmaconutrition practices in intensive care units
(ICUs) worldwide evaluating the compliance with the evidence-based
Canadian Critical Care Nutrition Clinical Practice Guidelines (CPG).
Methods
We conducted an international, prospective, observational, cohort
study between September 2014-June 2015. Participating sites en-
rolled critically ill adult patients on mechanical ventilation within the
first 48 hours of ICU admission and who remained for at least 72
hours in the ICU. Data on nutrition and pharmaconutrient practices
were collected from admission to ICU discharge or a maximum of 12
days. Variables related to the CPG are reported as overall averages
(or percentages) with the range of site averages.
Results
184 adult ICUs from 19 countries contributed 3926 patients to this
analysis. Sixty-four percent were male, mean age was 59 (16-102)
years old, average APACHE II score was 21.3 (1-55), and admission
SOFA score was 6.2 (0-18).
5.4% of all patients (best site: 75.6%, and worst site: 0.0% of patients)
received glutamine (GLN) by enteral, IV/parenteral or both routes. En-
teral GLN was administered in 4.6%, and IV/parenteral GLN in 1.0%
of patients. Moreover, 30% (0.0%-100%) of burn patients received en-
teral GLN, whereas this pharmaconutrient was provided in 4.4% of
trauma patients (0.0%-87.5%). 6.1% of patients received selenium as
single strategy or combined therapy. Most of ICUs avoid using
arginine-enriched enteral formulas which were provided in 5.5% of
patients (0.0%-94.4%). Fish oil (FO) enriched formula was adminis-
tered in 14.7% of all patients, whereas in those with ARDS was pro-
vided in 22.4%. In patients on PN (or EN + PN) soybean oil (SO)
based lipid emulsion (LE) was used in 25.3% of PN days. However, a
SO sparing strategy was used in 35.6% of days, including an olive oil
based LE: 13.0%, a mixture of SO, olive oil, medium chain triglycer-
ides (MCT), and FO: 16.1%.
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According to our recent data there is low utilization of enteral or par-
enteral pharmaconutrition in ICUs worldwide. The most frequently
used pharmaconutrient is enteral GLN in the context of burn injury
although we await the results of the ongoing RE-ENERGIZE trial
before making stronger recommendations for its use. Finally, in com-
pliance with current guidelines in PN patients alternative lipid emul-
sions are more commonly used.
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Introduction
With this study, we sought to describe the number of patients with
variceal hemorrhage and a balloon tamponade device (BTD) who (1)
survive to hospital discharge, and (2) survive to one-year following
hospital discharge.
Variceal hemorrhage is associated with high morbidity and mortality.
A BTD, such as the Sengstaken-Blakemore or Minnesota tube, may
be used in cases of acute, uncontrollable variceal hemorrhage, when
endoscopic and pharmacologic therapies prove insufficient. While
the use of these devices may be effective at controlling acute bleed-
ing, the effects on patient outcomes remain less clear.
Methods
In this retrospective study, we identified patients with a Sengstaken-
Blakemore or Minnesota tube placement during hospitalization be-
tween 2003 and 2014 via ICD-9 coding at a single, urban, tertiary
care center in Boston. Patient characteristics and outcomes were
summarized using descriptive statistics.
Results
A total of 34 patients with a BTD were identified. Median age was
57.5 (quartiles: 47.5, 62.75) and 76% (26/34) were male. Approxi-
mately 59% (20/34) of patients survived to hospital discharge, and
41% (13/32) were alive after one year. Two patients were lost to
follow-up. Of those surviving to hospital-discharge, 95% (19/20) had
undergone transjugular intrahepatic portosystemic shunt (TIPS)
during that hospitalization, while 36% (5/14) of patients who did not
survive to hospital discharge had TIPS. One patient underwent liver
transplantation during a subsequent hospitalization.
Conclusions
In this retrospective cohort of patients undergoing BTD therapy for
variceal hemorrhage, approximately 59% of patients were alive at
hospital discharge and 41% were alive after one year. Placement of a
BTD as a temporizing measure in the management of acute variceal
hemorrhage may be more beneficial than traditionally regarded, par-
ticularly when utilized to bridge patients to TIPS.
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Introduction
Our hypothesis is that psoas muscle index (PMI) is related with out-
comes in living donor liver transplantation (LDLT) patients. Liver
transplantation (LT) patients usually have low physiologic reserves
prior to LT [1]. In most LT centers, the MELD score is used for the
prioritization of organ allocation. However, MELD score does not in-
clude the nutritional and functional status of the patients. Sarcopenia
is defined as a loss of skeletal muscle mass and function with a risk
of adverse outcomes and it was found to be associated with elevatedpostoperative complications in LT patients [2]. PMI is calculated with
psoas muscle area/height2 (mm2/m2) and used to detect sarcopenia
[3]. Hence, it may be an outcome predictor in LDLT patients.
Methods
In this study, 261 patients who underwent LDLT between 2011 and
2014 were retrospectively evaluated. Patients who were <18 years
old, cadaveric liver transplant recipients and whose CT scans were
missing were excluded. Demographic data, body mass index (BMI),
PMI, MELD score, etiology, length of ICU stay, length of hospital stay,
postoperative 7th day acute kidney injury (AKI), requirement of renal
replacement therapy (RRT), reoperation, readmission and 1st year
mortality were recorded.
Results
The first quartile of PMI for male and female patients were 397mm2/
m2 and 298mm2/m2 respectively. In all patients, postoperative 7th
day AKI, RRT requirement and 1st year mortality were 12.3%, 8.2%
and 10.5%. There was no any correlation among PMI, BMI and MELD
score. PMI was positively correlated with increase in postoperative
7th day creatinine level and length of hospital stay (r2 = 0.02 P =
0.049 and r2 = 0.06 P < 0.001). In 56 patients with sarcopenia, RRT re-
quirement, reoperation, readmission and 1st year mortality were sig-
nificantly higher than non-sarcopenia patients (P = 0.001 P = 0.003
and p < 0.001 for others). In multivariate logistic regression model,
1st year mortality was only increased 29.5-fold (8.3-104.4) by sarcope-
nia (P < 0.001).
Conclusions
BMI, MELD score or conventional evaluation of LT candidate may
fail in many cases to predict prognosis after LT. Adding the PMI
measurement may improve the evaluation of the patients prior
to LT and can be used as an outcome predictor in LDLT
patients.
References
1. Englesbe MJ et al. J Am Coll Surg 2010; 211:271–278
2. Masuda T et al. Liver Transpl. 2014; 20:401–407
3. Kalafateli M et al. J Cachexia Sarcopenia Muscle 2016 Feb 01
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Introduction
The mortality rate in patients with severe liver dysfunction with
no option of transplantation is unacceptably high [1]. The main
aim of this study was to evaluate the usefulness of extracorpor-
eal liver support (ECLS) techniques in this group of patients.
Secondary aims were to identify independent risk factors and to
assess the predictive values of the following scoring systems:
Glasgow Coma Scale (GCS), Sequential Organ Failure Assessment
(SOFA), Acute Physiology and Chronic Health Evaluation (APA-
CHE) II, Simplified Acute Physiology Score (SAPS) II and Model
of End-stage Liver Disease United Network for Organ Sharing
(MELD UNOS) Modification in patients with severe liver
dysfunction.
Methods
Data from hospital admissions of 101 patients with severe liver
dysfunction (MELD UNOS > =18) who were admitted to the de-
partment of anaesthesiology and intensive therapy between 2006
and 2015 were retrospectively analysed. The study group was
Critical Care 2017, 21(Suppl 1):58 Page 52 of 70divided into two subgroups. SMT was a subgroup of patients re-
ceiving standard medical therapy, and SMT + ECLS was a sub-
group containing patients receiving standard medical therapy
complemented by at least one extracorporeal liver support
procedure.
Results
Significantly lower ICU mortality and 30-day mortality rates were
found in subgroup SMT + ECLS. In a multivariate model, inde-
pendent risk factors for ICU mortality proved to be the SOFA
score and prothrombin time. The highest discriminatory power
for ICU mortality was demonstrated for the SOFA score, followed
by APACHE II, SAPS II, MELD UNOS and GCS scores. For 30-day
mortality, however, the best discriminatory power was shown for
the SAPS II score, followed by SOFA, APACHE II, MELD UNOS and
GCS scores.
Conclusions
Further studies are needed to assess the contribution of nonbi-
ological ECLS procedures to a decrease in mortality rates in the
population of patients with severe liver dysfunction. The
independent risk factors for ICU mortality and 30-day mortality
were demonstrated to include the SOFA score and prothrombin
time. The SOFA, APACHE II, and SAPS II scores were better
predictors of death than the MELD UNOS Modification score
which is dedicated to the assessment of patients with liver
disease.
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peritonitis patients in intensive care unit
M Saleh, A Hamdy, A Hamdy, M Elhallag
Kasr Alainy, Cairo University, Cairo, Egypt
Critical Care 2017, 21(Suppl 1):P478
Introduction
Circulatory dysfunction is known in spontaneous bacterial peritonitis
(SBP) patients. We aimed to determine whether the degree of hyper-
dynamic circulation is significantly correlated with severity of liver
disease and poor outcome in SBP patients or not.
Methods
Sixty one patients diagnosed to have SBP were enrolled. In addition
to routine laboratory investigation, Child Pugh and APACHE II scores
were calculated. Degree of renal impairment was defined using
Acute Kidney Injury Network (AKIN) criteria. Stroke volume (SV) was
measured by M mode and 2- dimensional Doppler echocardiog-
raphy. Cardiac output (CO), and Systemic vascular resistance (SVR)
were also calculated. All data were statistically analyzed.
Results
SV, CO, SVR were significantly correlated with Child Pugh score, p
value <0.001, <0.001, and 0.011. In 46 (75.4%) patients had AKI, AKIN
grade is significantly correlated with SVR, SV, and CO. Inpatient mor-
tality occurred in 10 (16.4%) patients. Non-survivors had lower SVR
and higher SV and CO compared to survivors (1,805 ± 105 dyn.sec/
cm5, 80.3 ± 11.2 ml, and 6.7 ± 1.1 L/min vs 1,936 ± 504, 67.6 ± 12.7,
and 5.7 ± 0.9, p value 0.029, 0.005, 0.007 respectively). Using the Re-
ceiver Operating Characteristics (ROC) curve, the cut-off value of CO
that predict mortality was 5.89 L/min with sensitivity and specificity
measuring 80%, 70.6% respectively. The area under the curve (AUC)
is 0. 767 and 95% confidence interval (CI) is 0.566 to 0.968, p value
0.008. At this value, the odds ratio (OR) is 7.33 with p value 0.012.
Conclusions
Degree of hyper-dynamic circulation is significantly correlated with
the severity of liver disease and predicts poor outcome in SBP
patients.References
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The i.m.p.a.c.t system® device in acute liver failure: clinical
experiences in 7 adult patients
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Introduction
The I.M.P.A.C.T (Intein Mediated Purification with a Affinity Chitin-
binding Tag) System® Device is an extracorporeal support system
that is used in patients awating liver transplantation, or in patients
with sepsis, ARDS (acute respiratory distress syndrome), and hepatic
encephalopathy in order to bind toxins and cytokines. We report a
single center experience on the usefulness of the I.M.P.A.C.T System®
Device in patients with acute liver failure.
Methods
A retrospective analysis of 7 patients who recieved treatment with
the I.M.P.A.C.T System® Device due to acute or acute on chronic liver
failure at Baskent University Hospital Department of Critical Care be-
tween August 2015 to August 2016.
Results
The mean age of 6 males and 1 female was 55.2 ± 12.8 years. Five
patients had developed acute on chronic liver failure. Two patients
had acute liver failure due to toxins. APACHE II (Acute Physiology
and Chronic Health Evaluation) and MELD (Model for End-stage Liver
Disease) scores were 17.0 ± 3.7 and 33.0 ± 4.3, respectively. At least 1
and a maximum of 6 sessions of the I.M.P.A.C.T System® Device were
performed for each patient. Clinical and biochemical data were re-
corded before and after each of the I.M.P.A.C.T System® Device ses-
sion. Following the I.M.P.A.C.T System® Device session, the mean
total and direct bilirubin levels were lower when compared to the
pretreatment levels. [13.7 ± 6.6 vs 17.2 ± 8.3 mg/dl (p < 0.01) and 9.1
± 4.2 vs 11.6 ± 5.3 mg/dl (p < 0.01), respectively]. Change in serum
ammonia levels were statistically significant following the I.M.P.A.C.T
System® Device session (80.2 ± 80 vs 51.1 ± 25.5 mmol/l, p = 0.01).
There was an improvement on chest X-ray findings after therapy
among one of the patients who had acute liver failure due to intoxi-
cation (Fig. 35). Mean length of stay in the ICU was 67.1 ± 62.3 days.
One patient with acute on chronic liver failure is still being treated in
the ICU due to sepsis and acute kidney injury. Other 6 patients died
while awaiting liver transplantation during the follow up.
Conclusions
Liver function tests improved after treatment with the I.M.P.A.C.T Sys-
tem® Device. Tolerance of therapy was acceptable as the patients’
hemodynamics were stable during and following sessions. However,
controlled studies with larger number of patients are needed to
show the benefit of the I.M.P.A.C.T System® Device in patients with
acute liver failure.
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Effects of platelet count on thromboelastometric parameters in
patients with end-stage liver disease
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Introduction
Patients with End-Stage Liver Disease (ESLD) have long been
considered as naturally anticoagulated. Recent research has
proposed a new rebalanced approach. Nevertheless
thrombocytopenia remains a landmark of cirrhotic coagulopathy.
Our aim was to investigate the effect of platelet count on rota-
tional thromboelastometry (ROTEM) parameters in patients with
ESLD.
Methods
We prospectively included patients with ESLD admitted in our
ICU prior to liver transplantation. Exclusion criteria consisted of
prior pro- or anti- coagulant therapy, presence of hepatocellular
carcinoma or recent transfusions and splenectomy. 162 patients
were included in the final analysis. Demographic parameters, liver
functional tests, ROTEM assay (ExTEM, InTEM, ApTEM, FibTEM)
and platelet count were noted. ROTEM parameters included:
standard parameters (clotting time-CT, clot formation time-CFT,
maximum clot firmness-MCF) and derived (thrombin potential
index-TPI, maximum velocity of clot formation-MaxV, time to
MaxV-MaxVt, area under the curve-AUC and maximum clot
elasticity-MCE).
Results
The mean age in the study group was 50 ± 12 years and the mean
severity scores (MELD, MELD-sodium) were 19.2 ± 6.1, 21.5 ± 6.0 re-
spectively. The median platelet count was 74000 (12000-345000). A
strong correlation was found between platelet count and ExTEM CFT
(p = 0.03), ExTEM MCF (p < 0.01), ExTEM TPI (p < 0.01), ExTEM MaxV
(p = 0.04), ExTEM AUC (p = 0.01) and ExTEM MCE (p < 0.01). We also
noted a quadratic correlation between platelet count and ExTEM
MCF (R2 quadratic = 0.451) and MCE (R2 quadratic = 0.362) and a lin-
ear correlation between platelet count and ExTEM TPI (R2 linear =
0.466). A cut-off value of 70000 platelets was determined below
which ExTEM MCF and ExTEM TPI decreased under their normal
values.
Conclusions
Platelet count has an important effect on extrinsically activated
coagulation by ExTEM. Determining the cut-off point for clot in-
stability as measured by derived ROTEM parameters may aid in
establishing new thresholds for platelet transfusion in patients
with ESLD.
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Introduction
We assessed the hypothesis that diarrhea during critical illness
disrupts the gut-liver signaling axis through intestinal malab-
sorption of bile salts. Disrupted bile salt signaling could play a
role in critical illness associated cholestatic liver injury, which
occurs in up to 20% of ICU patients. We previously identified
diarrhea as an independent risk factor for critical illness-
associated liver injury (OR 4.1, 95% CI 1.2-14.5, p = 0.028, un-
published data), suggesting intestinal involvement in liver dis-
ease in the critically ill. The bile salt-induced enterokine
fibroblast growth factor 19 (FGF-19) is important for normal
gut-liver signaling, as it provides a negative feedback signal
that limits bile salt synthesis in the liver.Methods
We investigated plasma bile salt and FGF19 levels in critically ill pa-
tients. The study population consisted of enterally fed, mechanically
ventilated patients admitted to our intensive care unit (ICU). There were
no significant differences in demographic characteristics and ICU length
of stay between groups with and without diarrhea. Patients with a pri-
mary hepato-biliary diagnosis (i.e. biliary obstruction or cholangitis) or
admitted after elective surgery were excluded. After inclusion, alloca-
tion to a diarrhea group (N = 12) or no diarrhea group (N = 18) occurred
based on 24 hour fecal production > = 350 ml. Data were tested for
normality using the Shapiro-Wilk test and are presented as median
[interquartile range] or mean ± standard deviation. Mann-Whitney or t-
tests were used as appropriate.
Results
FGF19 levels were decreased in the diarrhea group (0.20 ± 0.12 vs.
0.29 ± 0.10 ng/mL, p = 0.03) indicating disturbed enterohepatic sig-
naling. Plasma bile salt levels were significantly increased in patients
with diarrhea compared to patients without diarrhea (9.8 [5.0-23.9]
vs. 4.5 [2.9-7.4] μmol/L, p = 0.01]). Bilirubin, alkaline phosphatase
(ALP) and gamma-GT levels were not significantly different between
the two groups.
Conclusions
Diarrhea in critical illness disturbs the normal enterohepatic cir-
culation of bile salts, as evidenced by reduced plasma levels of
FGF19. This in turn may lead to unopposed bile salt synthesis
in the liver. In conclusion, diarrhea and malabsorption may
cause liver injury during critical illness due to disturbed entero-
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Introduction
Although acute pancreatitis necrotizing (ANP) has a high mortality,
continuous regional arterial infusion (CRAI) of protease inhibitors has
been considered to be a promising method of reducing the
mortality.
Methods
This retrospective study was conducted among 44 institutions in
Japan from 2009 through 2013. Patients 18 years or older diagnosed
with ANP were consecutively enrolled.
Results
Of 1159 patients admitted, there were 101 (CRAI:66, non CRAI:33)pa-
tients with area of pancreatic necrosis >50%. In multivariable ana-
lysis, although CRAI of protease inhibitors was not associated with a
reduction in mortality and infection rate (odds ratio [OR] 0.67, 95%
confidence interval [CI] 0.19-2.36, p = 0.53; OR 0.64, 95%CI 0.18-2.25,
p = 0.49; respectively), associated with need for surgical intervention
(OR 0.25, 95%CI 0.07-0.85, p = 0.03).
Conclusions
CRAI of protease inhibitors may reduce the need for surgical inter-
vention in the treatment of patients with severe ANP.
References: Horibe M, et al. PMID: 26355545.
Fig. 36 (abstract P483). See text for description
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Introduction
The complication rate after pancreas transplantation (PTx) is
very high, with venous thrombosis being the most commonly
occurring complication that leads to early graft loss. There is a
lack of reliable methods to uncover complications. In this study,
we investigated whether microdialysis catheters could detect
complications at a timepoint where the grafts were still
salvageable.
Methods
34 consecutive patients underwent technically similar PTx. 17
were simultaneous pancreas-kidney transplantations (SPK) and
17 were pancreas transplantation alone (PTA). The arteries were
anastomosed “end-to-side” to the right common iliac artery and
an elongated portal vein was anastomosed “end-to-side” to the
inferior caval vein. The enteric anastomosis was performed by a
duodeno-dudenostomy. At the end of surgery, two microdialysis
catheters were placed anterior and posterior of the pancreas.
We measured glucose, lactate, pyruvate, and glycerol bedside
by sampling every 1-2 hours postoperatively.
Results
Of the 34 patients included, a total of nine patients developed
venous thrombi. The microdialysis catheters detected all thrombi
by a marked increase in lactate, which preceded any rise in
blood glucose levels, and in the absence of any clinical symp-
toms. Median anterior lactate was 2.5 mmol/L (interquartile range
(IQR) 2.2-4.1) and median posterior lactate was 2.9 (IQR 2.5-4.0) in
the patients with thrombi which was significantly higher than in
the uneventful group that had a median anterior and posterior
lactate values of 1.1 (IQR 0.9-1.6) (p = 0.003) and 1.8 mmol/L (IQR
1.1-1.9) (p = 0.007) respectively. The presence of a thrombus was
confirmed by CT. 4/9 grafts were rescued by angiographic inter-
vention, one did not require intervention, and four grafts were
explanted due to irreversible ischemic damage. All four patients
with rescued grafts remain insulin-independent more than one
year post transplantation.
In addition, three patients had leakages in relation to the
doudeno-duodenal anastomosis. This was detected by an in-
crease in glycerol that preceded any clinical signs for up to
fourteen days. One patient required relaparotomy, another
percutaneous drainage, and the last was managed with IV anti-
biotics alone. The three patients had higher median glycerol
levels in the anterior catheter compared to the non-events,
908μM (IQR 543-1355) vs. 63μM (IQR 51-124) respectively (p =
0.002).
Conclusions
Monitoring lactate and glycerol with microdialysis catheters detect
venous pancreas transplant thrombosis and enteral anastomosis leak-
age at an early stage, and may improve graft survival, patient
morbidity and survival.P485
Measurement of LDH in acute pancreatitis - time to let go
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Introduction
A widely adopted, accurate and convenient scoring system to
predict severity in acute pancreatitis has eluded surgeons down
the years. Despite not being supported by the most recent Inter-
national Association of Pancreatology guideline the modified
Glasgow score remains very widely used, in part because a score
of >/=3 is often claimed (by surgeons) as an indication for admis-
sion to Critical Care Unit (CCU). The score requires measurement
of Lactate dehydrogenase, as this is often not included on admis-
sion blood tests the patient must either be re-bled or the test
“added-on” to stored samples. Completing the score therefore in-
curs an additional expense. We sought to determine whether
completing the score (by measurement of LDH) has any value in
predicting CCU admission.
Methods
All patients admitted with a diagnosis of pancreatitis to our institu-
tion in 2015 were reviewed. The components of the Glasgow score
on admission were recorded along with admission to CCU, length of
stay and long term outcome. Relative risk of admission to CCU was
calculated in the presence or absence of LDH measurement and
again for normal or abnormal levels. An LDH level of >600 U/l was
regarded as abnormal. Repeated admissions of the same patient
were excluded.
Results
There were 229 new patient episodes of acute pancreatitis in 2015.
16 (7%) were admitted to critical care. One year crude mortality was
5.7%.
Patients who had complete scoring (including LDH) had a Relative
Risk of Critical Care admission of 1.27 (95% CI 0.42-3.79). Patients
with an abnormal LDH had a relative risk of CCU admission of 2.57
(95% CI 0.87-7.61)
Conclusions
95% confidence intervals for RR of CCU admission cross 1 for both el-
ements. These data suggest that not only is an abnormal LDH not a
determinant of CCU admission but also that measuring it at all is of
no clinical use. These findings support the recomendations of the re-
cent National Confidential Enquiry into Patient Outcome and Death
(NCEPOD) publication on pancreatitis. This review encouraged the
adoption of the IAP guidelines in the management of pancreatitis
which recommend a physiological score as sufficient in determining
severity and prognosis.
LDH measurement is an unnecessary additional expense in the man-
agement of pancreatitis.
References
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Introduction
Emergency laparotomy is a common abdominal operation that car-
ries a high mortality rate, recently reported in the UK at 3.6% to
41.7% [1]. With the drive to reduce associated morbidity and
Critical Care 2017, 21(Suppl 1):58 Page 55 of 70mortality, there is wide academic interest to examine every step in
the laparotomy pathway [2]. We aimed to establish whether patients
undergoing bowel resection at emergency laparotomy experience
any difference in critical care or hospital outcome dependent on
whether their bowel is defunctioned or a primary anastomosis is
performed.
Methods
Retrospective review of emergency or urgent laparotomies per-
formed at a large UK district general hospital between 2014-2015
where post-operative critical care admission was required. Data was
assimilated from the electronic database. We examined: baseline pa-
tient characteristics and predicted mortality, pathology, the presence
of soiling, need for repeated operation and subsequent pathology
found, organ support requirements, critical care and hospital out-
come and length of stay.
Results
We reviewed 106 patients and noted the pathology seen at initial
operation varied widely between the two groups, with those defunc-
tioned much more likely to have an inflammatory process or perfor-
ation found on surgical exploration. Patients with soiling at initial
operation were 4 times more likely to have a defunctioning stoma
formed. Both the APACHE II and ICNARC risk prediction models iden-
tified the defunctioned group as being at greater mortality risk; the
groups were otherwise well matched at baseline. In the subgroup of
patients with soiling of the abdomen at initial operation, hospital
length of stay was shorter (13 vs 18 days) and more patients were
discharged alive (81% vs 66%) if they had undergone defunctioning
as opposed to primary anastomosis. No significant difference in
organ support, need for repeated operation or overall critical care or
hospital mortality or length of stay was identified between the two
groups.
Conclusions
This is the first study to examine the impact of the decision to either
anastomose or defunction bowel at emergency laparotomy and link
this to post-operative morbidity and outcome. Our data suggests
that patients with soiling at initial operation have a lower critical care
and hospital mortality, and a shorter length of hospital stay if a
defunctioning stoma is performed. No other differences were noted
in any of the indices examined. This evaluation has significant impli-
cations both locally and nationally for the management of patients
undergoing emergency laparotomy.
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Introduction
The purpose of this study is to compare the clinical efficacy of intra-
venous (IV) pantoprazole intermittent bolus (IMB) dosing versus the
recommended bolus and continuous infusion (CI) in subjects with
upper gastrointestinal bleeding (GIB). The American College of
Gastroenterology treatment guidelines for GIB recommend IV panto-
prazole 80 mg bolus followed by 8 mg/h infusion [1]. In 2015, our
health system switched from CI pantoprazole to IMB dosing as a re-
sponse to an IV pantoprazole shortage. To our knowledge, there is
currently a paucity of literature, which directly compares the two
dosing strategies at consistent and specific dosages. This study aims
to contribute additional data to the current body of knowledge.
Methods
This retrospective chart review evaluated the treatment of GIB with
either pantoprazole CI or IMB. Patients who received IV pantoprazole
therapy for at least 24 hours and had an upper endoscopy (EGD)
with high-risk stigmata of bleeding were included. The primary out-
come was rebleeding within 3 days of starting pantoprazole.Rebleeding was defined as overt bleeding with a drop in hemoglobin
requiring packed red blood cell transfusion (PRBC) or additional
endoscopic or surgical intervention. Secondary outcomes included
rebleeding within 7 days, ICU length of stay (LOS), hospital LOS, and
72-hour PRBC requirements from start of pantoprazole. Statistical
analyses were conducted using R statistical software.
Results
Fifty-one patients treated with IMB and 41 patients treated with CI
were included. Baseline characteristics appeared to be similar be-
tween the two groups except for patients receiving an initial 80mg
bolus, which occurred more frequently in the CI group (CI 78% vs.
IMB 25.5%). There was no difference between either group for the
primary outcome with 4 patients in the IMB group and 7 patients in
the CI group who met criteria for rebleeding within 3 days (p = 0.20).
Rebleeding within 7 days was similar between groups (IMB 11 vs. CI
10, p = 0.94). The mean number of PRBC received in 72 hours was
2.19 units in the IMB group and 4.5 units in the CI group (p = 0.99).
There was a significant difference in ICU LOS (IMB 1 day vs. CI 2 days,
p = 0.02) but not in hospital LOS (IMB 4 days vs. CI 5 days, p = 0.29).
Conclusions
IMB pantoprazole was comparable to the guideline recommended CI
pantoprazole for the treatment of GIB in patients with endoscopic
findings of high-risk stigmata of bleeding. IMB pantoprazole could be
considered an equivalent alternative to CI pantoprazole in treatment
of GIB and deserves further evaluation.
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Introduction
Our aim was to audit the amount of sodium administered to our pa-
tients and the incidence of hypernatraemia.
ITU patients receive large amounts of IV fluid, often containing high
concentrations of sodium. Hypernatraemia is therefore more com-
mon and is associated with worse outcomes [1][2].
Retrospective data collection from ITU patient records over a 1
month period indicated that 96% of patients received >2mmol/kg/
day of sodium. 6% became hypernatraemic. During this time, use of
Hartmann’s as maintenance IV fluid (MIF) was standard practice.
NICE guideline CG174 specifies that maintenance fluid/sodium
should be given by infusion of 0.18% Sodium Chloride/4% Dextrose
(Dex/sal). Practice was changed and compliance audited. Audit stan-
dards used are shown in Table 14.
Methods
We retrospectively audited the records of all admissions to the ITU
during May 2016. There were 65 patients; of which 36 were excluded
(due to diagnoses that affect sodium balance), leaving 29 patients in-
cluded in the audit. Data collection included patient demographics,
length of stay, fluid type received, total sodium received from all
sources and serial serum sodium.
Results
We achieved four standards and failed one (*). [Table 15]
Total sodium received per patient reduced from a mean of 936mmol
to 314mmol. Sodium received in MIF as a percentage of total sodium
reduced from 59% to 35% Maintenance sodium was received at a
rate between 0.6-1.4mmol/kg/day in 83% of patients. 67% of patients
received >2mmol/kg/day of total sodium.
96% of patients started on dex/sal had a lower serum sodium on re-
peat. 30% of the normonatraemic (135-145mmol/l) patients became
hyponatraemic (<135mmol/l). On average these patients received
0.94mmol/kg/day maintenance sodium and 2.86mmol/kg/day total
sodium. 10% of patients received <0.6mmol/kg/day of maintenance
sodium, who all remained normonatraemic. There was a weak correl-
ation between percentage serum sodium change and sodium
Critical Care 2017, 21(Suppl 1):58 Page 56 of 70received (total and maintenance) but no correlation if it was cor-
rected for body weight.
Conclusions
We adhered to NICE standards well. We reduced total sodium admin-
istered and subsequent hypernatraemia. Hyponatraemia incidence
was increased which also adversely affects patient outcome [2]. Rec-
ommendations were made to raise awareness of dex/sal induced
hyponatraemia and to consider using MIF with 0.45% sodium
concentration.
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Guideline Source
1 Use Dex/sal for MIF (unless documented why not) NICE
2 Use fluid with 130–154mmol/l sodium for any resus NICE
3 Receive 0.6-1.4mmol/Kg/day of maintenance sodium NICE
4 Give <2.5L/day Dex/saline NICE
5 Patients with Critical Care induced hypernatraemia Local
Legend : Audit Standards








Table 16 (abstract P489). See text for description
Sodium levels (mmol/L) Survived Died % Mortality
<114 25 10 28.6
115-124 119 67 36.0
125-135 1723 751 30.4
136-145 4861 1606 24.8
146-155 387 295 43.3
>156 28 38 57.6
Legend : Comparison of dysnatraemia on mortaliyP489
Dysnatraemia and its impact on mortality on admission to
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Introduction
The impact of dysnatraemia on survival from Intensive Care (ICU) can
be related to the degree of hypo- or hypernatraemia [1-2]. To ex-
clude ICU acquired dysnatraemia we reviewed patients admitted to
ICU with normal and abnormal sodium levels.
Methods
A retrospective analysis of 10,311 consecutive patients admitted to our
mixed medical and surgical ICU at East Surrey Hospital was completed.
We recorded their lowest sodium level within the first 24 hours of ad-
mission. Patients were grouped as follows - Sodium <114, 115-124,
125-135, 136-145, 146-155, >156 mmol/L. Statistical comparison be-
tween the groups was carried out using Chi-squared analysis.
Results
Of the 10311 patients collated, 401 were excluded due to incomplete
data. Survival to hospital discharge was the primary endpoint. We
found that severe hyponatraemia (<114 & 115-124 mmol/L) does not
confer a statistically significant impact on likelihood of survival when
compared with the two groups of 125-135 & 136-145. However, sur-
vival with mild hyponatraemia 125-135 mmol/l carries a mortality of
30.4% when compared with normal sodium levels (136-145 mmol/L)
which has a mortality of 24.8%, p <0.0001. Patients who are hyperna-
traemic in the first 24 hours of ICU admission appear to have increas-
ing mortality rates associated with the degree of hypernatraemia. Asodium level greater than 156 mmol/L has a mortality rate of 57.6%
whereas 146-155 mmol/L is 43.3%. The differences between these
and when compared to the normal range of sodium are statistically
significant, P <0.0001
Conclusions
We found that hyponatraemia, unless mild, carries less statistical
weight when used as a prognostic tool than hypernatraemia when
measured in the first 24 hours of admission to ICU.
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Introduction
Peri-operative Acute Kidney Injury (AKI) is a common and serious compli-
cation after major surgery [1]. Whereas peri-operative risk factors associ-
ated with AKI after cardiac surgery have been well described [2], this is
not the case for major non-cardiac surgery. Recently, the impact of a
high chloride load on the pathogenesis of AKI has been suggested [3].
This study was performed in order to identify possible intra-operative
risk factors linked to peri-operative AKI development in a group of
non-cardiac surgery patients.
Methods
This single-centre, prospective observational study included adults
undergoing elective major abdominal (including vascular) surgery. Pa-
tients with chronic kidney disease (CKD) stage IV or V were excluded.
AKI was defined according to Acute Kidney Injury Network (AKIN) cri-
teria within 48 hours after surgery [4]. Patients pre-operative demo-
graphics (sex, age, hypertension, coronary artery disease, congestive
heart failure, chronic obstructive pulmonary disease, diabetes mellitus,
CKD stage) and intra-operative anaesthetic management (type of sur-
gery, intravenous fluids, blood products, vasopressors, mean arterial
blood pressure, urine output and blood loss) were evaluated as pos-
sible AKI predictors. Furthermore, chloride ion content of intra-
operatively administered crystalloids and colloids was estimated.
Results
Of 61 patients (47 males) included in the study, 10 (16.4%) developed
postoperative AKI (AKI group) and 51 did not (non-AKI group). After uni-
variate analysis, four intra-operative variables were identified as predictors
of AKI: Intra-operative blood loss (p = 0.002), transfusion of fresh frozen
plasma (p = 0.004) and red blood cells (p = 0.038), as well as high intra-
operative chloride load (p = 0.033, AUC= 0.715 ± 0.095, cut off value
>500mEq). The remaining pre- and intra-operative variables did not differ
significantly between the two groups.
Critical Care 2017, 21(Suppl 1):58 Page 57 of 70Conclusions: Isotonic saline administration has recently been associ-
ated with post-operative AKI, possibly as a result of the excess chlor-
ide load during cardiac surgery [5]. Our study’s preliminary results
indicate that a high intra-operatively administered chloride load is
strongly associated with increased risk of post-operative AKI in
patients undergoing elective major non-cardiac surgery.
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Introduction
High chloride (Cl) load is one of the putative causes of hyperchloremia
in critically ill patients. We aimed to assess and quantify the association
between chloride load during the first two days of ICU admission and
changes in chloride levels between admission and day 3.
Methods
We analyzed adult patients with at least two days of ICU stay included
in the MIMIC II. Cl load was calculated as the sum of the Cl infused in
the first 48 hours from common solutions (normal saline, half normal
saline, lactated ringer, HES). The association between change in Cl
levels (day 3 minus day 1) and Cl load was assessed by linear regres-
sion. We performed sensitivity analysis according to serum creatinine at
admission (<1 mg/dL; 1-2 mg/dL; 2-3 mg/dL or higher > 3 mg/dL), oc-
currence of any degree of acute kidney injury in the first 48 hours
(above KDIGO 1), in quartiles of diuresis in the first 48 hours and in oli-
guric (<0.5 mL/kg/h in the first 48 hours) patients.
Results
9,043 patients were included in the analysis. Median chloride load
was 350 mEq (IQ 162-579 mEq). On linear regression, higher chloride
load was weakly associated with an increase in serum chloride (coef-
ficient 0.001; SE 0.0002; p < 0.001 – Fig. 37, red line), but correlation
and R-squared were low (0.08 and 0.007, respectively). These findings
were consistent in all subgroups assessed.
Conclusions
Although a high chloride load is associated with an increase in serum
chloride, the association was weak even patients with low urinary
output and high creatinine. This suggests that chloride load may not
be the principal cause of hyperchloremia in critically ill patients.Fig. 37 (abstract P491). Density hexagonal binning for the
association between Cl load and change in ClP492
Hypercloremia and acid-base changes in critically ill patients
requiring fluid resuscitation
C Dominedò, AM Dell’Anna, A Monayer, DL Grieco, R Barelli, SL Cutuli,
A Ionescu Maddalena, E Picconi, C Sonnino, C Sandroni, M Antonelli
Catholic University of the Sacred Heart, A. Gemelli University Hospital,
Rome, Italy
Critical Care 2017, 21(Suppl 1):P492
Introduction
Hyperchloremia is common in ICUs [1]. Short term and in vitro stud-
ies [2] show that crystalloid infusions may lead to hyperchloremia
and metabolic acidosis due to low strong ion difference (SID). It is
not known if changes in serum chloride (sCl) concentration in vivo
yield to mid-term SID and acid-base (AB) imbalance. We performed a
study to assess the effects of sCl increase on SID and AB equilibrium
in critically ill patients.
Methods
The present monocentric, retrospective, physiological study enrolled
a cohort of critically ill adult patients admitted to ICU from January
2009 to June 2015, who required fluid resuscitation and developed
hyperchloremia (2 consecutive sCl values > =110 mEq/L). Changes in
AB and electrolyte equilibrium within ICU admission and the day of
maximum chloremia were studied. Data are expressed as median
[interquartile range].
Results
21 patients were included in the study: age 72 [58-81] years, female
9 (43%), SAPS II 50 [38-68]. At ICU admission 9 patients (43%) had
shock, SOFA was 8 [5-11], pH 7.37 [7.31-7.44], SID 27 [21-29] mEq/L,
sCl concentration 112 [110-117] mEq/L; 5 patients (24%) had hyper-
chloremia. Maximum sCl concentration (120 [116-122] mEq/L) was
observed in the remaining 16 patients 36 [24-48] hours after ICU ad-
mission and an administration of 3.8 [2.3-4.5] L of crystalloids. 9 pa-
tients (43%) died at 28 days follow up. In the overall cohort, sCl
increase was not accompanied by significant changes in SID and pH.
However, 7 patients (43%) developed hyperchloremic acidosis with
lower SID and 9 patients (57%) hypernatremic alkalosis with higher
SID. Patients with hyperchloremic acidosis during hyperchloremia
showed a higher clinical severity than those with hypernatremic al-
kalosis (respectively, MAP 65 [57-76] vs 95 [82-116] mmHg, p 0.006;
daily fluids administered 4532 [3813-5443] vs 2428 [2080-4243] mL, p
0.01; serum albumin 2.4 [2-2.8] vs 3 [2.7-3.4] mg/dL, p 0.07).
Conclusions
SCl concentration increase can be accompanied by pH variations, ac-
cording to sodium levels and SID changes. It has been suggested
that both hyperchloremic and hypernatremic patients have a higher
risk of mortality. Whether and to what extent AB alterations contrib-
ute to the detrimental effects of hyperchloremia on clinical outcome
remain unknown and further adequately powered studies are
warranted.
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Introduction
Our hypothesis is that there is an interaction between base ex-
cess chloride (BEcl) and standard base excess (SBE). We know
that electrolytes are independently related with acid-base status
(1). Even in acute respiratory acidosis, renal compensation occurs
on urinary output of sodium and chloride (2). SBE formula
Critical Care 2017, 21(Suppl 1):58 Page 58 of 70derivated from Van Slyke equation doesn’t include any electrolyte
effect (3). Yet, BEcl is defined as an effect of chloride on SBE and
calculated with (Na-Cl-32) in accordance with partitioned base ex-
cess approach (4). An interaction between BEcl and SBE can pro-
vide better understanding primary reasons and compensations of
acid-base disorders.
Methods
In this study, 2736 patients were retrospectively evaluated beetween
2011 and 2016. Patients who were <18 years old, readmitted, whose
ICU scores, blood gases and outcomes were unknown were ex-
cluded. Demographic data, blood gases’ parameters and outcomes
were recorded.
Results
Two thousand patients were included in this study. There were
positive correlation between BEcl and each of SBE, HCO3 and
PaCO2 (r2 = 0.22 P < 0.001; r2 = 0.29 P < 0.001; r2 = 0.27 P < 0.001).
In patients with lactate > 5mmol L-1, there was a positive correl-
ation between BEcl and lactate (r2 = 0.04 P = 0.011). In correlation
graphic of BEcl and SBE, it was found four different areas which
leaded four different clinical status such as SBE > 3 plus BEcl > 0
(the 1st area; contribution of hypochloremic alkalosis on alkal-
osis), SBE > 3 plus BEcl < 0 (the 2nd area; hyperchloremic acidosis
plus respiratory compensation), SBE < -3 plus BEcl < 0 (the 3rd
area; contribution of hyperchloremic acidosis on acidosis) and
SBE < -3 plus BEcl > 0 (the 4th area; hypochloremic compensation
in acidosis).
Conclusions
BEcl is positively correlated with SBE, HCO3 and PaCO2. Hence, it can
be used to explaine the effects of sodium and chloride on SBE. Actu-
ally, BEcl may lead a primary reason or a part of compensation of
any acid-base disorders.
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Introduction
Fluid therapy in critically ill patients, especially timing and fluid
choice, varies substantially between centres and countries. For
many Asian countries, there is few data about the common
practice volume therapy. We aimed to study the current
approaches in India, Taiwan and Malaysia concerning patient
populations, treatments and outcomes within the RaFTA
registry.
Methods
RaFTA is an observational study in Asian ICU patients focussing on
fluid therapy and related outcomes. Multivariable Cox regression was
performed to identify risk factors for increased 90 day mortality and
renal failure.Results
24 study centres joined the RaFTA registry and collected 3,187
patient data sets from November 2011 to September 2012. A fol-
low up was done 90 days after ICU admission. For 90 day mortal-
ity, significant risk factors in the overall population were sepsis at
admission (OR 2.185 [1.799; 2.654], p < 0.001), cumulative fluid
balance (1.032 [1.018; 1.047], p < 0.001), and the use of vasopres-
sors (OR 3.409 [2.694; 4.312], p < 0.001). For the use of colloids a
significant survival benefit was observed (0.655 [0.478; 0.900], p =
0.009). The initial colloid dose was not associated with an in-
creased risk for renal failure (OR 1.094 [0.754; 1.588], p = 0.635).
Exploratory research within the database suggests that timing
and protocol of colloid use might affect outcome for mortality: In
late colloid receivers (later than ICU day 3), the survival benefit
for colloids disappeared (1.798 [0.600; 5.383], while it was more
pronounced in early colloid receivers (ICU day 1, 0.523 [0.312;
0.878]).
Conclusions
After multivariable Cox regression analysis, colloid use was not asso-
ciated with an increased risk of mortality. Furthermore, our data indi-
cate that effects of colloids on clinical outcome may be dependent
on the time of use.P495
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Introduction
According to current guidelines [1], crystalloids and colloids are used
as the first line treatment in fluid resuscitation during massive bleed-
ing. However, they may have deleterious impact on haemostasis.
Therefore we aimed to investigate effects of balanced crystalloid and
colloid solutions on coagulation and fibrinolysis in vitro.
Methods
Blood samples drawn from 32 young healthy males were diluted
with study fluids to make a 20-vol% end-concentration. The fol-
lowing fluids were used: balanced crystalloid (Plasmalyte®), 4%
succinylated gelatin (Geloplasma®), 6% HES 130/0.4 (Volulyte®).
Rotational thromboelastometry (ROTEM®delta) and platelet
aggregometry (Multiplate®) were implemented at baseline and
after dilution. CBC, aPTT, PT, fibrynogen, D-dimers were also
performed.
Results
Both succinylated gelatin and HES showed deranged INTEM (CFT, AA,
A10 and MCF) and FIBTEM (A10, MCF) parameters (p < 0.01), however
the effect of HES was more apparent (Fig. 38). In EXTEM, only HES
significantly affected coagulation (i.e. CT prolongation). There was no
effect on fibrinolysis or platelet function, as evidenced by unchanged
ML and TRAP, respectively. In standard laboratory tests dilutional ef-
fect was found, however all investigated parameters stayed within
reference values. No correlation was found between functional and
standard coagulation tests.
Conclusions
Despite marked haemodilution balanced crystalloid cannot affect co-
agulation. Balanced colloids impair clot formation and firmness, how-
ever the effect of HES is more pronounced. None of the fluids
significantly impact fibrinolysis or platelet function.
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Fig. 38 (abstract P495) INTEM CFT and MCF after mixing with
study fluids
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Introduction
We examined the sublingual microcirculation in a porcine
model of THS to assess the impact of microcirculatory dysfunc-
tion on the development of TIC in animals treated with initial
0.9% saline or blood products. Development of trauma induced
coagulopathy (TIC) is an important modifiable factor associated
with excess morbidity and mortality following traumatic haem-
orrhagic shock (THS). Tissue hypoperfusion, possibly resulting
from impairment of the microcirculation, is a pre-requisite for
the development of TIC. The early use of blood products may
attenuate TIC but is logistically difficult and identification of pa-
tients at highest risk would allow more effective targeting of
this resource.
Methods
This study was conducted in accordance with the Animals (Scientific
Procedures) Act, 1986. 19 terminally anaesthetized Large White pigs
were subjected to a standardized hind-limb injury followed by a con-
trolled haemorrhage of approximately 35% of blood volume. A 30
min period of shock was followed by 60 min of hypotensiveresuscitation with either 0.9% saline or packed red cells:fresh frozen
plasma after which all animals were treated with PRBC:FFP. Sublin-
gual IDF videomicroscopy was performed and animals were divided
into above and below average perfused vessel density (PVD) groups
based on the lowest recorded measurement taken during the shock
and initial resuscitation phases.
Coagulation was assessed using thromboelastography (TEG) and PT,
APTT.
Results
8 animals had above average perfusion (PVD 10.5 ± 2.5 mm/mm2)
and 11 below average perfusion (PVD 5.5 ± 4.1mm/mm2). For ani-
mals initially treated with 0.9% saline (n = 10) there were significant
differences between those with above and below average perfusion
in terms of R time (14.7 ± 2.6 v 46.6 ± 26.9 s, p <0.01), MA (72.2 ± 3.4
v 66.7 ± 4.8 mm, p 0.01) and APTT (15.0 ± 2.8 v 18.3 ± 3.9 p 0.03) 60
min after the start of resuscitation. However, animals initially treated
with PRBC:FFP (n = 9) showed no such differences.
Conclusions
In a porcine model of complex THS the development of TIC
appeared to be associated with the presence of impaired microcircu-
latory perfusion and initial treatment with 0.9% saline. Early adminis-
tration of blood products appeared to attenuate TIC, even in the
presence of tissue hypo-perfusion.
References: © Crown copyright (2016), Dstl
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Introduction
Hypophosphatemia occurs in around 20% of patients in intensive
care units (ICU), similar to the incidence at the QEUH. There is
not a standardised phosphate (PO4) replacement calculation and
current practice in the QEUH is to replace 40mmol of PO4 as
standard. In 2013, a Dutch study concluded the following phar-
macokinetic equation to be effective when used for individualis-
ing PO4 replacement:
Dose(mmol) = (0.5* x weight(kg)) x (1.25&#450; – plasma PO4(mmol/
L)) [1]
*Volume of distribution (L/Kg)
ǂ Target plasma PO4 (mmol/L)
This study aims to assess the validity of this equation in our
population.
Methods
Electronic medical records were reviewed retrospectively to identify
patients who received PO4 replacement from August to November
2016. Patient characteristics, PO4 dosing and levels were collected.
The above equation was used to calculate a theoretical dose which
was then compared to the actual dose administered.
Results
Of 200 patients reviewed, 40 received intravenous PO4. Using the
calculation, 34 patients would have received lower doses than ad-
ministered following current practice (Fig. 39). Of these, 19 had PO4
within the therapeutic range (0.7-1.4) post administration of 40mmol.
The theoretical dose exceeded the actual dose in five cases. In total
there were 51 PO4 administrations, 40 of which did not reach the
target concentration of 1.25mmol/L defined in the equation. The
remaining eleven achieved levels >1.25mmol/L; five of which the
plasma concentration exceeded the upper limit of 1.4mmol/L. Using
the information collected a new average volume of distribution (Vd)
was calculated to be 1.2L/Kg.
Conclusions
The proposed pharmacokinetic equation for individualising PO4 re-
placement is not valid for QEUH ICU patients. One possible explan-
ation for this could be due to the difference in the apparent volume
Critical Care 2017, 21(Suppl 1):58 Page 60 of 70of distribution. A new volume of distribution and equation was calcu-
lated from the above data. This will be trialled and assessed for
validity.
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Table 17 (abstract P499). See text for description
Characteristics Non-survivor
n = 5
Survivor n = 54 p-value
APACHE IV score 145 (30.0) 108.9 (26.2) 0.005
PaCO2 (kPa) 4.93 (1.45) 2.89 (1.34) 0.002
24 hour urine volume (ml) 45 (17.5-110) 589.5 (153.8-1427.5 0.013
Maximum nor-adrenaline
(mcg/kg/min)
2.03 (1.36-2.94) 0.54 (0.11-1.63) 0.009
Time from admission to RRT (min) 1180 (515-2070) 386.5 (136.5-662.5) 0.043
Legend : Factors associated with ICU mortalityP498
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Introduction
Diabetic ketoacidosis in children (DKA) is characterized by the exist-
ence of some hydroelectrolitic disorders particularly serious which
not being founded and treated on time endangers life.
Methods
N = 116, from the ED, ICU and endocrinology for the period of
15.01.2014 and 01.09.2016. Two lots: I lot 48 children with DKA who
have been under treatments in the ED of pediatric resuscitation and
the II lot 68 children control group who have been under the treat-
ment in the department of endocrinology. They have been evaluated
primary and secondary emphasizing the signs of dehydration, blood
sampling for determining the ions of K, Na, Cl, P, acid-base balance,
glucose, and urinary ketones.
Results
Children were transported by the emergency in proportion of 81%.
According to age children > 9 have predominated, gender: b n = 60;
g n = 56 (p <0.001). Degree of dehydration: 42 children mild dehy-
dration under 4%, in 58 cases we founded moderate signs of dehy-
dration 4-7%, and children with serious signs of dehydration -16. We
have founded the level of K ions and of ABB while being hospitalized
and in dynamics. In lot I, we registered values of K under 3 mmol/l,
in comparison with the values of 3.5mmoles/l of K in the control lot
(p =0.001).They received infusion of crystalloid and K supplements,
the necessary volume and quantity of K was calculated separately ac-
cording to the known formula. After the infusion– in children from
the I lot: the initial values of Ph 7.09 ± 0.07; pCO2 11 ± 1.5; BE –(-)
18.7 ± 0.9 had a tendency of amelioration after 30 minutes in 6 cases,
in 19 cases just after 2 hours an amelioration, in 16 cases after 12
hours, simultaneously in other 7 cases the amelioration of the de-
scribed above parameters was observed after 24 hours. No child
needed the administration of Na bicarbonate for the normalization
of metabolic acidosis. The average time of treatment 13 ± 0.9 days in
I lot, in the control lot 7 ± 0.7 (p = 0.03).
Conclusions
1. Early administration of infusion with the goal of hydroeletrolitic
and acid-base balancing lead to a more rapid amelioration of the
hemodynamics in children with ketoacidosis and reduces the time of
being in-patient unit.
2. Correct administration of infusion therapy in ketoacidosis elimi-
nates the necessity of Sodium bicarbonate administration with the
goal of metabolic acidosis.P499
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Introduction
Metformin-associated lactic acidosis (MALA) is a severe condition
with inconsistent factors for mortality in previous studies. The rela-
tionship between the timing of commencement of RRT and survival
has not been investigated.
Methods
This is a 5-year retrospective case series in patients with MALA in a
regional hospital in Hong Kong. The primary outcome is to identify
factors associated with intensive care unit (ICU) mortality, specifically
to investigate the relationship between mortality and time from ad-
mission to RRT. The secondary outcomes are to investigate the char-
acteristics and outcomes of patients with different precipitating
factors and to identify factors for duration of RRT dependency.
Results
59 patients were eligible for analysis. Compared with the 54 survivors,
the 5 non-survivors had higher APACHE IV scores, APACHE IV predicted
mortality risk, temperature, heart rates, PaCO2 levels, and nor-
adrenaline dosage and lower first 24 hr urine volume and serum albu-
min. They were more likely to be on mechanical ventilation and suffer
from sepsis. They had longer time from hospital admission to com-
mencement of RRT. The ROC curve had AUC of 0.776 and sensitivity
and specificity of 80% if cut off value was set at 765.5 mins. Patients
with sepsis were found to be more severe with higher mortality. Sepsis
as a precipitating factor and high baseline serum creatinine level were
two factors identified for longer RRT dependence.
Conclusions
Our study identified factors associated with mortality in metformin-
associated lactic acidosis, including time from admission to com-
mencement of RRT, suggesting benefit of early RRT. Further pro-
spective studies may be necessary to determine the optimal timing
of initiation of RRT for MALA in future.P500
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Introduction
Contrast-induced nephropathy (CIN) was common complication of
radiologic procedures and increased morbidity, mortality, and ac-
celeration toward ESRD. The objective was to compare IV sodium
bicarbonate plus NAC and IV sodium chloride plus NAC to pre-
vent CIN in ED.
Fig. 41 (abstract P500). Chemistry from baseline to 72 hr
Critical Care 2017, 21(Suppl 1):58 Page 61 of 70Methods
We performed a prospective single-center RCT of 83 patients
who had GFR between 30-60 ml/min/1.73 m2. 42 patients re-
ceived IV sodium bicarbonate plus NAC 1 hour before contrast
and continued for 6 hours. 41 patients received IV sodium chlor-
ide plus NAC in the same manner. In both groups, NAC (1,200-
mg IV bolus before contrast injection then 1,200 mg orally twice
daily for 24 hours) was administered. Primary outcome was the
incidence of CIN.
Results
CIN occurred 4 patients (9.8%) in sodium bicarbonate group and
6 (15.4%) in sodium chloride group (P = 0.51). Sodium bicarbonate
group had significant increased GFR at 72 hours {50.1 (31.3, 99.8),
57.0 (24.8, 117.8), P 0.004} than Sodium chloride group {50.5
(30.3, 105.9), 57.9 (19.2, 99.4), P 0.06}.There were not statistically
significant in volume overload, renal replacement therapy and
mortality at 7 days
Conclusions
Hydration with sodium bicarbonate might be effective as sodium
chloride for prevention of CIN in emergency situations.
References
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Baseline Sodium Bicarbonate Plus NAC,
(N = 42)
Sodium Chloride Plus NAC
(N = 41)
P
Cr (mg/dl) 1.2(±0.3) 1.2(±0.3) 0.67
eGFR (ml/
min)
52.1(±15.5) 51.5 (±14.3) 0.86
Legend : baseline characteristic
Table 19 (abstract P500). See text for description
Outcome Sodium Bicarbonate
Plus NAC (N = 42)
Sodium Chloride
Plus NAC (N = 41)
p
CIN 4(9.8%) 6(15.4%) 0.51
Legend : Incidence of CIN
Fig. 40 (abstract P500). eGFR from baseline to Day 7P501
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Introduction
Contrast-induced nephropathy (CIN) is one of the most frequent
aetiologies af hospital-acquired acute renal failure (ARF). Strat-
egies to prevent CIN include the renal vasodilator theophylline
and hydration with sodium bicarbonate (NaBic). A recent study
demonstrated synergistic prophylactic effects of theophylline and
NaBic. Nevertheless, considering the total volume load of 9mL/kg
of NaBic 0.154 mmol/L and the potential pro-arrhythmic effects
of 200mg theophylline, haemodynamic side effects cannot be
ruled out.
Therefore, we analyzed the impact of NaBic hydration and theophyl-
line on haemodynamics in 22 ICU-patients with PiCCO-monitoring
(Pulsion Medical Systems SE; Germany).
Methods
Patients undergoing an X-ray examination with parenteral
contrast-medium (CM) received NaBic according the protocol by
Merten et al. (3ml/kg/h for 1h before CM and 1ml/kg/h for 6h
after CM) and 200mg of theophylline i.v. over 15min immediately
before CM.
PiCCO-measurements were performed immediately before (TPTD-1)
and after 1h-pre-hydration (TPTD-2), after theophylline (TPTD-3), after
CM (TPTD-4) and after the 6h- post-CM-hydration (TPTD-5). Primary
endpoint: Comparison of last vs. first PiCCOmeasurement. Statistics:
IBM SPSS 23.
Results
22 CM-enhanced computed tomographies were performed.
Comparison of the last (TPTD-5) to the 1st (TPTD-1) measurement
demonstrated significant increases in global end-diastolic volume
index GEDVI (817 ± 270 vs. 765 ± 229mL/m2; p = 0.038), cardiac index
CI (5.64 ± 1.81 vs. 4.34 ± 1.81 L/min/m2; p = 0.020) and cardiac power
index (0.87 ± 0.37 vs. 0.79 ± 0.38 W/m2; p = 0.037). By contrast, SVRI
(1254 ± 607 vs. 1513 ± 854 dyn*s*cm-5*m-2; p = 0.042) and pulmon-
ary vascular permeability index PVPI (1.66 ± 0.59 vs. 1.94 ± 1.03; p =
0.009) significantly decreased (p = 0.009). CVP, systolic and diastolic
arterial pressure, heart rate HR, dPmax, extravascular lung water
index, EVLWI and global ejection fraction GEF did not change. In
none of the patients there was a change in heart rhythm.
With regard to potential side effects of theophylline, we compared
haemodynamics before (TPTD-2) and after theophylline application
(TPTD-3). Theophylline application resulted in a moderate, but signifi-
cant increases in heart rate (99 ± 22 vs. 92 ± 20/min; p < 0.001) and
GEF (28.5 ± 7.0 vs. 27.7 ± 7.2%; p = 0.024). There were no changes in
heart rhythm.
Conclusions
NaBic according to the Merten-protocol and 200mg of theophylline
did not result in detrimental effects on haemodynamics. A slight in-
crease in heart rate immediately after theophylline was transient and
accompanied by an improvement in GEF.
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Introduction
Presepsin (PSEP) has been shown powerful prognostic validity in
inflammatory related conditions like sepsis and association with
disease severity, multi organ dysfunction syndrome and outcome.
We thought to evaluate the prognostic value of PSEP for outcome
prediction in patients undergoing elective cardiac surgery.
Methods
We included consecutive patients having cardiac surgery and mea-
sured plasma concentration of PSEP, NT-pro-BNP, PCT, leucocytes,
and cystatin C. PSEP was determined by using the PATHFAST Presep-
sin assay (LSI Medience corporation,Tokyo). Outcome measures were
in-hospital mortality, 6- month mortality and occurence of acute kid-
ney injury (AKI) during hospitalization.
Results
Patients with in-hospital mortality (n = 27, 3.2%) and 6-month
mortality (n = 49, 6.1%) had higher preoperative presepsin levels
than survivors: 1166 ± 1453 pg/mL vs. 258 ± 391 pg/mL; p < 0.001
and 913 ± 1215 pg/mL vs. 231 ± 194 pg/mL; p < 0.001, respect-
ively. C-statistics showed elevated presepsin level to accurately
predict occurrence of in-hospital mortality (AUC 0.88) and 6-
month mortality (AUC 0.87) whereas the EuroSCORE 2 showed
significantly less predictive power (AUC values 0.74 and 0.76) as
well as NT-pro-BNP (AUCs 0.77 and 0.79), PCT (AUCs 0.59 and
0.56), leucocytes (AUCs 0.58 and 0.63), and cystatin C (AUCs 0.76
and 0.74).
222 patients (25.9%) who developed AKI (AKI classification: 1 (n =
122), 2 (n = 54), 3 (n = 46)) revealed higher mortality and higher
presepsin values compared to patients without AKI (in-hospital
mortality: 8% vs 1.4%; preoperative presepsin: 441 ± 585 vs 233 ±
436 pg/mL; p < 0.001; postoperative presepsin: 927 ± 926 vs 426 ±
583 pg/mL; p < 0.001). ROC analysis of postoperative presepsin
showed the highest discriminatory power for risk prediction of
AKI occurence (AUC 0.78) and renal replacement therapy (AUC
0.88) during hospitalization in comparison with the other diagnos-
tic markers and EuroSCORE 2. Even after adjustment for confound-
ing factors (i.e. EuroSCORE 2, age, glomerular filtration rate, and
operation duration) presepsin remained an independent risk
predictor.
Conclusions
Preoperative PSEP is a predictor of postoperative mortality and AKI in
cardiac surgery patients, and is a stronger predictor than commonly
used factors. PSEP has proven as an independent risk indicator to
predict outcome and may be used for risk stratification in patients
scheduled for surgery.Table 20 (abstract P502). See text for description
AKIN = 0 (n = 635),
median (IQR)
AKIN = 1,2,3 (n = 222),
median (IQR)
RO-AUC
EuroScore II 3.15 (1.63-6.13) 6.23 (3.5-12.8) 0.701
PCT, ng/L 0.65 (0.30-1.59) 1.56 (0.60-5.34) 0.674
PSEP, ng/L 306 (228-436) 632 (378-1077) 0.782
Legend : Validity of EuroScore 2, PSEP, and PCT for detection of
post-operative AKIP503
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Introduction
Exertional rhabdomyolysis in long-distance runners has been re-
ported since the late 1970s as a condition precipitated by overheat-
ing, significant physical exertion and dehydration. The case report
concerns a 35-year-old man who was admitted to the ICU at the
27th hour after completing a 24-hour ultramarathon race during
which he ran a distance of about 205 km, after staying for a few
hours in the Cardiac Department where the man was admitted for
bradycardia (ventricular rhythm rate: 25 bpm), considerable fatigue
and whole body pain. During hospitalization in the Cardiac Depart-
ment, the patient was diagnosed with left ventricular hypokinesis
with the EF of 40%, marked hyperkalaemia (8.41 mmol/l) accompan-
ied by hyponatraemia (123 mmol/l) and hypochloraemia (86 mmol/l)
as well as elevated levels of creatinine (6.18 mg/dl), urea (220 mg/dl),
liver enzymes (AST – 6,799 U/I, ALT – 2,030 U/I), CK (332,900 U/l), CK-
MB mass (>300 ng/ml), troponin T (0.109 ng/ml), and anuria. The
level of myoglobin determined on day 2 of the patient’s ICU stay
was > 30,000 ng/ml.
Methods
Aside from standard treatment, with a view to managing hyperkalae-
mia and protecting the kidneys from further damage, CVVHD CiCa
haemodialysis with an EMIC2 filter was performed, leading to a rapid
stabilization of the patient’s clinical condition including sinus rhythm
recovery. The EMIC2 filter and/or the CVVHD CiCa kit was/were ini-
tially replaced every 12-24 hours. At the same time, the patient, who
was monitored haemodynamically, despite anuria received fluid ther-
apy so as to achieve mild arterial hypertension due to hypervolae-
mia. The rate of ultrafiltration was adjusted to the patient’s hydration
level.
Results
The treatment administered to the patient led to establishing a diur-
esis of over 400 ml/day on day 6 after admission. CVVHD was discon-
tinued on day 11 of hospitalization, when the patient’s spontaneous
diuresis was 1,600 ml/day. Following CVVHD discontinuation, diuresis
was aided by the intake of mannitol and the continuous infusion of
furosemide. The patient was discharged on day 17 of hospitalization,
in the polyuric phase of up to 9,300 ml/day (eGFR 17.40 ml/min/1.73
m2).
Conclusions
A combination of intensive fluid therapy provided under haemo-
dynamic monitoring with continuous renal replacement therapy
using a large pore filter ensuring myoglobin filtration in patients with
acute renal failure caused by exertional rhabdomyolysis is a safe
method of patient management which may reduce kidney damage
and speed up the recovery of normal renal function after exercise-
induced rhabdomyolysis.
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Introduction
Cardiac surgery with cardiopulmonary bypass (CPB) triggers a sys-
temic inflammatory response syndrome (SIRS) that is associated with
postoperative morbidity and mortality. Steroids may attenuate this
response but there is currently controversy over its use. This SIRS is
associated with acute renal injury (AKI) during the ICU stay.
We aimed to assess the effects of two dosage of steroids in CPB in
AKI development during ICU stay.
Fig. 42 (abstract P505). Multivariate analysis
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Retrospective observational study of a cohort of patients that
underwent to cardiac surgery at our institution between 2006
and 2014. Two groups were compared, one group administers 1
gr of methylprednisolone (MTPN) during cardiopulmonary bypass
and another group administers 2 gr. AKI development during ICU
stay was defined as impaired renal function with elevation to
twice baseline creatinine or need of renal replacement therapy.
Demographic data, clinical and surgical variables were collected
from de Hospital database. Values expressed as mean +/- SD or
%. Significant variables in the univariate analysis were entered
into a multivariate logistic regression model to calculate the odds
ratio with confidence interval 95%.
Results
4573 patients; 64.8 males; 67.78+/- 11.13 years old; BMI 28.36 +/-
6.81; Logistic EuroScore 6.36 +/- 4.85; ICU stay 6.58 +/- 15.41
days; postoperative bleeding at first 24 hours 560.74 +/- 447.95
cc; preoperative haemoglobin 13.58 +/- 5.72 gr/ dL; preoperative
urea and creatinine 51.39 +/- 23.76; 1.13 +/- 0.57 mg / dl respect-
ively. By pass time 104.31 +/- 231.75; cross clamp time 71.76 +/-
32.74 minutes. Two groups were compared: group 1: MPNL (1 gr)
;group 2 with 2 gr of MPNL during CPB and analyzed its relation
with the development of AKI during ICU stay. Patients who re-
ceived higher doses of steroids had a lower risk of developing
AKI: Relative Risk 0.891, 95% CI (0.817 to 0.972) p = 0.009. Multi-
variate analysis showed that a dose of 2 grams of MTPN reduced
the incidence of AKI in the postoperative period of cardiac sur-
gery OR 1.44 95% CI (1.09 to 1.91) p = 0.012.
Conclusions
Higher dose of steroids was shown to reduce the incidence of AKI
after cardiac surgery.P505
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Introduction
An augmented renal clearance (ARC) has been described in some
critical patient groups [1]. The aim of this study was to identify fac-
tors predicting supranormal glomerular filtration in critically ill pa-
tients with normal plasma creatinine and polyuria.
Methods
This is a prospective study in a surgical and medical intensive care
unit (ICU). From October 2015 to October 2016, patients with normal
plasma creatinine and polyuria (>3 liters of urine / 24 hours) were in-
cluded. We exclude individuals referred from another hospital. Cre-
atinine clearance, sodium concentration and diuresis were calculated
from a 24-hours urine collection. Percentile 75th was determined to
define supranormal glomerular filtration (199 ml / min / 1.73 m2).
The logistic regression model was used to identify independent asso-
ciated variables.
Results
Thirty-six patients were included in the study. Twenty three patients
increased renal clearance (>130 ml / min / 1.73 m2). Nine (25%) pa-
tients were above 75th percentile (>199 ml / min / 1.73 m2). Seven
patients had a neurological cause of admission. In multivariate ana-
lysis, the volume of diuresis for 24 hours predicts ARC (Fig. 42).
Conclusions
A relationship between ARC, urinary sodium and diuresis volume
should be studied in a larger cohort of patients.
References
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Introduction
Several biomarkers have been suggested as early predictors of acute
kidney injury (AKI) after orthotopic liver transplantation (OLT). Systemic
and urinary neutrophil gelatinase-associated lipocalin-2 (NGAL) appear
to be promising predictors of AKI after OLT, but their clinical benefit re-
mains to be proven [1, 2]. Recently, systemic macrophage migration in-
hibitory factor (MIF) has been proposed as an early indicator for
requirement of renal replacement therapy after OLT [3]. We hypothe-
sized that either systemic or urinary MIF can predict the development
of AKI after OLT with comparable power as systemic and urinary NGAL.
Methods
This prospective, observational pilot study was performed at the Medical
University of Vienna after local ethics committee approval and registra-
tion at clinicaltrials.gov (NCT02695979). Concentrations of MIF and NGAL
were measured in serum and urine samples collected from patients
undergoing OLT. Acute kidney injury was classified according to the
KDIGO criteria, with stages 2 and 3 summarized as severe AKI. Areas
under the receiver operating curves (AUC) were calculated to assess pre-
dictive values of MIF and NGAL for the development of severe AKI.
Results
Forty-five patients (mean age 55 ± 8 years) were included. Nineteen
patients (38%) developed severe AKI within 48 hours after OLT. After
OLT, MIF concentrations in serum and urine were greater in patients
with AKI than those without AKI. In contrast, only urine NGAL con-
centrations, but not serum NGAL concentrations were greater in pa-
tients with AKI than those without AKI. At the end of OLT, serum MIF
was predictive of AKI (AUC 0.73; 95% confidence intervals, CI [0.55-
0.90]; P = 0.03), while urinary MIF, serum NGAL, and urinary NGAL
were not. On the first postoperative day, serum MIF (AUC 0.78; CI
[0.62-0.93]; P = 0.006), urinary MIF (AUC 0.71; CI [0.53-0.88]; P = 0.03),
and urinary NGAL (AUC 0.79; CI [0.64-0.93]; P = 0.02) were predictive
for AKI, while serum NGAL was not.
Conclusions
In the setting of OLT, serum MIF predicted severe AKI earlier than
serum NGAL and urinary NGAL.
References
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Introduction
A significant portion of patients does not achieve full renal recovery
by 90 days after an episode of acute kidney injury (AKI). This study
aimed to elucidate the factors that predict lack of full renal recovery
on Day 90 (D-90) in critically ill patients with AKI.
Critical Care 2017, 21(Suppl 1):58 Page 64 of 70Methods
The study population included all patients who showed KDIGO stage
2/3 AKI upon ICU admission or during ICU stay in a regional acute
hospital over the period 1/1/2011-31/12/2013 and who survived on
D-90. Patients with prior end stage renal failure were excluded. Renal
recovery was regarded as ‘full’ if serum creatinine (SCr) < =125%
baseline, which was defined as the lowest known SCr value in the
preceding 3 months before ICU admission.
Results
Among 3687 patients admitted to ICU during the study period, base-
line renal function was available in 87.3%. 843 patients fulfilled the
inclusion criteria. AKI was attributed to sepsis in 52.2%. 177 patients
(21.0%) did not achieve full renal recovery on D-90, and their charac-
teristics included older age (67.2 vs. 63.3 years, p = 0.004), lower body
weight (57.4 vs. 60.8 kg, p < 0.001), non-surgical admission diagnoses
(cardiovascular disease RR 1.85, renal disease 1.71), presence of co-
morbidities (diabetes mellitus RR 1.70, malignancy 2.04), lower serum
albumin level (27.0 vs. 28.7g/L, p = 0.012), lower hemoglobin level
(9.5 vs. 10.4 g/dL, p < 0.001), higher admission SCr (226 vs. 158 umol/
L, p < 0.001) and requirement of renal replacement therapy (34.5%
vs. 21.6%, p < 0.001) during ICU stay. Hypovolemia was a less fre-
quent cause of AKI in these patients (20.9% vs. 36.5% in patients
who had full renal recovery on D-90, p < 0.001). Logistic regression
analysis showed that diabetes mellitus, malignancy, admission for
cardiovascular disease, AKI unrelated to hypovolemia, SCr >110umo/
L and hemoglobin <10g/L on ICU admission were independent pre-
dictors for lack of full renal recovery on D-90.
Conclusions
Medical comorbidities (such as diabetes mellitus, malignancy, anemia
and cardiovascular disease), AKI not attributed to hypovolemia, and
elevated SCr level upon ICU admission are risk factors associated
with failure of full renal recovery at three months after an episode of
AKI in critically ill patients.
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Introduction
Peri-operative Acute Kidney Injury (AKI) is a well defined entity asso-
ciated with significant morbidity and mortality [1]. While several
serum and urine AKI biomarkers have been identified in the cardiac
surgery population [2], the predictive value of those markers in non-
cardiac surgical patients has not been extensively studied. The aim
of this prospective observational study was the evaluation of differ-
ent prognostic biomarkers in a cohort of patients undergoing elect-
ive major surgery.
Methods
61 patients, 67.1 ± 10 years old, with no chronic kidney disease (CKD)
stage IV or V undergoing elective major abdominal surgery were
studied. AKI was defined according to Acute Kidney Injury Network
(AKIN) criteria within 48 hours after surgery [3]. At pre-defined time
points [Pre-op (pre-operatively), RR (recovery room), Post-op (24 & 48
hours post-operatively)] the following biomarkers were measured:
Serum creatinine (Scr), Cystatine C (Scyst), Retinol Binding Protein
(SRBP), urine á1-microglobulin (Ua1-micr), â2-microglobulin (Uâ2-
micr), Transferrin (Utransf) and Albumin (Ualb). Fractional excretion
of sodium (FeNa) and urea (FeUr) were calculated as well.
Results
10 out of 61 patients (16.4%) developed AKI. In univariate analysis el-
evated Pre-op Ua1-micr value (p = 0.032), as well as elevated RR
levels of Scyst (p = 0.004) were strongly associated with peri-operative AKI development. At 24hours, post-op Scyst (p = 0.001),
SRBP (p = 0.002), Ua1-micr (p = 0.002), FeNa (p = 0.010) and FeUr (p =
0.007) were also strong markers of AKI. The remaining markers did
not differ significantly between the two groups.
Conclusions
Urine á1-microglobulin and serum RBP have been recognised as
markers of early tubular damage in diabetic nephropathy [4]. Our
preliminary results identified these two low-molecular weight pro-
teins as possible early markers of peri-operative AKI in a well-defined
cohort of non-cardiac surgical patients. With the exception of dia-
betic nephropathy and acute-on-chronic renal injury [5-7], this is the
first study recognising the potential of these two novel biomarkers
for early prediction of peri-operative AKI.
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Introduction
Bioelectrical impedance analysis (BIA) is a fast and non-invasive tech-
nique used to evaluate hydration status. As acute kidney injury (AKI)
remains one of the most common complications after cardiac sur-
gery, the aim of this study is to determine whether BIA can be used
to predict AKI.
Methods
This was a prospective observational study, conducted in cardiac sur-
gery centre of Vilnius University hospital Santariskiu Clinics. Consecu-
tive patients scheduled for elective cardiac surgery were enrolled
during a period of one year. BIA was performed one day prior sur-
gery; relevant demographic and clinical data was gathered. These pa-
tients were observed until discharge from hospital or up to one
month. Impaired renal function was defined by the Society of Thor-
acic Surgeons (STS) proposed criteria of renal failure (RF). The most
accurate BIA markers were selected and further analysed.
Results
618 patients were enrolled. Most of these patients were men
67% (n = 414), had a CABG procedure 61.5% (n = 380) and were
at low operative risk with a median Euroscore II value of 1.76
[1.06-2.50]. The mean values of BIA parameters were as follows:
ICW (mean = 25.67, SD = 7.68), ECW (mean = 16.40, SD = 4.69), TBW
(mean = 42.07, SD = 12.32), ECW/TBW ratio (mean = 0.39, SD = 0.01)
and phase angle (PA) (mean = 5.54, SD = 0.92). STS RF rate was
4.2% (n = 26). ROC AUC analysis of the BIA parameters revealed a
positive predictive effect of ECW/TBW (AUC = 0.63 CI95%: 0.51-
0.76 p = 0.021) and a negative predictive effect of PA (AUC = 0.63
CI95%: 0.51-0.74 p = 0.03) for RF. The univariate regression ana-
lysis of RF risk factors produced a standardized risk of 1.52 times
(CI95%: 1.13-2.06 p = 0.006) for 0.01 increase of ECW/TBW and a
risk of 1.66 times (95% CI: 1.07-2.60 p = 0.025) for a decrease of 1
degree of PA. These results are presented in Fig. 43.
Conclusions
BIA parameters can be used to stratify risk of RF for patients sched-
uled for cardiac surgery. However, further studies are needed to de-
termine whether these factors are independent of other predictors.
Fig. 43 (abstract P509)., Predictive risk of ECW/TBW and phase
angle for STS renal failure
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Introduction
Extracellular histones are cytotoxic molecules that are associated to
cell stress and cell death. Presence of extracellular histones has been
linked to multiple inflammatory–driven pathologies such as auto-
immunity, tissue injury and sepsis [1]. We previously showed that the
presence of extracellular histones correlates with mortality in sepsis
patients [2], a disease state in which histones are considered as im-
portant mediators in disease progression. A potential role for his-
tones in another condition in which tissue condition is considered of
vital importance, in organ donation and graft function and survival,
is still unknown. The aim of this study was therefore to assess
whether an association exists between the presence of extracellular
histones in machine perfusates and deceased donor kidney viability.
Methods
Extracellular histone H3 was determined in machine perfusates of
390 donation after circulatory death (DCD) kidneys by semi-
quantitative Western Blotting. Corresponding graft function and sur-
vival were assessed to study a potential association with the pres-
ence of histone H3 in the perfusate fluid.
Results
Extracellular histone H3 concentrations were significantly higher in per-
fusates of DCD kidneys with post-transplant graft dysfunction (primary
non-function (PNF) median 0.73μg/ml (IQR, 0.44-1.00), p < .001) and de-
layed graft function (DGF) (median 0.70μg/ml (IQR, 0.43–0.98), p
< .001)) compared to immediate functioning kidneys (median 0.42μg/
ml (IQR, 0.07–0.78)). We identified histone H3 as an independent risk
factor for both DGF (OR = 2.152 (1.199–3.863)) and one year graft failure
(HR = 1.386 (1.037-1.853)), but not for PNF (OR = 1.342 (0.900-2.002)).
Conclusions
Extracellular histone concentrations in perfusates of kidneys with
post-transplant graft dysfunction were significantly higher than in
those grafts that show an immediate function. Follow-up studies are
planned to further investigate the potential of cytotoxic extracellular
histones in the assessment of post-transplant graft function and sur-
vival, as well as possible histone-based interventions to optimize
graft preservation protocols.
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Introduction
Prolonged cold ischemia time (CIT) is associated with an increased is-
chemia and reperfusion injury resulting in an increased damage to
the graft, as well as a delayed graft function. The aim of this study
was to figure out the impact of prolonged CIT on the clinical course,
the inflammatory immune response and related cell cycle arrest,
respectively cell death.
Methods
In total, 91 patients were evaluated for short-term complications and
delayed graft function within 10 days after the kidney transplant-
ation. 48 patients received a graft from deceased donors, whereas 43
underwent living donor transplantation. Blood and urine samples
were collected before surgery, immediately after the end of the sur-
gical procedure, and 1, 3, 5, 7 and 10 days later. Plasma and urine
levels of total keratin 18 (total K18) and caspase cleaved keratin 18
(ccK18), plasma levels of Interleukin-6 (IL-6) and urine levels of
insulin-like growth factor-binding protein-7 and tissue inhibitor of
metalloproteinase-2 (IGFBP-7/TIMP-2) were measured.
Results
An initial interim analysis of one third of all participating patients re-
vealed a significantly prolonged CIT in patients undergoing kidney
transplantation from deceased donors, resulting in an increased in-
flammatory response as well as a significantly increased necrotic cell
death. In these patients urinary IGFBP-7/TIMP-2 and plasmatic total
keratin 18 was demonstrated to be of value for the detection of a
delayed graft function in the early phase after kidney transplantation
as assessed by receiver operating characteristic (ROC)-analyses.
.
Conclusions
For early identification of patients at high risk for delayed graft func-
tion, the implementation of IGFBP-7/TIMP-2 and total keratin 18 mea-
surements in routine diagnostics after kidney transplantation should
be taken into consideration.
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Introduction
Acute kidney injury (AKI) in critically ill patients is associated with in-
creased morbidity and mortality. The renal resistive index (RRI), de-
rived from the Doppler spectrum of segmental and interlobar
arteries, is a rapid, non-invasive diagnostic technique, mainly studied
in assessing renal-allograft status, that has been recently proposed to
predict renal outcomes in critically ill patients [1]. The objective of
our study was to evaluate the accuracy of RRI measurement on In-
tensive Care Unit (ICU) admission in detecting acute kidney injury
(AKI) development the upcoming 48 hours.
Methods
We performed a prospective observational study in a multidisciplin-
ary university ICU. Patients requiring mechanical ventilation, without
pre-existing chronic renal failure were enrolled. Clinical data includ-
ing serum creatinine and urine output were collected. Illness severity
scoring systems (APACHE II and SOFA) were calculated on the first
ICU day. The RRI was calculated according to the following formula:
RRI = (peak systolic velocity – end-diastolic velocity)/peak systolic
Critical Care 2017, 21(Suppl 1):58 Page 66 of 70velocity as the average of all measured values. The index was mea-
sured within the first 24 hours of ICU admission, after initial
hemodynamic stabilization. AKI was defined according to the Kidney
Disease Improving Global Outcomes (KDIGO) Clinical Practice Guide-
lines [2]. ROC curves were constructed in order to evaluate the AUC
of RRI for AKI prediction.
Results
Sixty-three mechanically ventilated, critically ill patients were in-
cluded in the study, (median age 66 years, 55% were males). Me-
dian values for APACHE II and SOFA scores were 18 and 9,
respectively. AKI developed in 24 patients (38%) during the first
48h post-ICU admission; 14 patients (22%) had AKI already on
ICU admission. Continuous renal replacement therapy (CRRT)
underwent 44% of patients with AKI and the all-cause ICU mor-
tality rate was 38%. AUC of RRI for AKI diagnosis on admission
was 0.94 (CI: 0.86-1.0), while for AKI prognosis within the first
48h after admission (in the subset of patients who had no AKI
on admission) was 0.96 (CI: 0.90-1.0). The total predictive ability
of RRI for AKI development (both diagnosis and prognosis) within
the first 48h after ICU admission was 0.95 (CI: 0.88-1.0). AUC of
RRI for CRRT initiation prediction during ICU stay was 0.81 (CI:
0.69-0.93).
Conclusions
These results suggest that an increased RRI on ICU admission may be
used as a predictor of AKI development early in the course of ICU
stay.
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Introduction
Few studies reported the deleterious association between Acute Re-
spiratory Distress Syndrome (ARDS) and development of Acute Kid-
ney Injury (AKI). We aimed to evaluate the association of AKI defined
by Acute Kidney Injury Network (AKIN) criteria and poor outcome in
ARDS patients.
Methods
Sixty four patients admitted with ARDS and mechanically ventilated
were enrolled. In addition to routine labs and APACHE II score, lung
injury severity scores (LISS) were calculated upon admission and after
one week. Degree of renal impairment was assessed using AKIN cri-
teria (grade 1, 2, 3). Patients were stratified into 2 groups according
to their degree of renal impairment. Patients were followed during
their hospital stay. All data were statistically analyzed.
Results
The mean age of the studied patients was 47.23 ± 10.12 years; 33
(51.6%) were males. Mean PO2/FIO2, and LISS on admission were
169.95 ± 31and 3.06 ± 0.54 respectively. In 27 (42.2%) of patients who
had significant renal impairment, 15 (23.3%) and 12 (18.8%) patients
had AKIN grade 2, and 3 respectively. In these patients, the follow up
LISS and length of hospital stay were significantly higher compared
to other patients: 3.33 ± 0.74 points, and 19.11 ± 6.37 days, and vs
2.84 ± 0.57, and 12.38 ± 4.21, with P value 0.004, and <0.001 respect-
ively. Also, they had a higher need to use vasoactive agents; 21
(55.3%) patients vs 6 (23.1%) and spend more days on mechanical
ventilation 14.18 ± 4.59 days vs 8.51 ± 3.77, with P value 0.019 and
<0.001 respectively. Inpatient mortality was significantly higher in pa-
tients with significant renal impairment compared to others; 18
(66.7%) vs 6 (23.1%), P value 0.019.
Conclusions
AKI defined by AKIN criteria is associated with poor outcome in ARDS
patients.References
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Introduction
Renal ischemia-reperfusion injury is a common cause of acute
kidney injury in intensive care and surgery. Besides the acute
ischemic injury the reperfusion causes additional harm to the
tissue, possibly by formation of free oxygen radicals and
microcirculatory derangement. Recently novel mono-organic
nitrites of 1, 2-propanediol (PDNO) were synthetized and
shown to rapidly and controllable deploy NO in the circulation
when administered intravenously. We hypothesized that
intravenous infusion of PDNO during renal ischemia reperfu-
sion would improve post-ischemic renal function and
microcirculation.
Methods
Sixteen sheep were anesthetized, mechanically ventilated and sur-
gically instrumented. The left renal artery was completely
clamped for 90 min and the effects of ischemia and reperfusion
was studied for a total of 8 hours. 15 min prior to the release of
the clamp an intravenous infusion of PDNO (n = 8) or vehicle (1,
2 propanediol + inorganic nitrite, n = 8) was initiated (180 nmol/
kg/min for 30 min, thereafter 60 nmol/kg/min for the remainder
of the experiment).
Results
Renal artery blood flow, cortical and medullary perfusion, diur-
esis and creatinine clearance decreased in the left kidney post
ischemia. However, in the sheep treated with PDNO urine
production and creatinine clearance was significantly higher
post ischemia compared to vehicle treated animals (1.7 ± 0.5 vs
0.7 ± 0.3 ml/kg/h, p = 0.04 and 7.5 ± 2.1 vs 1.7 ± 0.6 ml/min, p =
0.02, respectively). This was associated with an augmented im-
provement in left renal medullary perfusion and oxygen uptake
in the PDNO-group (73.1 ± 9.2 vs 37.4 ± 4.9 percent of baseline,
p = 0.004 and 2.6 ± 0.4 vs 1.6 ± 0.3 ml/min, p = 0.02, respectively.
Mean arterial blood pressure was significantly reduced by PDNO
(82.6 ± 2.6 vs 93.6 ± 2.8 mmHg, p = 0.008) but was still within
normal limits. Importantly, total renal blood flow was not af-
fected and there were no signs of increased blood
methemoglobin concentrations.
Conclusions
The impairment in renal function and microcirculation caused by
ischemia and reperfusion was blunted by intravenous infusion of
the novel NO donor PDNO. This effect was achieved without
severe systemic hypotension or a significant increase in
methaemoglobinemia.
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Our aim was to analyze the impact of cumulative fluid balance (CFB)
estimated at the start of renal replacement therapy (RRT) and during
treatment in critically ill patients with acute kidney injury (AKI) on
outcome.
Methods
Retrospective analysis of patients who received RRT for AKI in a
multidisciplinary University Hospital based Intensive Care Unit (ICU).
Total CFB on the day of RRT initiation was estimated in ml and % of
baseline body weight (BW).
Patients’ demographics, anthropometrics, laboratory data and Se-
quential Organ Failure Assessment (SOFA) scores were collected. Out-
comes of interest were hospital mortality and length of stay in ICU.
Results
1030 patients received acute RRT of whom 43.5% died in hospital.
The median CFB on day of initiation of RRT was 1076ml (1.38% of
BW). (Fig. 44)
Patients with CFB >10% BW had a significantly higher hospital mor-
tality but were also sicker. (Table 21)
There was a significant association between CFB at initiation of RRT
and mortality and between CFB on the last day of RRT and mortality.
Conclusions
In critically ill patients with AKI, CFB at initiation of RRT and at discon-
tinuation of RRT was associated with hospital mortality.Fig. 44 (abstract P515). CFB on first day of RRT
Table 21 (abstract P515). See text for description
Parameters CFB ≤10% BW CFB >10% BW p
Age in years, mean 62.8 63.8 0.55
SOFA score on 1st day of RRT, mean 10.1 11.5 0.0002
Days in ICU, mean 13.8 21.3 0.0001
Hospital mortality 0.42 0.54 0.025
Legend: Comparison between patients with CFB above and below 10% BW










All complications (n) 5 36 41 5 <.001
CRB (n) 4 12 16 4 <.005
Dysfunction(n) 2 25 27 2 <.005
Legend Table 22:P516
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Introduction
The use of central venous catheter (CVC) both as temporary and per-
manent haemodialysis access is increasing; nonetheless there are
few recent studies comparing the outcome of long-term dialysis CVC
(LT-CVC) and short-term dialysis CVC (ST-CVC). Consequently the aimof the present study is to analyze the side events and the complica-
tions related to ST-CVC and LT-CVC inserted in patients included in a
haemodialysis program at our centre.
Methods
We analyzed retrospectively, based on a computerized prospectic
system of data collection, personal and clinical data of a group of pa-
tients enrolled in a dialysis program, technical features of the cathe-
ters in use, unexpected events and catheter-related complications
Results
The outcome of 153 catheter were analysed (72 patients, 14.008
catheter-days, 34 long-term dialysis catheter, 119 short-term dialysis
catheter). Removal for complications was less common with LT-CVC
and jugular ST-CVC (IR respectively of 0.6 and 1.7 per 1000 catheter-
days) than with femoral ST-CVC (IR of 12 per 1000 catheter-days, P <
0.001). Catheter-related bacteraemia (CRB) rates were 0.5 per 1000
catheter-days for LT-CVC, 1.4 for jugular ST-CVC and 4.0 for femoral
ST-CVC. No significant differences were found between LT-CVC and
jugular ST-CVC (Table 22). Complication-free survival of femoral ST-
CVC was worse already within the first weeks (P < 0.001).
Conclusions
Based on our results, no significant difference was found in complica-
tions and unexpected events derived from the use of LT-CVC and
jugular ST-CVC, while the dialysis femoral ST-CVCs show an high but
predictable incidence of complications within the first weeks. Our
findings point out that jugular ST-CVC could be used longer than ex-
pected but a new evaluation of catheterization techniques is still
needed.P517
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Introduction
Regional citrate anticoagulation (RCA) is recommended as standard
anticoagulation mode for continuous renal replacement therapy
(CRRT). A major complication of RCA-CRRT is systemic citrate accumu-
lation. We studied the predictive capability of lactate concentrations
and time-dependent lactate clearance for citrate accumulation.
Methods
We performed the retrospective, observational study at a university
hospital with 6 ICUs. Included patients treated with RCA-CRRT were
screened for metabolic signs of citrate accumulation during the first
48 hours of treatment.
Results
During the observational period of 3 years, a total of 1061 patients
treated with RCA-CRRT were included in the analysis. Citrate accumu-
lation during the first 48 hours of therapy was observed in 24 pa-
tients (2.26%). Patients were further stratified according to the initial
lactate concentration before RCA-CVVHD: the incidence of citrate ac-
cumulation was 0.77%, 4.67% and 6.33% in patients with normal lac-
tate, elevated lactate (≥2.2 mmol/L), and severe hyperlactatemia (≥4
mmol/L) respectively. ROC-AUC of initial lactate concentration for the
prediction of citrate accumulation was 0.789 (95% CI 0.714–0.864, p
< 0.001). Optimal cut-off from ROC (2.39 mmol/L) showed strong
negative prediction (99.28%; 95% CI 98.33–99.77%), but weak posi-
tive prediction (5.21%; 95% CI 3.16–8.01%). The slope-intercept of
lactate kinetic over 48h was positive and significantly higher in
Critical Care 2017, 21(Suppl 1):58 Page 68 of 70patients with citrate accumulation compared to those without (+0.2
vs. -0.006 mmol/L/h, p < 0.001). In the group of patients with initial
severe hyperlactatemia (≥4 mmol/L) the median calculated lactate
clearance at 6h, 12h and 18h was at each time-point positive and
significantly higher compared to patients with citrate accumula-
tion (24.0% vs. -9.8%, 48.1% vs. -20.5% and 59.4% vs. 2.3%,
respectively; p < 0.001 for each time-point). The 12h lactate
clearance showed the highest ROC-AUC value for citrate accumu-
lation (0.839; 95% CI 0.751–0.927) with an optimal cut-off value
of 24.3%.
Conclusions
The risk of citrate accumulation during RCA-CRRT is low even in cases
with initially severe hyperlactatemia. Our study stress out the import-
ance of lactate kinetics in assessing a risk of citrate accumulation.P518
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Introduction
In all RCA protocols used for CRRT citrate is partially infused into
patient and metabolized, thus leading to alkalization of blood
and risk of metabolic alkalosis. When using trisodium citrate solu-
tion for RCA, protocol has to compensate for extra sodium, as
well as for alkalization from metabolized citrate. In RCA-CVVHD
using calcium-free, sodium-reduced, and bicarbonate-reduced di-
alysate (Ci-Ca Dialysate, Fresenius Medical Care) and calcium (Ca)
substitution, filter clearance is essential to maintain bicarbonate
(BIC) and electrolyte control. In consequence, loss of filter clear-
ance may cause metabolic alkalosis, hypercalcemia, and hyperna-
tremia resistant to per protocol adaptions. Aim of study:
Evaluation of incidence of metabolic/electrolyte disturbances con-
sistent with loss of filter clearance and outcome of disturbances
after filter change.
Methods
During a 6 months period 191 consecutive patients were treated
with RCA-CVVHD on 6 ICUs of a university hospital and prospectively
observed for disturbances consistent with loss of filter clearance.
Results
From 191 patients, 13 (6.8%) showed at least one episode of meta-
bolic alkalosis with hypernatremia and hypercalcemia, resistant to
per protocol adaptations. None of the circuits gave pressure alarm.
Filter was replaced after detection of disturbance. Median filter run-
time until change was 63 h (range: 8 to 72). Median BIC showed sig-
nificant increase at time of filter replacement (33.9 mmol/L; 95%CI
31.5–36.4; max 42.0), compared to values 48 hours (25.6 mmol/L;
95%CI 24.5–29.3) before replacement (p = 0.009). After filter change
BIC decreased, reaching significant decrease at 24 h (27.9 mmol/L;
95%CI 27.0–30.7; p = 0.037). Ionized Ca also showed significant in-
crease (1.22 mmol/L; 95%CI 1.18–1.31; max. 1.39) compared to 48 h
(1.16 mmol/L; 95% CI 1.11–1.20) before replacement (p = 0.009). After
filter change Ca decreased, reaching significant decrease after 16 h
(1.11 mmol/L; 95%CI 1.05–1.15; p = 0.038). Blood sodium increased
until filter replacement (148 mmol/L; 95%CI 145–149; max 154) com-
pared to 48 h before change (144 mmol/L; 95% CI 142–146) without
reaching significance (p = 0.140). After filter change sodium de-
creased to 141 mmol/L (95%CI 140-146) at 48 h (p = 0.305).
Conclusions
During RCA-CVVHD using calcium-free, sodium- and bicarbonate-
reduced dialysate the incidence of metabolic and electrolyte distur-
bances consistent with reduced filter clearance is high and can occur
after short filter run-time. Caution must be taken unless metabolic al-
kalosis can be severe and immediate filter replacement is mandatory
to correct disturbances. Further analysis is necessary to understand
causes of early reduced filter clearance.P519
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Introduction
In citrate CVVH it has been established that a post-filter ionized Cal-
cium (iCa) of below 1.4 mg/dL (0.35 mmol/L) is associated with a clin-
ically significant and usable anticoagulant effect [1], promoting
circuit survival. However, recent studies have demonstrated the limi-
tations of measurements of low iCa (including high variance) on
standard apparatus [2]. As part of larger prospective randomized
study conducted in critically ill patients with AKI, treated with citrate
CVVH, citrate concentrations were measured post-filter and com-
pared to post-filter iCa values to establish a functional, clinically ap-
plicable threshold for anticoagulation, utilizing post-filter citrate
concentration (PfC) as marker instead of iCa.
Methods
After written, informed consent, randomization took place to low dose
citrate (2.5 mmol/L blood flow in the filter) or high dose citrate (4.5
mmol/L) as anti-coagulant, targeting a post-filter iCa of resp. 1.3-1.6
mg/dL (0.325-0.4 mmol/L) and 0.8-1.1 mg/dL (0.2-0.275 mmol/L). After
adjusting blood flow for patient weight, settings on the Prismaflex®
were adjusted to ensure the citrate concentrations in the filter by
adjusting pre-filter citrate buffer rates (Prismocitrate 18/0®) and to cor-
rect for predilution. By adjusting buffer rates post-filter (Prismocal B22®)
accordingly, a total clearance of 30 ml/kg/h was ensured. To limit the
effects of citrate accumulation, values for PfC were measured 1 hour
after initiation of CVVH and compared to iCa. The same blood gas ana-
lyser was used in all measurements (ABL800 radiometer®) for iCa.
Results
12 patients were included in the high citrate group, 12 in the low
group. There were no differences between the 2 groups for gender,
weight, age, or total and ionized calcium at initiation of CVVH. After
1 hour of CVVH, the median iCa in the high group was 1.13 mg/dL
(IQR 0.35) vs.1.92 mg/dL (IQR 0.31) in the low group (p < 0.05). Me-
dian Pfc in high was 790 mg/L (IQR 89) vs. 512 mg/L (308) in low (p
< 0.05). There was a strong inverse correlation between PfC and iCa
(r = -0.641, p < 0.005).
Conclusions
The (inverse) correlation between PfC and iCa is robust. Based on the
line of correlation plotted, a PfC value above 700 mg/L signifies clinic-
ally significant anticoagulation. Further commercialization of assays for
measurement of citrate concentrations could lower costs and deem iCa
measurement, with its recently described drawbacks, redundant. Fur-
ther studies, utilizing PfC, could play a role in determining minimal cit-
rate concentrations needed for circuit survival over longer periods and
for the limits of citrate dosing before accumulation takes place.
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Introduction
Acute kidney injury (AKI) is of high prevalence in critically ill patients
and is associated with an important morbidity and mortality (1). Con-
tinuous renal replacement therapy (CRRT) is a common modality in
its treatment (2). Besides the primary aim to substitute impaired renal
Critical Care 2017, 21(Suppl 1):58 Page 69 of 70function, a secondary, unintentional phenomenon is carbon dioxide
clearance. The purpose of this pilot study is to quantify the clearance
of carbon dioxide by CRRT.
Methods
In a pilot setting of a hemodynamically en metabolic stable, critically
ill patient with AKI and continuous venovenous hemofiltration
(CVVH), on several points of the circuit (Fig. 45) blood sampling and
analysis were performed. This during a standard CRRT run with and
without citrate anticoagulation and without bicarbonate use in the
predilution fluid. A software calculator was designed to quantify car-
bon dioxide removal. Necessary parameters are CVVH effluent flow,
predilution and postdilution flow.
Results
Differences in pCO2 are not contributive as a quantitative measure-
ment due to dilution of the blood passing through the circuit. In this
context CO2 content was calculated using flow values. The overall re-
moval of CO2 was 29ml/min or 70 mmol/h, an equivalent of 24% of
CO2 content in a circuit with citrate. Without citrate we found a
clearance of 27ml/min or 54 mmol/h equal to 19% of CO2 content
removal.
Conclusions
CVVH for traditional ICU use had a hidden component which can be
calculated: the extraction of CO2. This hidden force can rise to 24%
of CO2 content.
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Introduction
Metabolic acidosis is a common event among patients with multiple
organ failure. When it is caused by an impaired carbohydrate metab-
olism due to hypoxia, lactic acidosis may occur increasing blood lac-
tate and reducing pH. Our group has integrated the treatment of
acidosis into an Advanced Organ Support (ADVOS) system based on
albumin dialysis. It consists of 3 circuits that allow elimination ofwater and protein bound toxins, regeneration of the albumin used in
the process and stabilization of pH [1]. The aim of this work is to
show these features of the ADVOS system by means of lactate elim-
ination, pH stabilization and bilirubin clearance in an ex vivo model
for metabolic acidosis and comparing them with a normal renal dia-
lysis machine (NIKKISO DBB-03).
Methods
An ex vivo model for metabolic acidosis with liver involvement was
designed setting a continuous infusion of lactic acid into 5 liters por-
cine blood, which was spiked with bilirubin (275 mg/dl) before. Blood
was dialyzed through the ADVOS system for 2 hours at 200 and 400
ml/min blood flow (BF). A dialysate pH of 9 was set. To determine
the maximum lactate addition and removal, lactic acid infusion was
progressively increased until blood pH was out of physiological
ranges. Once the maximum addition was determined, tests were re-
peated with the NIKKISO machine using a BF of 400 ml/min. Lactate,
pH and bilirubin levels were analyzed pre- and post-dialyzer every 15
minutes. Blood was checked for hemolysis at the beginning and the
end of the experiments.
Results
The ADVOS system was able to stabilize the blood pH in a physio-
logical range till a maximum lactic acid addition of 3.1 mmol/min (BF
400 ml/min). Moreover, with a BF of 200 ml/min up to 1.9 mmol/min
(75%) of lactate was eliminated, which would result into a proton
elimination of 4,464 mmol/day. Additionally, the ADVOS system re-
moved significantly more bilirubin from blood as the NIKKISO DBB-
03 machine (66% vs. 21%). Although the NIKKISO DBB-03 machine
achieved a higher lactate elimination rate of 80%, blood pH de-
creased to 6.90.
Conclusions
During a continuous infusion of up to 3.1 mmol/min of lactic acid in
an ex vivo model for metabolic acidosis, blood pH decreased to 6.90
under conventional hemodialysis. With the ADVOS system, blood pH
remained stable between 7.35 and 7.45 and additionally an efficient
elimination of bilirubin was achieved. Hence, ADVOS has a potential
advantage for the treatment of critically ill patients with multiple
organ failure.
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Introduction
Ultrasonography of inferior vena cava (IVC) is a guide to estimate
central venous pressure [1]. Lung ultrasound is an effective method
of evaluating extravascular lung water (EVLW) [2]. The observation of
B-lines resolution and the collapse index of IVC represent a valid
guide to improve continuous renal replacement therapy (CRRT) man-
agement. The aim of this work was to demonstrate the role of chest
and IVC ultrasound in the assessment of the variation of fluid status
in patients undergoing CRRT.
Methods
We enrolled patients undergoing CRRT during their ICU stay. Patients
were assessed for lung and IVC ultrasound immediately before CRRT
(T0) and after 12 (T12), and 24 (T24) hours. B-lines were counted and
the reduction of IVC diameter was measured using the collapse
index. We also recorded for each patient at T0 and T24: PaO2/FiO2,
Leukocytes (WBC), Procalcitonin (PCT), and the volume of fluid
removed. We obtained written informed consent from the patients.
Results
A total of 14 patients undergoing CRRT were recruited. PaO2/FiO2
ratio, PCT and WBC count improved in all patients from T0 to T24. B-
lines resolution was also reached in all patients as demonstrated by
a Comet-Score. (Fig. 46)
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abdominal surgery. Moreover, one of them suffered from a severe tri-
cuspidal valve failure, making it the measure not reliable. Therefore,
we measured the IVC collapsibility index (Δ ø IVC %) in 10 patients;
the collapsibility index did not significantly change before and after
CRRT.
Conclusions
We found that fluid removal during CRRT can be clearly monitorized
by chest ultrasound. Lung chest ultrasound is a non-invasive, simple
method performed at the bedside that provides accurate information
on EVLW variations and, consequently, very useful for an appropriate
management during CRRT.
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Introduction
Continuous renal replacement therapy (CRRT) is a common neces-
sity in ICUs, whether for those with end-stage renal disease
(ESRD) or those with acute kidney injury (AKI). Mortality is highin both situations, with reported rates above 50% in centres of
excellence [1, 2]. Recovery of renal function among survivors of
an acute insult is usually good [1] but some suffer long-term
renal impairment as a consequence. Our aim was to examine
short- and long-term mortality and recovery of renal function
among patients requiring CRRT in ICU. Our goal was that findings
from this study would support evidence-based decision making
among intensivists when faced with critical illness and the poten-
tial need for CRRT.
Methods
All patients admitted to our centre’s ICU between January 1st 2012 and
December 31st 2014, who required CRRT, were included in the study.
Information gathering was from the patient data on these records
and public death records.
Results
Our cohort was of 450 patients, with a median APACHE II score on
admission of 27.8. Overall in-hospital mortality among patients re-
quiring CRRT was 46% (n = 208). Mortality in ICU was 37%. The in-
hospital mortality rate in medical patients was 52%, and the rate was
higher in AKI patients (48.5%) than in ESRD patients (31.7%). At one
year, mortality for the total population was 54%. Outcomes for ESRD
patients at one year are poorer than in the short term, with 17% of
ESRD patients who survived to discharge dying within the next year,
compared to 14% of AKI patients. Regarding renal function, we
found a dialysis-dependency of 34% among survivors to ICU dis-
charge; when those with known ESRD were excluded, the rate was
21%. Among those with AKI who survived to hospital discharge, the
dialysis-dependency rate was 7%.
Conclusions
Our data show a varying pattern of concordance with previous work.
Overall mortality is lower both in the short- and long-term than in
other countries [1, 3], but this may reflect differences in study popu-
lations and pre-admission medical status, rather than truly different
outcomes. In those with ESRD, our work shows that although they
may be considered high-risk patients for ICU, their outcomes are
equal and often superior to AKI patients; this may influence intensi-
vists to more readily accept these patients to a higher level of care.
Finally, regarding recovery of renal function, our analysis suggests
that the risk of lasting renal failure in survivors of acute insults requir-
ing CRRT, is low.
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